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ABSTRACT
Given the seriousness of obesity as a health issue, accurate measures of
obesity are important for research, diagnostic and weight loss programmes.
The standard accepted measure is body mass index (BMI), but over-reliance
on BMI and body mass is a limitation of current research and the need for
more sensitive measures of body composition is recognised. The work
described in this thesis compared the utility of traditionally used
anthropometric measures (TAM)1 with alternative anthropometric measures
(AAM)2.
Study One compared change in TAM with change in AAM in individuals on a
self-determined weight loss programme. It was hypothesised that AAM would
show greater magnitudes of change than TAM. Level I ISAK3 anthropometric
assessments were conducted monthly on 10 male (58.5 ± 16.5 years) and
50 female (52.2 ± 14.9 years) overweight/obese individuals over a year.
L8SF and endomorphy showed significantly greater magnitudes of change
than body mass and WHR, however comparable magnitudes of change to
BMI and %BF. Thus, the hypothesis was accepted for L8SF and
endomorphy compared to mass and WHR only. L8SF represents body
composition and does not require transformation from other variables.
Furthermore, it showed significant change that weight-related parameters
failed to identify. Therefore it is concluded that this measure could be used to
monitor weight loss. Conversely, the benefits of somatotype were less
evident and due to the time and expertise required to obtain these measures,
it is concluded that somatotype should not be considered for routine use.
Study Two examined if anthropometric measures were correlated with
psychological risk factors. Participants in Study One completed Fox &
Corbin's Physical Self-Perception Profile (PSPP) measuring constructs of
1Traditionally used anthropometric measures (TAM): BMI, body mass, waist-hip-ratio (WHR)
and percent body fat (%BF).
2 Alternative anthropometric measures (AAM): sum of 8 skinfolds (L8SF), global somatotype
and somatotype sub-components; endomorphy, mesomorphy and ectomorphy.
3 International Society for the Advancement of Kinanthropometry (ISAK)
physical condition, body attractiveness and physical self-worth. It was
hypothesised that MM would show stronger correlations to PSPP constructs
than TAM. Findings identified that high BMI, body mass, %BF, I:SSF and
endomorphy were associated with low physical self-perceptions. However
there were no differences in the strength of relationships with MM or TAM,
and changes in PSPP constructs showed weak correlations with changes in
both measures. Thus the hypotheses were rejected. It is concluded that
focusing on health-related behaviours, as opposed to reducing
anthropometric measures, may be a more constructive approach to reducing
obesity.
Study Three tested the hypothesis that MM would show stronger
associations to markers of metabolic syndrome (MetSyn) than TAM. Level I
ISAK3 profiles were conducted on 6 male (47.9±1S.0 years) and 20 female
(43.4 ± 17.4 years) overweighUobese participants on self-determined weight
loss programmes. Blood markers" were measured through capillary fingertip
blood samples. Waist circumference, systolic and diastolic blood pressure
were recorded to obtain all the diagnostic criteria for MetSyn. All measures
were repeated after a 6-month interval. BMI and mass showed strongest
correlations with MetSyn markers and moderate relationships were identified
between weight loss and improvement in MetSyn components. The
hypothesis was rejected. It is concluded that the clinical utility of somatotype
measures in assessing change in MetSyn status appears limited and weight
loss should be the first line treatment of MetSyn.
In conclusion, somatotyping appears to have limited utility for monitoring
change in overweighUobese individuals and no obvious benefit in assessing
an individual's health status from a physiological or psychological standpoint.
However I:SSF, that reflects changes in body composition and is sensitive to
change, may be a useful measure to monitor weight loss in
overweighUobese individuals.
3 ISAK:International System of the Advancement of Kinanthropometry
4 Blood markers: High density lipo-protein cholesterol, blood glucose and triglycerides
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1. INTRODUCTION
1.1 Statement of the problem
In 2005, the World Health Organisation (WHO) estimated that there were 1.6
billion overweight adults aged 15 years and above and at least 400 million
obese adults, worldwide. Over the last quarter of a century the prevalence of
obesity in Great Britain has almost trebled (Rennie & Jebb, 2005) and figures
from the Health Survey for England (2007) estimated that 24% of men and
25% of women were classified as obese. In 2003, estimates identified that
the UK had the highest percentage of deaths (8.7%) attributable to excess
weight in Europe (Banegas et al., 2003).
The negative impact of obesity on health is considerable, including increased
risk of several chronic diseases such as type II diabetes mellitus (Bray,
2003), hypertension (Francischetti & Genelhu, 2007), stroke (Abraham &
Llewellyn-Jones, 2001), cardiovascular disease (Allender & Rayner, 2007;
Hu et al., 2005) and cancer (McMillan et al., 2006). Moreover, obesity is
associated with an increased risk of discrimination and bias in situations
concerning employment (Pingitoire et aI., 1994; Roehling, 1999), healthcare
(Oberrieder et al., 1995; Wadden et al., 2000) and education (Neumark-
Sztainer et aI., 1999). For some obese individuals these stigmatisations,
discriminatory attitudes and behaviours can trigger or exacerbate
psychological issues such as decreased mood, increased anxiety, low self-
esteem and body image disturbances (Lawrence & Kopleman, 2004;
Swinburn & Egger, 2004).
In addition to the negative physiological and psychological health outcomes
associated with obesity, there is also an increasing economic burden of
obesity on a national and global scale. Direct costs of obesity are estimated
to cost the British economy more than £3.6 billion a year. Including all people
who are overweight this cost could rise to between £6.6 and £7.4 billion
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(Donnellan, 2003), and with the addition of the wider cost to the economy in
lower productivity and reduced output, this could rise by a further £2.1 billion
a year (National Institute for Clinical Excellence, 2003). Therefore, it is
apparent that both the individual and economic costs of obesity are prevalent
and development of appropriate strategies to counteract obesity is urgently
needed.
Current projections suggest that the prevalence of overweight and obesity is
likely to continue to rise (James, 2004) and it is evident that reliable and valid
measures of adiposity are needed to monitor these changes (Nevill et al.,
2006). The measurement of obesity is an area that has been extensively
researched and the standard measure that is currently accepted is that of
body mass index (BMI), measured in kg.m-2 (Carmichael, 1999; Romero-
Corral et al., 2008). However, despite the ease and simplicity of this method,
BMI does not distinguish fat from muscle, bone and other lean body mass
(Burkhauser & Cawley, 2008; Garcia et al., 2005; Norton & Olds, 1996).
Therefore, it is impossible to determine accurately if a fluctuation in body
weight is due to a change in muscle, body water, or fat (Sargent et al., 2000)
and BMI can give very misleading measures of the progress of fat loss
(Prentice & Jebb, 2001). Furthermore, although weight gain associated with
adverse physiological outcomes and increased morbidity, increases in a
linear fashion with increases in BMI (Allan, 2004; Aronne & Segal, 2002),
increased risk also relates to total body fat and body fat distribution
(Burkhauser & Cawley, 2008; Eckel, 1997; Heyward & Wagner, 2004;
Snijder et al., 2006).
Abdominal fat has been shown to provide an independent risk estimate
beyond BMI alone (Sharma & Kushner, 2009), thus waist circumference
(WC) and waist-to-hip-ratio (WHR) are anthropometric measurements
recommended for routine use (Foreyt & St Jeor, 1997; Koning et al., 2007).
Many researchers have declared WC the preferential method over the WHR
to define obesity (Chan et al., 2003), thus WC is the preferred index for
monitoring weight loss (Gibson, 2005). However, although in population
2
studies BMI andwe are considered reasonable surrogate measures of body
and visceral fat, respectively (Lean et aI., 1996; Rankinen et aI., 1999), when
applied to individuals they lack sensitivity and specificity (Eston, 2002;
Wellens et al., 1996). Furthermore, changes in BMI and WC do not always
reflect improvement in overall health or functioning (Sharma & Kushner,
2009).
Direct and indirect techniques to measure body constituents have been
developed, with different levels of accuracy, practicality, and cost (Foreyt &
Jeor, 1997; Sardinha & Teixeira, 2005). These include hydrostatic weighing,
scanning by dual-energy x-ray absorptiometry (DXA), computerised
tomography (C'T), magnetic resonance imaging (MRI) and bioelectrical
impedance (BIA) (Heyward, 2001; Pontiroli et aI., 2002. Although these
approaches achieve reliable results, the instrumentation is expensive,
impractical for individual use and cannot be easily transported to test sites in
large-scale intervention and epidemiology projects (Foreyt & Jeor, 1997; Van
Loan, 1997).
1.2 Purpose and significance of research
Weight loss and weight management programme effectiveness are often
based solely on participant weight change and/or change in BMI (Busetto et
al. 2004; Dansinger et al., 2005; Ensrud et al., 2003; Roux et al., 2004; Thai
& Wadden, 2005). However, there is much research evidence documenting
the limitations of weight-related parameters to provide reliable assessment of
body fat and its distribution over time (Burkhauser & Cawley, 2008; Garcia et
al., 2005; Miller et al., 2000; Nevill et al., 2006; Sargent et al., 2001; Sharma
& Kushner, 2009). Consequently, there is a need for measures of body
composition that are sensitive to intra-individual change (Teixeira et al.,
2005).
Determining the thickness of the skin at specific sites is the simplest and by
far the most widely used method of gaining useful estimations of body fat
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(Sharp, 1995). Together with girth measurements, they are useful for
monitoring body composition changes over a period of time (Bean, 1996). As
identified by Nevill et al. (2006), both BMI and skinfolds are encompassed in
a further measurement system known as 'somatotype'. The method of
somatotyping combines an appraisal of relative adiposity, musculo-skeletal
robustness and linearity into a three number rating - summarising the
physique as a unified whole (Gakhar & Malik, 2002; Kaur, 2009). Used to
describe the changes in physique during growth, ageing and training,
(Duquet & Carter, 2001), somatotype provides an accurate, detailed
summary of individuals body composition (Norton, & Olds, 1996).
Somatotype is calculated from ten anthropometric dimensions including
stretch stature, body mass, four skinfolds, two limb girths and two bone
breadths. There are known limitations to the measurement of skinfolds, some
of which tend to be accentuated in obese subjects (Van Loan, 1997).
However, adequate training and practice, alongside the development of an
accreditation scheme developed by the International Society for the
Advancement of Kinanthropometry (ISAK), has contributed to the precision
and reliability of results obtained through this method. Furthermore, when
used appropriately, the tools of anthropometry, which are portable and
relatively inexpensive (Bellisari & Roche, 2005), provide valid results
(Stewart et aI., 2003) and can be laboratory based or field based (Norton &
Olds, 1996).
The measurement of skinfolds in overweight/obese individuals routinely
takes place, despite the techniques' documented limitations (Cordero-
Macintyre et al., 2000; Mayo et al., 2003; Raatz et al., 2005; Slentz et al.,
2004); however the application of somatotyping in an overweight/obese
population has received little attention. Commonly used to describe the
changes in physique during growth, ageing and training (Duquet & Carter,
2001), this technique may also identify changes in composition of obese
individuals. As such, the main focus of the research is to examine and
compare magnitudes of change in a range of traditionally used
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anthropometric measures (BMI, body mass, WHR and percent body fat
(%BF)), with alternative anthropometric measures (sum of 8 skinfolds
(L8SF), global somatotype and somatotype sub-components; endomorphy,
mesomorphy and ectomorphy) over a 12 month period in an
overweight/obese population. Throughout this thesis the phrases 'traditional
anthropometric measures' and 'alternative anthropometric measures' will
refer to the measures specified above.
The use of somatotyping, a more holistic measure of one's body, may also
have utility in evaluating an individuals metabolic risk (Katzmarzyk et al.,
2003) and may be a more useful method of assessing physique from a
psychological perspective (Norton & Olds, 2002). Thus, secondary aims
include investigating the relationship between somatotype and physiological
variables (specifically metabolic syndrome markers) and psychological
variables (specifically physical self-perceptions), in an overweight/obese
population.
1.3 Summary of individual chapters
This chapter has provided a brief context to the research and has identified
the purpose and significance of the research. Following discussion of the
prevalence and aetiology of obesity, Chapter 2 moves on to review the
techniques used to identify obesity and measure the composition of the
human body, highlighting their strengths and limitations. The concept of
somatotyping is introduced and the importance of monitoring body
composition using measures that are sensitive to change is highlighted.
Finally, the financial and health consequences of obesity are reviewed,
focusing primarily on physiological and psychological health consequences.
Chapter 3 details the anthropometrical procedures utilised in all studies that
comprise this thesis, following International Standards for the Advancement
of Kinanthropometry (ISAK) guidelines. Specific methodological details are
provided in subsequent chapters. Particular mention is made of quality
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assurance methods implemented to increase reliability and validity of
anthropometric data.
Chapter 4 introduces Study One, comparing change in traditional and
alternative anthropometric measures in an overweight/obese population, in
order to identify the most discernible anthropometric measure of change. In
the first instance the change in these measures were examined over a 4
month period to determine that the measures were changing significantly,
thus permitting longitudinal investigation (Part A). Prior to comparing the
change in traditional and alternative anthropometric measures over an
extended time period of 12 months (Part B), consideration of the
controversies surrounding the measurement of change and the issues
associated with unit variation when analysing and comparing variables are
discussed. This was an issue in Study One and various analysis methods
are presented, and justification provided, for the choice of analysis used in
the data analysis conducted in Part B.
Chapter 5 provides an overview of the relationship between obesity and
psychological health, an area that is less clearly delineated in comparison to
the medical co-morbidity of obesity that is readily apparent (Steinbeck,
2004). The chapter introduces the self-concept, focusing on the development
of the multidimensional self-concept and more specifically, perceptions of the
physical self that are thought to have important implications on psychological
health (Carron et al., 2003). This is followed by a review of research
examining the relationship between physical self-perceptions and body
composition. Fotlowinq the development of adequate instrumentation to
assess physical self-perceptions, researchers have been able to establish
links between physical self-perceptions and body composition; however this
research has primarily focused on BMI, body mass and %BF. Subsequently,
Study Two therefore, aimed to provide an understanding of the link between
physical self-perceptions and alternative anthropometric measures.
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Identifying an anthropometric measure that demonstrates a higher
discernible change than other anthropometric measures would be of greater
value if that measure could also be correlated with health risk factors, for
example elements of metabolic syndrome (MetSyn). It is known that
traditional measures of obesity correlate with some MetSyn markers,
however whilst evidence of an association between characteristic
somatotypes and some diseases and conditions exists, this is scarce and
has not focused on MetSyn markers specifically. Therefore, in Chapter 6,
Study Three examined the relationship between traditional or alternative
anthropometric measures and MetSyn in an overweight/obese population,
and the relationship between their associated changes over a 6 month
period. A review of pertinent research in the area of MetSyn is provided and
evaluation of the methodological procedures and instrumentation used for
the collection of haematological data considered.
The contribution of the individual studies in line with the original research
aims, along with the practical implications of the research findings is
described in Chapter 7. Limitations of the body of work are considered and
suggestions made for further research directions.
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2. LITERATURE REVIEW
Using a hierarchical approach to searching for literature, as proposed by
Strauss and Sackett (1998), various methods were used to obtain
information such as searching databases of reviewed high quality literature,
searching evidence based journals for review articles and routine searches
of PubMed, Medline, Elsevier/Science Direct and other search engines.
Search terms remained broad to ensure relevant studies were not missed
and following key word searches backward and forward searching
techniques, as discussed by Levy and Ellis (2006), were employed to obtain
a wide literature background. A stepped approach to compiling material was
utilised and literature summarised under broad categories. These categories
were then analysed in order to identify appropriate sub-headings. Initial
summaries were then re-examined and relevant sections incorporated into
the review under the appropriate headings. As a consequence of this
thematic organisational approach, the literature review is divided into three
parts. The first part of the review provides a definition of obesity and details
the prevalence of obesity in the UK and the aetiology of obesity. Following
this a review of the techniques used to identify obesity and measure the
composition of the human body, focusing on their strengths and limitations
are discussed. Finally the consequences of obesity are reviewed, focusing
primarily on the physiological and psychological consequences.
2.1 Obesity
2.1.1 Defining obesity
Overweight and obesity are both labels for ranges of body mass that are
greater than what is generally considered healthy for a given height (Centre
for Disease Control & Prevention, 2009). More specifically, obesity is defined
as an excessively high amount of body fat or adipose tissue in relation to
lean body mass (Foreyt & St.Jeor, 1997). A commonly used assessment of
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obesity is the body mass index (BMI) (Carmichael, 1999), calculated by
dividing a person's body mass in kilograms by their height in metres squared
(kq.m"). Consensus has been reached when defining obesity in adults, and
is said to occur when a person's BMI is >30kg.m-2as a result of them gaining
weight to the point of seriously endangering their health (ACSM, 2000). A
person with a BMI >40kg.m-2 is considered to be severely or morbidly obese
(Miller, 2004). Super-obesity, although not officially recognized as a weight
category, has been arbitrarily defined as when an individual's actual body
mass exceeds their estimated ideal body mass by 225%, or by more than
200 pounds (90.7kg), or a BMI of >50 kg/m2 (Raftopoulos et al., 2005). A
summary of weight classification based on BMI, graded to indicate the
degree of risk to health, is given in Table 2.1.
Table 2.1. Weight classification based on BMI (kg.m-2)
BMI (kg.m-2) Description Risk of co-morbidities
18.5-24.9 Healthy Weight Average
25-29.9 Overweight Increased
30-34.9 Grade I Obesity Moderate
35-39.9 Grade II Obesity Severe
>40 Grade III Morbid Obesity Very severe
World Health Organisation (1997)
These BMI cut-off points, used by the Centre for Disease Control (CDC) and
World Health Organisation (WHO) as the standard definitions of overweight
and obesity, provide benchmarks for assessment. However, the risks of
disease in all populations can increase progressively from lower BMI levels.
Furthermore, the cut off points were derived primarily in European
populations to correspond to risk thresholds for a wide range of chronic
diseases and mortality (Razak et al., 2007).
There is ongoing debate as to whether these criteria for obesity and
overweight are appropriate for non-European populations and despite
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heterogeneity and widely varying disease risk and obesity prevalence in
ethnic groups, ethnic-specific BMI cut-off points are not used in Europe
(WHO expert consultation, 2004). The justification for this being, that ethnic-
specific cut-off points for BMI are thought to increase confusion in health
promotion, and disease prevention and management in the increasingly
multicultural societies in Europe.
2.1.2 Prevalence of obesity
The impact of obesity is so diverse and extreme that it has led to it being
regarded as one of the greatest public health problems of our time (Gill et al.,
1999). In the year 2000, estimations of the prevalence of obesity in
established market economies (Europe, USA, Canada, Australia etc.)
suggested an average prevalence in the order of 15-20% (Seidell, 2000). It is
expected that more recent estimates of 300 million obese people worldwide
could double by year 2025 if no action is taken against this threat
(Formiguera & Canton, 2004). Estimations of the percentage of men and
women in England, who are classified as obese have increased from 13.6%
and 16.9% in 1993, to 24% and 25% in 2008, respectively (Zaninotto et al.,
2008; Health Survey for England;HSE, 2008). Figure 2.1 shows trends in
obesity in England over the last decade (Rennie & Jebb, 2005).
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Figure 2.1. Secular trend in the prevalence of obesity (% with BMI>30kg.m·2)
in Health Survey for England in men and women (Rennie & Jebb, 2005). 10
The largest increases in obesity prevalence are seen in the younger age
groups with prevalence doubling in both men and women in the 25-34 years
age group. Childhood obesity rates are also increasing rapidly in developed
countries (Dehgan et al., 2005). For example from 1984-1998 Lobstein et al.,
(2003) documented a 12% increase in prevalence of obesity in children aged
7-11 years, rising from 8% to 20%. More recent estimations of childhood
obesity indicate that 28% of boys and 36% of girls in the UK are now
overweight or obese (International Obesity Task Force, 2009). By 2010 the
number of overweight children across the European Union was estimated to
reach 26 million, increase at an estimated rate of 1.3 million a year
(International Obesity Task Force, 2006).
Data from the Health Survey for England (HSE) (2004) identifies the varying
prevalence in obesity across ethnic groups, being particularly low in female
Chinese and Bangladeshi communities (8%) and highest among women in
Black African (38%), Black Caribbean (32%) and Pakistani (28%) groups.
Black Caribbean and Irish men had the highest prevalence of obesity (25%).
It should be noted that the HSE 2004 report used the same definition of
overweight and obesity for ethnic groups as used for the general population
as there are no agreed ethnicity specific BMI cut off points. The use of
standard BMI cut off points in measuring obesity and overweight among
certain ethnic groups is under debate, therefore the results of the HSE 2004
prevalence data of ethnic groups should be interpreted with caution.
2.1.3 Etiology of obesity
The etiology of obesity is regarded as a complex interaction of genetic,
environmental, and behavioural factors (Aronne, 2002); it is not attributable
to one specific factor (Donnellan, 2003). This is one reason why it is so
difficult to treat (Rimmer, 1994). Support for the involvement of genetic
factors in the development of obesity comes from studies of nuclear families,
follow-ups of adopted children, and comparisons of monozygotic and
dizygotic twins (Bray, 2003). However, despite the identification of several
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clear endocrine abnormalities that cause obesity, they are rare and should
be considered as part of the diagnostic process (British Nutrition Foundation,
1999). Furthermore, whatever the influence the genotype has on etiology of
obesity, it is generally attenuated or exacerbated by non-genetic factors
(Afridi & Kahn, 2004). Additionally, whilst some people are more genetically
susceptible to weight gain than others, the genetics of the population have
not changed significantly in the past 20 years, so the increase in obesity can
be attributed to other non-genetic factors (National Audit Office, 2001).
Weight maintenance results from achieving a state of energy balance in
which total energy intake from food is matched by total energy expenditure,
composed primarily of resting metabolic rate, the thermic effect of feeding,
and physical activity (Van Zant, 1992). An important, though simple concept
of obesity, is that it results from an imbalance between energy intake and
energy expenditure (Carmichael, 1999). Energy balance determines whether
body fat increases, decreases, or remains the same (Brooks et al., 1996).
Hill and Peters (1998) support this concept, suggesting that the current
epidemic of obesity is caused largely by an environment that promotes
excessive food intake and provides obstacles to physical activity. However,
the upward trend for obesity in the UK appears to parallel an increase in
physical activity. For example, statistics on physical activity in England,
published by the HSE (2010) indicate that physical activity levels have
increased among both men and women, with 39% of men and 29% of
women meeting the recommended levels in 2008 (at least 30 minutes of
moderate intensity activity at least 5 times a week), compared with 32% and
21% respectively in 1997. However, this means that 6 out of 10 men and 7
out of 10 women are still not meeting the recommended levels of physical
activity. Furthermore, when examining physical activity levels achieved by
overweight/obese individuals, these levels are lower than those achieved by
their normal weight counterparts.
Table 2.2 highlights the reduction in activity levels with increasing BMI
among adults in England. For example, in 2003, 44% of normal weight adult
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males (BMI: 18.5-24.9kg.m-2) participated in recommended levels of physical
activity, compared with just 16% of morbidly obese adult males (BMI: <40
kg.m-2).
Table 2.2. Adults (>16years) reaching recommended guidelines for physical
activity levels by body mass index and gender in England, 2003.
Percentage reaching recommended guidelines of activity*
Normal Overweight Obese excl. Morbidly
(18.5 - 24.9 (25-29.9 morbidly obese obese
kg.m-2) kg.m-2) (30-39.9kg.m-2) (>40kg.m-2)
Men 44 37 31 16
Women 30 25 18 18
*30 minutes or more on at least 5 days a week
(Adapted from Health Survey for England, 2003)
To prevent weight gain or regain, the current recommended guidelines of
physical activity may be insufficient for many individuals, particularly in
today's "obesogenic" environment (Saris et al., 2003). Research suggests
that prevention of weight regain in formerly obese individuals requires 60-
90minutes of moderate intensity activity or lesser amounts of vigorous
intensity activity per day, five days a week (ACSM, 2000). Thus the above
results indicate that whilst physical activity levels have increased over the
last decade, the level of physical activity reached by individuals may not be
of sufficient level to maintain a healthy weight and prevent the upward trend
in obesity
Many factors contribute to today's obesogenic environment and obesity
trends continue to increase dramatically, in part, as an unintended
consequence of the economic, social, and technological advances that have
contributed to unhealthy dietary habits and sedentary behaviour during the
past several decades (Aronne, 2002). For example, the increasing
availability of energy dense foods, the substitution of physically active leisure
with sedentary pastimes such as television, computers and the internet, and
the decline of walking as a mode of transport, are all factors that have
contributed to the increasing prevalence of obesity (Donnellan, 2000). This
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increasing incidence of obesity is a major health concern, since it is an
important risk factor for numerous life-threatening and debilitating diseases
(Carmichael, 1999).
2.2 Measurement of obesity
2.2.1 Current indices of obesity
As simple as the definition of obesity appears, establishing the best
technique to measure obesity has been a matter of dispute (Franzosi, 2006,
James, 2005). Since the 1950s it has been recognized that fat distribution,
independent of overall obesity, is associated with metabolic disturbances and
increased disease risk (Snijder et al., 2006). Consequently, because of its
importance to health, body composition is commonly investigated in
epidemiological, clinical, and population studies (Moreno et al., 2003).
Methods include measurement of body mass, body mass index (BMI), waist
circumference (WC), waist-hip-ratio (WHR), skinfold thickness and
somatotype (Carmichael, 1999; Crawford, 2002).
2.2.1.1 Weight-related parameters
Weight-related parameters, such as body mass and BMI, are the most
commonly used methods to determine obesity status and measure success
within weight management programmes (Carmichael, 1999). Body mass is
an easy, precise measure, and values greater than 120 percent of the
average expected for height and sex have been considered indicative of
obesity in many studies (Rowland, 1990). However, despite the ease and
simplicity of this method, it is impossible to determine accurately if a
fluctuation in body mass is due to a change in muscle, body water, or fat
(Brooks et al., 2001). Furthermore, using this method to evaluate responses
to dietary-exercise treatment has the potential to result in false conclusions
regarding success and change in health status, because significant fat can
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be lost and muscle mass gained with little change in overall body mass
(Rowland, 1990).
BMI has become the standard by which a person's relative weight is
measured (Crawford, 2002) and its use as a standard population level
assessment is advantageous due to its simplicity (Brooks et al., 2001). The
BMI categorisation system, now used internationally, has made it easy to
estimate and compare the prevalence of the overweight and the obese in
populations (Webb, 2000). However, these reference ranges, recommended
by the WHO and used to determine level of risk, are based on studies using
data from healthy adult Caucasians (WHO, 1997). This limits their application
to populations and individuals of different ethnic origins and health status.
Increases in average height and body size over generations also limit the
application of universal BMI cut-offs to the current population (Cook et al.,
2005), particularly in the extremities of the height scale where BMI's intrinsic
mathematical limitations become more evident (Ricardo & Araujo, 2002).
Furthermore, BMI does not differentiate between the non-fat and fat masses
or accurately represent an individual's health status (Burkhauser & Cawley,
2008; Garcia et al., 2005; Norton & Olds, 1996), nor does it account for
factors such as size of body frame, proportion of lean mass, gender and age
(O'Meara et al., 2001). Additionally it is not sensitive enough to recognize
small yet clinically significant weight losses (Cook et al., 2005). Moreover,
Blair and LaMonte (2006), point out that much of the extant prospective data
indicate that there is little difference in risk across a very wide range of BMI
values, suggesting it is fat distribution that is important in terms of health risk.
Consequently, BMI is best viewed as a measure of heaviness (Norton &
Olds, 1996).
The specificity and adequacy of weight related parameters is controversial
because they do not allow a precise assessment of body composition
(Garcia et al., 2005). The body is composed of two elements: lean body
tissue (Le. muscles, organs, bones and blood) and body fat or adipose tissue
(Heymsfield et al., 1990). The proportion of these two components in the
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body is called body composition (Bean, 1996). Both the total amount of body
fat and the way in which fat is regionally distributed in the body are principal
risk factors for the high rate of chronic disease in individuals who are obese
(Heyward & Wagner, 2004). Consequently, body composition is commonly
investigated in epidemiological, clinical, and population studies (Moreno et
al., 2003). Reliable methods for measurement of body fat and fat distribution
are therefore important.
2.2.1.2 Waist circumference/waist-hip-ratio
Much research has suggested that, to classify overweight individuals
accurately with respect to health risks, both BMI and an indicator of fat
distribution must be considered (Bray, 2003). The health risks of obesity are
compounded by the influence of fat which is distributed around the waist
(Bray, 2003; Chan et al., 2003; Webb, 2000). For this reason, WC and WHR
are commonly used as an assessment of fat distribution and the risks
associated with obesity (Dalton et al., 2003; Onat et al., 2004). Whilst the
measurements are less direct methods of assessing body fat status
compared to more advanced techniques such as dual-energy x-ray
absorptiometry (DXA) and magnetic resonance imaging (MRI) (Sharp, 1995),
they are simple and useful tools for gauging the priority that should be
attached to weight reduction in different individuals (Webb, 2000).
A report by the WHO suggests that increased obesity-related health risks are
present when the WC exceeds 94 cm (37 inches) in men, or 80 cm (32
inches) in women (WHO, 1997). The higher the WC, the more substantial
this risk becomes, as documented by Lean et al. (1995) who found that a
WC of 102 cm in men and 88cm in women corresponded to a BMI of 30
kg.m-2. Lean et al. (1995) recommended that men with WC s94 cm and
women with WC s80 cm should gain no further weight, and men with WC
>102 cm and women with WC >88 cm should reduce their weight. These
simple cut-off points may be helpful for the classification of Caucasian adults,
however in other ethnic groups or older age groups they are less appropriate
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(Snijder et al., 2006) as different ethnicities have different body builds and
proportions and research indicates that adipose tissue distribution for a given
WC is altered substantially by age (Kuk et al., 2005).
It is important to acknowledge the numerous measurement protocols
available for the measurement of WC, which may contribute to measurement
error when used interchangeably. For example, a literature review by Wang
et al., (2003) identified 14 different descriptions for the measurement of WC,
and organised these into four groups defined by specific anatomical
landmarks; immediately below the lowest rib; at the narrowest waist;
midpoint between the lowest rib and the iliac crest; and immediately above
the iliac crest. When comparing the magnitude and reliability of WC
measured at these 4 sites, reproducibility for all sites was high (intraclass
correlation (r) values >0.99), however the sites significantly differed in
magnitude from each other, in a sex-dependent manner (Wang et al., 2003).
These differences could have important implications in clinical practice and
within research utilising both WC and WHR, which incorporates a WC
measure. The issue of varying measurement protocols is not restricted to
WC alone. For example, numerous protocols for the measurement of stature
also exist, including stretched and unstretched techniques (Tillmann &
Clayton, 2001).
WHR is a simple indicator of body fat distribution. It is the circumference of
the body at the waist divided by the circumference around the hips (Webb,
2000). Cut-off scores for increased health risk have ranged from 0.91 to 1.0
for men and from 0.80 to 0.91 for women (Norton & Olds, 1996). A value
greater than the recommended thresholds, indicates excess fat in the
abdomen and a higher health risk (Bean, 1996). In comparison to WHR, WC
alone is a more crude measurement for abdominal obesity, whereas WHR
takes advantage of a reference of body size, hip circumference. Dalton et al.,
(2003) in a comparison of the use of BMI, WC and WHR as predictors of
cardiovascular disease (CVD) risk factors also concluded that WHR is the
most useful measure of obesity in terms of predicting CVD risk. Furthermore,
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in a large cross-sectional study of 313 men and 382 women, Seidell et al
(2001) showed that after adjusting for BMI and age, WHR was highly
correlated with visceral fat but not subcutaneous fat, with we highly
correlated with both visceral and subcutaneous fat.
Visceral fat volume has been found to be the strongest independent predictor
of metabolic risk in men and women matched for total body fat but differing in
visceral fat mass (Fried & Ross, 2004). In a large, diverse population with a
broad age range Elsayed et aI., (2008) identified an association between
WHR and visceral fat; however no association was evident between WHR
and subcutaneous fat. This may explain why WHR is a better predictor of
health outcomes than we. In contrast, studies by Kamel et al. (1999), who
compared WC measures against DXA measures, and Onat et al. (2004) who
compared a range of anthropometric indices against C'T, both suggest that it
is we that is more strongly associated with visceral fat. Despite this,
research indicates that hip circumference is inversely associated with the
development of cardio-metabolic risk factors and eVD (Koning et al., 2007),
with weaker associations observed between type II diabetes mellitus
(T2DM), eVD and WC (Snijder et al., 2006). Table 2.3 summarises some of
the strengths and limitations of WHR and we.
Table 2.3. Strengths and limitations of WHR and we
WHR WC
Applicability in large
Very high1 Very high1
populations studies
Capability to detect
Poor due to validity of serial Preferred index in
change
measurements and genetic comparison to WHR3
component to WHR2I3
Predictor of health Strong association with Weaker association with
T2DM and cardio-
outcomes cardio-vascular risk factors"
vascular risk factors"
Predictor of Association with visceral
subcutaneousl Association with visceral fat6 fat and subcutaneous
visceral fat fat617
1 .. • £1 . ~, . . ..Sniider et al. (2006), Dalton et al. (2003), Gibson, (2005), KOninget al.
(2007); 5Snijderet al. (2007); 6Hanet al.(2006); 7Seidell et al. (2000)
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The research discussed above indicates small differences in the
discriminatory capabilities of we and WHR, thus from a clinical perspective,
it may not be possible to advocate one measure over the other. However, as
a tool to monitor change in body composition, we may be more useful as it
is not confounded by serial measurements.
2.2.2 Assessing body composition
2.2.2.1 Levels of human body composition
Body composition is the common name for the methodology of dividing the
body into different compartments (Heymsfield et al., 1990). It is common to
explain human structure in terms of increasing organizational complexity
ranging from atoms and molecules to the anatomical, described as a
hierarchy of cell, tissue, organ, system and organism (Hawes & Martin, 2001)
(Fig.2.2). Each level has clearly defined components and the sum of
components is equal to the total body weight (Salmi, 2003). Knowledge of
the interrelationship of constituents within a given level or between levels is
also important, and may be useful for estimating the size of a particular
compartment (Hawes & Martin, 2001).
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Figure 2.2. The five levels of human body composition according to Wang et
al. (1992). 19
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Approximately 50 elements comprise body composition at the atomic level.
One element, oxygen, constitutes >60% of total body mass, with the addition
of carbon, hydrogen, nitrogen, calcium and phosphorus accounting for >90%
of total body mass. The remaining 44 elements comprising less than 2% of
total body mass (Wang et al., 1992). At the molecular level of organisation
more than 100,000 chemical compounds can be reduced to five main
chemical groupings; lipid, water, protein, carbohydrate and mineral (Hawes &
Martin, 2001). At the cellular level the body is divided into cell mass,
extracellular fluid (ECF) and extracellular solids (ECS) and at the fourth level
of organisation (tissue system), these components are further organised into
tissues, organs, and systems (Wang et al., 1992). At the whole body level
the body is considered as a single unit representing body size, shape,
density, surface area and external characteristics (Hawes & Martin, 2001).
2.2.2.2 Measurement techniques
Due to the numerous terms used in body composition literature, prior to
discussing measurement techniques used to measure body composition it is
first necessary to define commonly used terminology (Table 2.4).
Table 2.4. Body composition terminology
Term Definition
Body fat mass Quantity of triglyceride fat in the body
Adipose tissue Fat plus supporting cellular and extra-cellular tissues
mass (pure fat 83%, protein 2%, water 15%
Lean body mass Non-adipose tissue body mass (body cell mass plus
extracellular water and extracellular solids)
Fat-free mass Lean body mass plus non-fat component of adipose
tissue
Body cell mass Cellular components of the body including
extracellular water (lean body mass minus
extracellular water and extracellular solids)
Extracellular solids Total body bone mineral (skeleton) plus fascia and
cartilage (skeleton 85%, others 15%)
Morgan & Madden (1996)
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The quantity of triglyceride fat in the body is defined as body fat mass,
whereas adipose tissue is defined as fat mass together with its' supporting
cellular and extracellular structures (Morgan & Madden, 1996). Fat-free mass
is the sum of all body tissues minus all body fat (essential and non-
essential).The lean body mass (LBM) is the FFM with the inclusion of
essential (non-adipose) lipids (Hawes & Martin, 2001); however LBM is
sometimes used erroneously as a synonym for FFM. The cellular
components of the body, including intracellular water are defined as body cell
mass and extracellular solids consists of total body bone mineral, that is the
skeleton.
As direct measurement of body composition in vivo is not possible in
humans, a series of indirect estimations of body constituents have been
developed. Most interest has been directed at the two-compartment (2-C)
model (molecular level) that suggests total body weight is the sum of two
categories: fat mass and fat-free mass (Ellis, 2000). By assuming that
density values of fat-free mass, potassium, and water are stabilized and
constant, estimates of absolute and relative body fat can be made (Hawes &
Martin, 2001). The assumption of a constant composition of fat free mass is
central to the 2C-model and methods, however many clinical studies have
demonstrated that the 2-C model has limited applicability with regard to its
use in different ages, gender and ethnic groups.
Recently there has been a move away from the 2-C model toward three (3-
C) or four-component (4-C) models (Brodie et al., 2005). These models
partition body weight into three or four body weight fractions, respectively
(Heymsfield et al., 1990). For example, 3-C models control for inter-individual
variation in fat-free mass by partitioning weight in to fat mass, total body
water and fat-free dry mass (Withers et al., 1998). 4-C models divide body
weight into fat mass and the constituents of fat-free mass, namely the
aqueous, protein, and mineral fractions (Heymsfield et al., 1990). As more
components are measured in these models, fewer assumptions are required
and these are regarded as superior to 2-C methods. However, they are more
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difficult to perform, in terms of cost and expertise (Norgan, 2005) and the use
of 2-C models are still considered valuable in most cases when assessing fat
and fat free ratios against total body weight (Salmi, 2003).
Many methods are available to estimate total body fat or adipose tissue, with
different levels of accuracy, practicality, and cost (Sardinha & Teixeira,
2005). The earliest and probably the most frequently used 2-C model is
based on the measurement of total body density, most commonly using
hydrodensitometry or underwater weighing (Ellis, 2000). These are generally
considered criterion reference methods (Garcia, 2005). Other methods used
to obtain reference measures of body composition include computerized
tomography (CT), MRI, neutron activation analysis and DXA (Heyward,
2001; Pontiroli et al., 2002). Because these reference methods do not
measure body composition directly, but rather predict it from measurement of
body properties, none can be singled out as a 'gold standard' for in vivo body
composition assessment (Heyward, 1996). Direct analysis of body
composition can only be carried out by chemical analysis of cadavers
(Hosking et al., 2006). Thus all techniques suffer from methodological error
when collecting raw data, and error in the assumptions by which raw data
are converted to final values (Wells & Fewtrell, 2006).
Furthermore because of the costs of the reference methods in terms of time
and money, together with the need for tester expertise (Snijder et al., 2006)
many are not practical in epidemiological studies or for routine clinical use
(Table 2.5). Consequently there are no normative data on body fat content
that can be .used as clinical or surveillance tools (Prentice & Jebb, 2001).
Whilst techniques such as bioelectrical impedance analysis (BIA) and DXA
do not require as much training as skinfold and circumference to achieve
reliable results, these techniques suffer from practical and methodological
limitations. DXA instrumentation is expensive and cannot be easily
transported to test sites in large-scale intervention and epidemiology projects
(Van Loan, 1997). BIA, whilst inexpensive and readily available to the public,
uses population specific prediction formulas, and prediction errors may be
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too large for valid individual assessment in clinical situations (Deurenberg,
1996).
At the whole-body level of body composition, other anthropometric measures
used to assess the size, composition and proportions of body segments
include skinfold thicknesses, circumferences, skeletal breadths and segment
lengths (Heyward & Wagner, 2004). These measures have been adopted as
substitute measurement methods in clinical and public health works
(Heyward & Wagner, 2004; Batisita, 2004) as they are applicable to large
samples and can provide national estimations and data for the analysis of
secular changes in representative samples (Loan, 1997; Bellisari & Roche,
2004).
Table 2.5. Capability of different body fat measurements to estimate total
body fat and fat distribution (reproduced from Snijder et al., 2006).
Capability Capability Applicability in
Method measuring measuring fat large population
total body fat distribution studies
eT Moderate Very High Low
MRI High Very High Low
DXA Very High High Moderate
DenSitometry Very High Very Low Low
Dilution Techniques High Very Low Moderate
BIA Moderate Very Low High
BMI Moderate Very Low Very High
WHR, He, WHR, SAG-O Low High Very High
Skinfolds Moderate Moderate High
Laboratory measurements: CT, computed tomography; MRI, magnetic resonance
imaging; DXA, dual energy x-ray absorptiometry.
Field measurements: BIA, bioelectrical impedence analysis; BMI, body mass index,; WC,
waist circumference; HC, hip circumference; WHR, waist-to-hip ratio; SAG-D, sagittal
abdominal diameter
Determining the thickness of the skin at specific sites is the simplest and by
far the most widely used method of gaining useful estimations of body fat
(Sharp, 1995). Together with girth measurements, they are useful for
monitoring body composition changes over a period of time (Bean, 1996).
The skinfold is a measure of the thickness of two layers of skin and the
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underlying subcutaneous fat (Heyward & Wagner, 2004). It is assumed that
determination of skinfold thickness by calipers provides a localized estimate
of subcutaneous fat, which has been used as an index of total body adiposity
or relative body fatness (Rowland, 1990). The thickness of the skinfold at
various defined body sites is measured and the sum of these skinfolds is
determined (Webb, 2000).
Skinfold measurements can be used to predict total body fat using anyone
of a number of predictive equations available in the literature (Norton & Olds,
1996). It is important when equations are applied to estimate the total body
fat of an individual, that they are derived from a similar population, as using
an inappropriate equation may produce systematic prediction error in
estimating body composition (Brooks et al., 1996). Factors such as age,
gender, ethnicity, level of body fatness, and physical activity level should be
considered (Heyward & Wagner, 2004). Many current equations show a lack
of accuracy in predicting body composition in overweight and obese
populations (Sartorio et al., 2000) and there is a scarcity of equations
developed specifically to predict %BF in participants with a BMI >34 kg.m-2
(Horie et al., 2008).
Whilst there is a substantial literature available on the subject of skinfold
measurement, there are known limitations to the measurement of skinfolds,
some of which tend to be accentuated in obese subjects (Van Loan, 1997).
However, the accuracy of this method can be improved through multiple
measurements by a single, experienced observer (Norton & Olds, 1996) and
when used appropriately the tools of anthropometry can provide valid results
(Stewart et al., 2003). Furthermore the development of an accreditation
scheme developed by the International Society for the Advancement of
Kinanthropometry (ISAK) has contributed to the precision and reliability of
results obtained through this method.
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2.2.2.3 ISAK
Anthropometry, like any other area of science, depends upon adherence to
the particular rules of measurement as determined by national and
international standards bodies (Norton & Olds, 1996). There have previously
been attempts to standardise anthropometric measures, however these did
not achieve international recognition (Stewart et al., 2003). ISAK has strived
to develop standardised protocols and, following a successful model
pioneered in Australia, formulated an accreditation scheme recognising four
levels of technical expertise (Stewart et al., 2003). These include: technician
(restricted profile), technician (full profile), instructor and criterion
anthropometrist (Appendix 1). The measurements included in full and
restricted profiles are detailed in Appendix 2.
The need for an ISAK anthropometry accreditation scheme evolved from
recognition of the concern for and the need to: standardise techniques and
applications, increase the competencies of individuals involved in
kinanthropometry; and establish means whereby professionals within the
field and the public consumer can recognise professional competence at
different levels (Australian Institute of Sport, 2006). The ISAK accreditation
system for anthropometrists has operated since 1996 with the aim of
establishing a global standard for anthropometry. Over 3000
anthropometrists from 49 countries have been accredited in anthropometric
measurement techniques under this scheme (ISAK, n.d.). Adoption of these
standards allows standardisation of measurements between participants and
of repeated measurements on the same participants. Furthermore, it allows
comparisons to be made locally, nationally and internationally between
sample groups.
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2.2.2.4 Levels of validation
In addition to the five levels of organisation (Fig.2.2), there are three levels of
validation in body composition. The validity of a method is the extent to which
it accurately measures a quantity of which the true value is known (Hawes &
Martin, 2005). Table 2.6 orders body composition methods into levels of
validity. This distinguishes components that are measured from those where
the component of interest is derived by transformation of a measured
property of the body on the basis of various biological and technical
assumptions (Norgan, 2005).
Table 2.6. Levels of validation of body composition methods (Hawes &
Martin, 2001).
Method Validation Approach
Level
Dissection
Direct measurement of body fat by(cadaver I
dissection of subject
studies)
Densitometry
CT
II
Indirect measurement, assumptions
MRI based on qualitative measures
DXA
Anthropometry
III
Doubly indirect, regressed against a
BIA level II method
Laboratory measurements: CT, computed tomography; MRI, magnetic resonance
imaging; DXA, dual energy x-ray absorptiometry;BIA, bioelectrical impedence analysis.
Body composition analysis is unusual in that only cadaver dissection (level I
validation) can give truly valid measures (Hawes & Martin, 2001). Level II
measures are indirect (i.e. some quantity other than fat is measured to
enable an estimation of fat mass from the measured quantity) and Level III
measures are doubly indirect as they are derived by applying a regression
equation against a level II method, almost always densitometry or in recent
years DXA-based equations (Hawes & Martin, 2001)
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Many studies have compared the validity of these body composition analysis
techniques in normal weight, healthy populations (Maddalozzo et al., 2002;
Sun et al., 2006), ageing populations (Reilly et al., 1994; Chen et al., 2007)
and athletic populations (Utter et al., 2005; Silva et al., 2006). However, the
ability of most methods to measure change is less than the measurement of
absolute values (Norgan, 2005) and there is little research comparing body
composition methods over a period of weight loss (Frisard et al., 2005).
Studies that have used overweight or obese populations and investigated the
application of various body composition methods during weight loss include
those by; Frisard et al. (2005), Kim et al. (2005), Ritz et al. (2007) and
Weyers et al., (2002).
DXA and air displacement plethysmography (ADP) have been found to be
sensitive enough to measure moderate body composition changes with
weight loss (Weyers et al., 2002), however these methods are expensive,
limiting their applicability for routine use (Van Loan, 1997). Evans et al.,
(1999) compared estimates of change in %BF from DXA (level II measure),
skinfold thickness, BIA and BMI (level III measures), with estimates from a 4-
C model in a group of obese women (n=27). Changes in %BF averaged
2.1±1.0%, -1.2±1.4%, and -2.4±1.6% in control, diet only, and aerobic
exercise groups, respectively. Results indicated that errors in estimation of
the change in %BF were comparable in all techniques when compared with a
4-C model (range ± 2.0-2.4% of body mass). Additionally the type of weight
loss intervention (diet or aerobic exercise) did not affect the magnitude of
error in the assessment methods.
Frisard et aI., (2005) assessed body composition using DXA (level II
measure), BIA and ADP (level III measures) before and after a 6 month
weight loss program in overweight adults (n=56). BIA and ADP under- and
over-estimated %BF, respectively, compared with DXA. However,
cororrelation coefficients of both methods were relatively high compared with
DXA for measuring change in body composition and all were found to be
sensitive enough to detect changes with weight loss (,-2 range 0.57-0.63).
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The results of these two studies suggest that skinfold thickness and BIA may
be valid techniques in overweight/obese populations.
In contrast, a study that compared the use of skinfold thickness, BIA and
DXA in non-obese participants and obese participants, found skinfold
thickness and BIA to be preferable techniques to analyse body composition
in non-obese participants, with DXA considered the method of choice in
obese patient monitoring (Erslecan et al., 2000). Furthermore, Kim et al.,
(2005) found significant discrepancies at baseline %BF estimated by DXA
and BIA, with the lack of agreement being more pronounced in larger or
more obese persons. This suggests that BIA is not as valid in this population.
In light of the conflicting research regarding the validity of body composition
analysis techniques, Hawes & Martin (2001) suggest that the best use of
body composition techniques is for repeated measures in the same
individuals over a period of time. Furthermore, a study by Puller et al., (1992)
suggests that skinfold thickness estimation equations proved to be as good
as 3-C models and DXA in estimating group mean fatness and the best of
the field techniques for individual estimates of fatness.
2.2.3 Somatotyping
Various systems for classifying physique and assessing the body shape and
composition of individuals have been proposed over the centuries (Carter &
Heath, 2005). This has led to the system called "somatotyping" as proposed
by Sheldon (1940), and subsequently modified by others, notably Parnell
(1985) and Heath and Carter (1967). A somatotype is a quantified
expression or description of the present morphological conformation of the
human body (Duquet & Carter, 2009). Classification of human body types
can be attributed as far back as Hippocrates, though a systematic approach
was not implemented until the twentieth century. The tri-polar somatotype
devised by Sheldon was later revised by Heath and Carter in the 1960s into
a phenotypic method based on calculations made up of ten anthropometric
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measurements. The Heath-Carter method of somatotyping is now the most
universally applied (Kalichman & Kobyliansky, 2007) and can be obtained in
three ways; 1) the photoscopic somatotype; 2) the anthropometric
somatotype; and 3) the anthropometric plus photoscopic somatotype.
The photoscopic somatotype is based on visual inspection of the subject, or
photographs taken according to standardised instructions (preferably a front,
a side and a back view) (Carter & Heath, 2005). Practice and experience is
required to make consistently valid and reliable ratings using the photoscopic
method and few people get the opportunity to become criterion raters using
photographs (Norton & Olds, 1996).
Ten anthropometric measures are needed to calculate the anthropometric
somatotype: stretch stature, body mass, four skinfolds (triceps, subscapular,
supraspinale, medial calf), two bone breadths (biepicondylar humerus and
femur), and two limb girths (arm flexed and tensed, calf). The instruments
needed to measure these dimensions (Appendix 3) are portable and
relatively inexpensive (Bellisari & Roche, 2005) thus enhancing its
applicability in laboratory and field bases studies. Furthermore, providing
measurements are taken by proficient technicians, these anthropometric
dimensions can provide an accurate, detailed summary of individual's body
composition (Norton, & Olds, 1996). Anthropometric measurement followed
by photoscopic evaluation is considered the criterion method (Ducquet &
Carter, 2009). In the absence of photographs, the anthropometric
somatotype provides the best estimate of a criterion somatotype (Carter &
Heath, 2005) and is the method that will be applied for identifying
somatotype within this investigation.
2.2.3.1 Somatotype rating
The somatotype is expressed as a numeral on a continuous scale that
theoretically starts at zero and has no upper limit. It summarises the
physique as a unified whole, independent of size, by combining the appraisal
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of adiposity, musculoskeletal robustness and linearity, into a three-number
rating (Ouquet & Carter, 2001). Ratings of % to 2 % are considered to be low,
3 to 5 as moderate, 5 % to 7 % and above as very high (Carter & Marfell-
Jones, 1994). The numerals are always recorded in the same order,
representing endomorphy, mesomorphy, and ectomorphy components
respectively (Carter & Marfell-Jones, 1994).
2.2.3.2 Endomorphy
Endomorphy refers to relative fatness of the body (Norton & Olds, 1996). It
also describes corresponding physical aspects such as roundness of the
body, softness of the contours, relative volume of the abdominal trunk, and
distally tapering of the limbs (Ouquet & Carter, 2009). Body mass tends to be
centred in the lower abdomen and hip region, giving a pear-shaped
appearance (Fig.2.3A), and endomorphs tend to have relatively low
metabolic rates and gain weight faster compared to the ectomorphic or
slender person (Grandjean, 1999).
Both genetics and environment influence the presence of phenotypic
somatotype (Carter & Heath, 2005). For example, Spalding et al., (2007)
report that adipocyte number is a major determinant for fat mass in adults
and that this number stays constant, even after marked weight loss in both
lean and obese individuals. This indicates that the number of adipocytes is
set during childhood and adolescence and this could provide partial
explanation for high endomorphy ratings. However, in order to create an
energy deficit that promotes weight loss and a reduction in fat mass, energy
intake needs to be reduced and/or energy expenditure needs to be increased
(Stiegler & Cunliffe, 2006). Individuals with excess body mass may find it
difficult to sustain the physical activity levels required to create an effective
energy deficit, thus exacerbating their endomorphic state.
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2.2.3.3 Mesomorphy
Mesomorphy refers to the relative musculo-skeletal robustness of the body
(Norton & Olds, 1996). It also describes corresponding physical aspects such
as the apparent robustness of the body in terms of muscle or bone, the
relative volume of the thoracic trunk, and the possibly hidden muscle bulk
(Fig.2.3B). Predominant mesomorphs have little or no trouble with body
weight fluctuations and are stronger and more robust than ectomorphs and
endomorphs (Duquet & Carter, 2001).
Again a genetic influence may play a part in mesomorphy ratings as to a
large extent testosterone secretions determine the rating of this component
(Carter & Ackland, 2009), with high testosterone levels associated with
significant gains in fat-free mass, muscle size and strength (Bhasin et al.,
2001). However, lifestyle activity may also contribute to degree of
mesomorphy, for example those in active professions, or who participate in
regular physical activity may become more muscular in comparison to
individuals in less active professions, or who do not train.
2.2.3.4 Ectomorphy
Ectomorphy refers to the relative slenderness of the body (Norton & Olds,
1996). It also describes corresponding physical aspects such as the
apparent linearity of the body or fragility of the limbs, in absences of any
bulk, be it muscle, fat or other tissues (Duquet & Carter, 2001). Ectomorphs
are small framed, low fat individuals (Fig.2.3C).
The factors which prevent normal weight gain and muscular development are
appetite and metabolism. Relative resting metabolic rate is increased in
individuals with low fat and increased lean mass, thus making it difficult for
ectomorphs to gain weight and muscle (Grandjean, 1999). Ectomorphic
characteristics may also be a consequence of individuals' behaviours such
as low caloric intake.
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Figure 2.3. Bodies displaying endomorphic (A), mesomorphic (B), and
ectomorphic (C) characteristics (bodytypes.wordpress.com, 2008).
Table 2.7 on the following page describes the various characteristics
associated with the different ratings for each somatotype SUb-component.
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2.3 Importance of monitoring body composition
In both the prevention and treatment of obesity, many strategies such as
dietary interventions, behavioural therapy and the promotion of physical
activity are considered important (Cooper & Fairburn, 2001). However,
methods used to report weight loss have been multiple and occasionally
contentious (Oeitel et aI., 2007). Weight loss and weight management
programme effectiveness is often based solely on participant weight change
(Roux et al., 2004). However focusing on weight loss alone can be
misleading as it does not account for individual variability (Sargent et al.,
2000). In a study of the effects of exercise on weight loss (Fig.2.4) by Pavlou
et al., (1985), 72 obese males were randomly assigned to a weight loss
program involving exercise or no exercise. The advantage of exercise would
appear modest if only weight change (kg) was considered. However, body fat
analysis revealed that the exercise group lost 11.2 ± 1.5kg fat vs. only 5.2 ±
1.6 kg in the non-exercise group (p<0.06).
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Figure 2.4. Effect of exercise on composition of weight loss (Pavlou et al.,
1985).
In a meta-analysis of resistance and aerobic exercise programs in weight-
maintenance regimes, Prentice & Jebb (2001) further highlight the
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importance of considering body composition. They found that changes in
body weight led to misleading impressions about underlying changes in body
fat. This was particularly evident with resistance exercise that tends to build
muscle mass. For example, Figure 2.5 indicates that the assumed change in
body fat (simply derived as 75% of weight loss) in the resistance group was
0.1 kg increase. However, body composition evaluation showed that the
actual change (directly measured fat loss) was a decrease of over 2kg.
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Figure 2.5. Assumed vs. actual changes in body fat after resistance or
aerobic exercise (Prentice & Jebb, 2001).
Sedentary Aerobic
In a comprehensive review of the influence of physical activity on abdominal
fat, Kay & Singh (2006) systematically evaluated 19 randomised controlled
trials and 8 non randomised controlled trials. They cited the most dramatic
average decreases in visceral fat of 48% and 44%, in studies by Donnelly et
al., (2003) and Pochlman et al., (2000) respectively. These decreases
occurred in the absence of change in body mass. Furthermore, a review of
pre-treatment predictors of weight control conducted by Teixeira et al.,
(2005) highlight an exclusive or excessive focus on weight as an outcome,
as a limitation of current research. Moreover, they suggest that where
possible, body composition should be accounted for if the analytical method
used is sensitive to intra-individual change.
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2.40besity and its consequences
Obesity leads to much human suffering by contributing to chronic disease
and premature mortality; it also entails a substantial cost to the National
Health Servivce (NHS) and to the wider economy (National Audit Office,
2001). There is also a major social and societal cost that is difficult to
measure (Lean, 1998).
2.4.1 Financial consequences of obesity
The problem of obesity has, until recently, remained un-addressed as a
public health issue (Carlisle, 1998) and the relationship between BMI and
future healthcare costs has received little attention (Thompson et al., 2001).
This issue is of increasing importance as the numbers affected by obesity
and the associated diseases are ever increasing and the countries' health
services may be unable to cope in the future (Carlisle, 1998). A report by the
National Audit Office (2001) highlighted the first authoritative estimate of the
cost and consequences of obesity in England, providing a conservative
estimate of the cost of treatment of obesity to the NHS at £1.5 billion a year
in 1998. In 2002, the direct cost of treating obesity was estimated at between
£45.8 and £49.0 million and between £945 million and £1,075 million for
treating the consequences of obesity (Allender & Rayner, 2007). By 2010
obesity and its consequences are expected to cost the British economy more
than £3.6 billion a year. Including all people who are overweight this cost
could rise to between £6.6 and £7.4 billion (Donnellan, 2003), and with the
addition of the wider cost to the economy in lower productivity and reduced
output, this could rise by a further £2.1 billion a year (National Institute for
Clinical Excellence, 2003).
The estimated economic costs of obesity vary in different countries, at
different times and depend on thresholds used to define obesity (British
Nutrition Foundation, 1999). However, all available estimates conclude that
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somewhere between 1 and 7% of total healthcare budgets are attributable to
overweight and obesity, depending on the methods of analyses used (Lean,
1998). There are also large costs associated with the care of diseases
attributed to obesity.
The use and cost of medications are markedly increased in the obese
compared with non-obese patients, with studies estimating that of the health
care expenses attributable to obesity in affluent countries, approximately
30% are pharmaceutical costs for treating obesity-related disorders (Gould et
al., 2004). In 2008, almost 1280,000 prescription items were dispensed for
the treatment of obesity compared with just over 127,000 prescriptions in
1999 (an increase of 900%) (NHS, 2010). In a retrospective cohort study of
the relationship between obesity and future health care costs, Thompson et
al., (2001) found that individuals with BMI ~ 30 had 36% higher annual
healthcare costs, including 105% higher pharmacy costs and 39% higher
costs of primary-care visits than their normal weight counterparts. Whilst
these findings suggest that future healthcare costs are higher for persons
who are overweight, the study limitations should be considered. The use of
self-reported height and weight used in the study (Brener et al., 2003) has its
limitations and furthermore, only 56% of those contacted responded to the
mail survey that was used to identify the study cohort. Therefore the impact
of possible response bias on the findings is unknown (Thompson et aI.,
2001).
It is evident from the data discussed above that the financial costs of obesity
are high and are continuing to rise as the prevalence of obesity increases.
Without intervention the financial costs of obesity could have serious
implications on the NHS; however there is a need for more prospective
studies to provide more accurate estimates of the costs of obesity.
Furthermore, the cost-effectiveness of strategies to control obesity needs to
be considered.
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2.4.2 Physiological consequences of obesity
2.4.2.1 Obesity and co-morbidities
Numerous large scale epidemiological cohort studies have established that
excess body weight (as established by BMI) is an important risk factor for a
range of primary co-morbid conditions (Steinbeck, 2004). Each year, CVD is
responsible for 37% of total deaths in the UK, and cancers a further 27% of
deaths. It is accepted that at least part of the cause of these diseases are
due to overweight and obesity (Allender & Rayner, 2007). Approximately
30,000 people die each year from co-morbid conditions which include heart
disease, T2DM and hypertension (Brooks et al., 1996). Furthermore, health
problems directly relating to the carriage of excess adipose tissue are also
evident in the obese (Lawrence & Kopleman, 2004). These include
osteoarthritis of weight bearing joints (British Nutrition Foundation, 1999),
aches and pains, and dyspnea on mild exertion (Lawrence & Kopleman,
2004). Respiratory diseases such as obesity hypoventilation syndrome and
obstructive sleep apnea syndrome are also strongly associated with obesity
(Formiguera & Canton, 2004). Inability to take part in activities of daily living,
immobility, psychosocial and economic problems, and disability are often
associated problems seen in obese individuals, in addition to the major co-
morbidities (Deitel & Shikora, 2002).
The weight gain associated with adverse outcomes and increased morbidity,
increases in a linear fashion with increases in BMI (Aronne & Segal, 2002;
Allan, 2004). For example obese women are almost 13 times more likely to
develop T2DM than non-obese women, whilst obese men are twice as likely
to have hypertension compared to non-obese men (Pi-Sunyer, 2004). The
risk (in comparison with a BMI below 23kg.m-2) increases more than 20-fold
when BMI exceeds 35kg.m-2 (Bray, 2003). Stroke is twice as common among
the morbidly obese and obese women have twice the risk of developing
bowel or rectal cancer, and osteoarthritis than their normal weight
counterparts (Abraham & Llewellyn-Jones, 2001). The health consequences
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of obesity are vast, with virtually all people with BMI > 40 kg.m2 developing
some physical symptoms by the age of 40, and the majority requiring
medical attention or drug therapy for secondary conditions by the age of 50
years or 60 years (Bray, 2003). However, although the relationship of obesity
to mortality indicates that obesity begins to be of clinical importance at a BMI
of approximately 30 kg.m-2 examination of morbidity data shows that health
penalties start at a much lower level (British Nutrition Foundation, 1999). For
example, in Europe and North America, between 8% and 15% of disability
adjusted life years lost are attributed to overweight and obesity (WHO, 2003).
This further highlights the importance of treating obesity.
Although the risk of obesity related co-morbidity increases as BMI increases,
increased risk also relates to body fat distribution (Eckel, 1997). For
example, Janssen et al., (2002) found that individuals with high WC values
were increasingly likely to have hypertension, diabetes, and dyslipidemia,
compared with those with normal we values. There is however reluctance
towards replacing BMI with we as a clinical health risk measurement (Bray,
2004), with a general consensus that we cannot fully replace BMI (Bigaard
et al., 2003) although it's use as a measure of central adiposity may improve
the criteria for assessing risk (Janssen et al., 2004). When examining the
independent associations of we and BMI with all-cause mortality in a cohort
of middle-aged men and women, Bigaard et al (2003) found that WC alone is
a good predictor of mortality when BMI is >25, however when BMI is <25
BMI is also important for the mortality rate. Bigaard et al., (2004) suggest that
further studies investigating other endpoints related to obesity are needed.
2.4.2.2 Obesity and metabolic syndrome
The increasing prevalence of obesity has been accompanied by a parallel
increase in the prevalence of the metabolic syndrome (MetSyn)
(Liberopoulos et al., 2005). MetSyn is a clustering of inter-related risk factors
that identify individuals at increased risk of developing evo and T20M
(Byrne & Wild, 2007). The concept of MetSyn has evolved over recent years,
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but with the recognition that obesity is becoming a major global health
problem, the interest in this syndrome has experienced a dramatic increase
as well as a conceptual evolution (Laclaustra et al., 2007).
Four organisations have provided clinical criteria for diagnosing MetSyn
including WHO, the European Group for Study of Insulin Resistance (EGIR),
the National Cholesterol Education Program Adult Treatment Panel III
(NCEP ATP III) and the International Diabetes Federation (IDF) (Table 2.8).
In 1998 the WHO clinical criteria required the presence of insulin resistance
(Alberti & Zimmett, 1998). The EGIR criteria also consider the presence of
insulin resistance for the clinical diagnosis of the MetSyn, although unlike the
WHO criteria does not require results of a glucose tolerance test (Wild &
Bynre, 2006). The NCEP ATP-III criteria eliminated the insulin resistance
requirement in 2001 but require the presence of 3 out of 5 equally weighted
abnormalities. Furthermore, the IDF clinical criteria require the presence of
abdominal obesity (Le. increased WC) (Alberti, Zimmet & Shaw, 2005) and
emphasised ethnic-specific cut-offs for this measure (Alhassan et al., 2008).
NCEP ATP III considers abdominal obesity one of the 5 equally weighted
metabolic abnormalities (NCEP Expert Panel, 2001). It is important to note
that the existing clinical criteria for MetSyn can lead to substantially different
estimated prevalence of MetSyn within a population (Alhassan, et al., 2008)
and therefore could potentially impact research findings. Much research has
examined similarities and differences between the MetSyn clinical criteria
and the impact these criteria have on identifying individuals with the
condition. For example, in a study of 256 postmenopausal women (mean
BMI 32 ± 4kg.m-\ up to 23% of participants were classified differently as
either having or not having MetSyn, according to the clinical criteria used
(Alhassan et al., 2008). These results confirm results of previous study
conducted by de Simone et al., (2007), who reported that IDF clinical criteria
identified more individuals as having MetSyn than other clinical criteria. A
higher rate of diagnosis has also been seen in WHO criteria compared with
ATP III (25.1 vs. 23.9%) in a population of 8608 participants in the USA
(Lin,Chiou et al., 2004).
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The prevalence of MetSyn varies with the country, ethnic origin and the
definition used (Bauducea et al., 2007). It is estimated that 47 million US
adults meet the NCEP criteria for MetSyn (Liberopoulos et al., 2005) and in
the UK the prevalence of MetSyn in adults is estimated to be at least 15%
(Byrne & Wild, 2007). MetSyn is clinically important and relevant to primary
care due to the increased risk associated with it (Fig.2.6). For example
MetSyn accounts for around half of attributed diabetes, a quarter of incident
cardiovascular (CV) disease, and CV mortality associated with MetSyn is
estimated at 37% (Byrne & Wild, 2007) to 291% (Lakka et al., 2002).
Abdominal
Obesity
METABOLIC
SYNDROME
Type II
diabetesCardiovascular Disease &
Complications
Diabetic
Complication
Figure 2.6. Progression and outcome of the MetSyn (Grundy, 2006).
The development of specific recommendations for managing MetSyn has
been limited due to lack of published randomised controlled trials, however it
is estimated that 50% of the diseases in MetSyn can be treated by lifestyle
modification. These lifestyle modifications include weight loss (in
overweight/obese individuals), increased physical activity and dietary
modification (Byrne & Wild, 2006). Due to the absence of an identified
unifying pathophysiological mechanism of MetSyn (Cornier et al., 2008),
these treatment modalities aim to improve the individual MetSyn parameters,
as opposed to treating MetSyn in itself.
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Weight loss is a well established method for treating all components of
MetSyn (NIH, 2008) and is best achieved by reducing energy intake and
increasing energy expenditure (Eckel et al., 2005). The primary goal is to
achieve a 10% reduction in total body weight in overweight/obese individuals
with MetSyn (Grundy, 2007). Dietary composition for the treatment of
MetSyn is consistent with general dietary guidelines that recommend
increased intake of fruit and vegetables, low intake of saturated and trans
fats and reduced consumption of sugars. However, long term data suggest
that key predictors of metabolic risk factor reduction are dependent upon
degree of dietary adherence and associated weight loss, rather than diet
type (Dansinger & Schaefer, 2007). Regular and sustained physical activity
has also been shown to prevent MetSyn (Ford et aI., 2005) and research
evidence suggests that physical activity improves all components of MetSyn
such as lowering LDL-C and TG levels (Katzel, 1997), increasing HDL-C
levels (Liberopoulous et al., 2007; Reaven, 2008) and reducing hypertension
(Whelton et al., 2002). However, the amount and intensity of physical activity
required to prevent or reverse MetSyn has yet to be established.
While lifestyle modification resulting in weight loss can achieve clinically
significant benefits, approximately 50% of people with MetSyn do not reach
treatment targets without drugs (Byrne & Wild, 2006). Guidelines for the
treatment of obesity recommend consideration of pharamceutical therapy for
weight loss for individuals with a BMI ~30kg.m-2, or those with a BMI
~27kg.m-2 and associated comorbidities. Therefore, the majority of patients
who meet MetSyn criteria will meet the criteria for considering
pharmaceutical weight loss therapy. Sibutramine and orlistat are currently
the only approved weight loss drugs and have been shown to have
therapeutic effects on individual components of MetSyn (Bray & Greenway,
2007). However, there are no specific drug treatments recommended for
MetSyn beyond medications that improve its individual components, namely
hypertension and dyslipidemia (Meigs et al., 2003).
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MetSyn risk factors tend to co-exist more commonly than would be expected
by chance. For example, diabetes and obesity are twice as common among
people with hypertension compared to those with normal blood pressure
(Hardman & Stensel, 2009). A defining feature of the MeySyn is insulin
resistance and it has been argued that the clustering of components that
make up MetSyn only occurs in insulin-resistant persons (Harman & Stensel,
2009). Elevated insulin levels can lead, directly or indirectly, to the
characteristic metabolic abnormalities seen in individuals with MetSyn. For
example, several potential mechanisms have been proposed to explain the
association between insulin resistance and hypertension, including increases
of the sympathetic nervous system caused by insulin resistance and
overactivation of the renin-angiotensin-aldosterone system caused by
hyperinsulinaemia (Engeli & Sharma, 2001). Insulin also exerts multiple
influences on lipid metabolism, promoting the synthesis of fatty acids in the
liver and inhibiting the breakdown of fat in adipose tissue, leading to high
plasma concentrations of triglycerides (Harman & Stensel, 2009).
The IOF consider abdominal obesity an essential criterion, and assign this
abnormality a central aetiological role. Nearly half the variation in insulin
sensitivity amongst individuals is accounted for by variations in body fat
distribution, and there is increasing evidence that abdominal fat accumulation
is related to hypertension, hypertriglyceridemia and lipo-protein disturbances
(Bonithon-Kopp et al., 1992). Weight reduction can improve insulin sensitivity
and glucose tolerance, thus over-fatness and insulin resistance are closely
linked. Furthermore, numerous studies have identified the link between
abdominal obesity and insulin resistance (Ascaso et aI., 2003, Haffner,
2006). However, whether insulin resistance is causative of abdominal
obesity, or both correlate with some other factor is unknown and there is no
clear proof of a causal link between visceral fat accumulation and insulin
resistance.
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Whether physique, constitution and disease are interlinked to each other has
always been a great point of interest (Singh, 2007). Numerous large scale
epidemiological cohort studies have established that excess body weight (as
established by BMI) is an important risk factor for a range of primary co-
morbid conditions (Steinbeck, 2004; Wolk et al., 2003; Gus et al., 2004).
Furthermore, as discussed above, abdominal obesity is also linked to range
of metabolic disturbances. There is also some limited documented evidence
of characteristic somatotypes being associated with some diseases and
conditions (Herrera et al., 2004). For example, a combination of high scores
on the SUb-component of mesomorphy and endomorphy are believed to
increase cardiovascular risk (Carter & Heath, 2005) and adverse lipid profiles
have also been identified in individuals with dominant endomorphy and
mesomorphy SUb-componentscores (Carter & Heath, 2005). Furthermore, a
cross-sectional survey conducted by Koleva et aI., (2002) examined the
association between global somatotype and its SUb-components and the
prevalence of several chronic diseases.
2.4.3 Psychological consequences of obesity
Being obese can carry a strong, negative social stigma (Puhl & Brownell,
2001) and discriminatory attitudes and behaviours occur towards the
overweight and obese in many areas including employment (Pingitoire et al.,
1994; Roehling, 1999), healthcare (Oberriede et al., 1995; Wadden et al.,
2000) and education (Neumark-Sztainer et al., 1999). For example, in the
United States late adolescent obesity in women in 1981 was found to
correlate with lower incomes in 1988, compared to women who had not been
overweight (Gortmaker et al., 1993). In the UK, men who had been obese at
16 years in 1974 earned 7.4% less than their non-obese peers at age 23
(Sargent & Blanchflower, 1993). Furthermore, Viner and Cole (2005) found
that men who were obese in adulthood were more likely to have left school
without any qualifications, with similar findings reported by Gortmaker et al.
(1993) and Laitinen et al. (1999) in female cohorts. For some obese
individuals negative stigmatisations, discriminatory attitudes and behaviours,
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particularly evident in modern Western countries (Abraham & Llwellyn-Jones,
2001), can trigger or exacerbate psychological issues such as decreased
mood, increased anxiety, low self-esteem and body image disturbances
(Lawrence & Kopleman, 2004; Swinburn & Egger, 2004). Women and
adolescent girls appear to suffer these negative consequences the most; this
is potentially due to increases societal pressures on women to be thin
(Carpenter et al., 2000).
There is an extensive body of research literature that recognises the
detrimental physiological consequences of obesity (Steinbeck, 2004)
however the psychological distress assumed in obese people is not
supported by consistent literature (Carr et al., 2007; Hill, 2005). Studies such
as those by Dong et al. (2004), Wadden et al., (2006) and Carr et al., (2007)
have found a negative relationship between body weight and psychological
well-being and Schwartz and Brownell (2004) found obesity to be a cause of
psychological distress leading to reduced quality of life. Furthermore, in a
structured 12-week weight loss program Rippe et al. (1998) found weight
loss to yield significant health and psychological benefits in moderately
obese females and recommendations were made to consider psychological
aspects of obesity and weight loss as well as physiological features. In
contrast, other studies have found no significant association between obesity
and negative psychological consequences. For example in a sample of 322
patients with T2DM, Herpertz et al., (2000) identified no relationship between
BMI and depressive symptomatology, low self-esteem or general psychiatric
symptomatology. Some studies have also demonstrated an apparent
protective effect of excess body weight on psychological distress
(Fabricatore & Wadden, 2004; Goldney et al., 2009).
Methodological shortcomings have been identified in the area of obesity and
psychological variables, in particular regarding body image. Literature that
has focused on psychological correlates of obesity within obese populations
has tended to focus on severe obesity (Adami et al., 1999; Batsis et al.,
2009; Bocchieri et al., 2002; Thonney et al., 2010). There is considerable
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heterogeneity in the obese population (Carr et al., 2007; Kimm et al., 1997;
Schwartz & Brownell, 2004) therefore it is not clear how these findings
generalise to the larger population of overweight, obese individuals. It has
been hypothesised that extremely obese persons appear to be at greater risk
of psychological distress compared to moderately obese individuals
(Fabricatore & Wadden, 2004) with Hill and Williams (1998) finding body
dissatisfaction to worsen with increasing degree of obesity. Obesity has also
been associated with increased levels of depression, mainly among persons
with severe obesity (Onyike et al. 2003). Friedman and Brownell (1995)
conducted a review on the psychological correlates of obesity and identified
the need to move on from research that compared obese and non-obese
individuals and consider the influence of degree of obesity.
Substantial evidence suggests a link between physical activity and reduced
anxiety (Steptoe & Butler, 1996; Thirlaway & Benton, 1996), decreased
depression (Blumenthal et aI., 1999) and improved cognitive functioning
(Sallis et al., 1999). However research has shown that the physiological
adaptation achieved through being physically active has no direct influence
on psychological functioning (Plante et aI., 1998). It has since been
hypothesised that the psychological benefits of physical activity programmes
are related more to the perception of improved fitness than to objective
improvements (Delignieres et al., 1994). Fox (2000) also suggests that actual
physical changes may be unnecessary to improve self-perceptions. Although
correlational analysis cannot establish causation, more recent research
findings of studies conducted by Shaw et al., (2000), Van Vorst et al. (2002),
and Polman and Borkoles (2007), oppose the view that changes in self-
perceptions are purely based on psychological mechanisms. However,
further research is needed to identify whether the changes in self-
perceptions are explained by physiological and/or anthropometrical variables
(Polman & Borkoles, 2007).
It is also worth noting that there is no clear separation between psychological
factors that function as causes of obesity and the psychological effects of
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obesity (Fabricatore & Wadden, 2004), although the conclusion that
psychological factors associated with obesity are more likely to be
consequences than causes is generally accepted (Lissner, 1997).
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3. GENERAL METHODS AND INSTRUMENTATION·
This chapter details the general data collection methods and techniques
utilized in the studies that comprise this thesis. Specific methodological
details will be provided in subsequent chapters. Particular mention is made
of quality assurance methods implemented to increase reliability and validity
of data. Additionally, approaches to somatotype analysis are detailed. All
studies received ethical approval from the BioSciences Research Ethics
Committee of the University of Portsmouth.
3.1 Anthropometrical data collection
To ensure standardisation of data collection procedures, all restricted
anthropometric profiles (Table 3.1) were conducted in accordance with ISAK
guidelines (Marfell-Jones et al., 2006), by the author, a level II accredited
anthropometrist.
Table 3.1. Measurements included in a restricted anthropometric profile
Basic Skinfolds (mm) Girths (cm) Breadths (cm)
Height (cm) Triceps Arm (relaxed) Humerus
Weight (kg) Subscapular Arm (flexed & tensed) Femur
Biceps Waist (minimum)
Iliac crest Gluteal (maximum)
Supraspinale Calf
Abdominal
Front thigh
Medial calf
Images A and B (Fig.3.1) are examples of landmarks that are used to identify
the exact location of the measurement sites. These are identifiable skeletal
points which generally lie close to the body's surface. Locating and marking
the landmark is pre-requisite for reproducible and valid measurements
(Stewart et al., 2004). Images C and D (Fig. 1) represent examples of
skinfold measures.
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Figure 3.1. Landmarks for iliac crest (A) and supraspinale skinfolds sites (8)
and examples of abdominal skinfold (C) and iliac crest skinfold (0)
measurements (Ross et al., 1999)
The skinfold was grasped and lifted (raised) at the marked line (Fig.3.2a) so
that a double fold of skin plus the underlying subcutaneous adipose tissue is
held between the thumb and index finger of the left hand (Fig.3.2b). The
caliper, held at a 900 to the surface of the skinfold at all times, was applied
1cm away from the edge of the thumb and finger at a depth of approximately
mid-fingernail (Fig.3.2c). Measurement was recorded two seconds after the
full pressure of the caliper was applied.
Figure 3.2. Examples of skinfold measuring technique (healthgoods.com,
1998).
A cross hand-technique was used for all girth measurements, ensuring no
visible indentation of the skin, as depicted in images E and F (Fig.3.3).
Considerable pressure was applied when conducting breadth measurements
in order to compress the soft tissue overlying the bone in obese individuals
(G & H - Fig.3.3).
Figure 3.3. Examples of arm relaxed and gluteal girths (E&F, respectively) and
humerus breadth (G) and femur breadth (H) measurements (Ross et al., 1999)
3.1.1 Equipment
Body height and mass were measured using a portable stadiometer
(Leicester, Bodycare, UK) and electronic weighing scales (524J/BMI, Avery-
Weightonix, UK), to a precision of 0.1cm and 0.1kg respectively. Participants
wore minimal clothing when being weighed. Common problems associated
with the accuracy of anthropometric measures include use of calipers that do
not exert constant pressure at the skinfold site, and use of a stretchable,
cloth tape measure (Utley, 1990; Van Loan, 1997). Therefore, in the present
studies skinfolds were measured using calibrated Harpenden skinfold
calipers (John Bull, UK) and girths using Thinline anthropometric tape (Lufkin
W606PM, USA). Breadths were measured using small sliding calipers
(Rosscraft, UK). Replicate determinations of each measure were made to
calculate a mean score. If any two independent assessments varied by more
than 5% (skinfolds) and 1% (girths and breadths), a third measurement was
taken and the median score recorded.
3.1.2 Data handling
Using the data collected in the anthropometric profile, BMI (kg.m-2) and WHR
(waist girth/gluteal girth) were calculated. L8SF was calculated by summing
the skinfolds listed in Table 3.1. The calculations of the anthropometric
somatotype sub-components, which use 10 variables, are shown in Box 3.1.
Transformation of skinfold measures to body density (BD) was done using
Durnin and Womersley's (1974) equation, then further transformation to %BF
using the Siri equation (Box 3.2).
A number of prediction equations are available in the literature (Norton &
Olds, 1996) however it is important that participants are measured using an
equation derived from a similar population; as using an inappropriate
equation may produce systematic prediction error in estimating body
composition (Brooks et al., 1996). In contrast to other equations derived
from athletic populations, Durnin and Womersley's (1974) sex specific
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equations used a sample of 209 males and 272 females with varying body
types (from obesity clinics, health clubs, sport organisations and other
sources). Therefore its use in an overweight/obese population was deemed
more appropriate.
To calculate endomorphy:
Endomorphy = -0.7182 + 0.1451 x LSF - 0.00068 x LSF2 + 0.0000014 x LSF
To calculate mesomorphy:
Mesomorphy = 0.858 X HB + 0.601 x FB + 0.188 x CAG + 0.161 x CCG girth -
H x 0.131 + 4.5
To calculate ectomorphy:
Three equations are used according to the height-weight ratio (HWR):
If HWR is greater than or equal to 40.74 then
Ectomorphy = 0.732 x HWR - 28.58
If HWR is less than 40.75 and greater than 38.25 then
Ectomorphy = 0.463 x HWR -17.63
If HWR is equal to or less than 38.25 then
Ectomorphy = 0.1
Where: LSF = (sum of triceps, subscapular and supraspinale skinfolds) x
(170.18 height in cm); HB = humerus breadth; FB = femur breadth; CAG =
corrected arm girth; CCG = corrected calf girth; H = height; HWR =
height/cube root of weight.
CAG and CCG are corrected for the triceps or calf skinfolds respectively as
follows: CAG = flexed arm girth - triceps skinfold/10; CCG = maximal calf girth
- calf skinfold/1 o.
Box 3.1. Equations to derive somatotype sub-component scores (Carter, 2002).
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Durnin and Womersley's body density prediction equation (1974)
Males:
BD = 1.1765 - 0.0744 (log10X1)
Where; BD= body density; X1(mm) = L4 skinfolds (triceps, biceps,
subscapular, iliac crest in mm)
Females:
BD = 1.1567 - 0.0717 (log10X1)
Where: BD = body density; X1(mm) = L4 skinfolds (triceps, biceps,
subscapular, supraspinale in mm)
Siri %BF prediction equation (1961)
%BF = (495/ Body Density) - 450
Where: %BF = percent body fat; BD = body density
Box 3.2. Equations to derive body density (Durnin & Womersley, 1974) and
%BF (Siri, 1961).
3.1.3 Technical error of measurement
As with any quantitative biological measure, in anthropometric assessment it
is important to minimize error (Moreno et al., 2003). High levels of error can
render statistical comparisons invalid, and errors can artificially inflate the
variance associated with a particular measurement (Bailey & Byrnes, 1990).
Furthermore, empirical data have shown that the measurement error can
compromise a wide variety of univariate and multivariate statistical methods,
particularly those that rely on correlation, regression, and covariance
(Halligan, 2002). Therefore prerequisites for increased precision and
improved interpretation of results include good quality control, involving both
reduction in instrumentation and human error (Goto & Mascie-Taylor, 2007).
A number of methods of measuring inconsistency are available but the
preferred method involves calculation of either intra- or inter-technical error
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of measurement (TEM) initially, relative TEM (%), and then the coefficient of
reliability (Ulijaszek & Kerr, 1999). TEM gives information on the error margin
of a trait and therefore is an accuracy index (Goto & Mascie-Taylor, 2007).
This index is adopted by ISAK (Perini et al., 2005). If the same assistant has
measured an individual on two occasions (a measure of intra-TEM), or two
assistants have measured the same individual (inter-TEM), then the formula
for TEM is:
where D is the difference between the two measurements,
and N is the sample size.
The units of TEM are the same as the units of the measurements to which
they apply. Hence, for skin-folds the units are in millimetres and
circumferences are in centimetres etc. It is also possible to compute the
relative TEM (%TEM), which provides an estimation of the error magnitude
relative to the size of the measurement (expressed as a percentage) and is
analogous to the coefficient of variation. This is calculated by dividing the
TEM by the mean measurement:
(
TEM)%TEM = X * 100
Measurement of at least 10 participants must be obtained for the calculation
of intra- and inter-observer errors of measurement (Moreno et al., 2003). To
examine reliability and ensure minimal error within the current studies, the
anthropometrists' intra-technical error or measurement (intra-TEM), relative
TEMs and co-efficient of reliability were calculated. All were within
acceptable ranges as defined by ISAK (Appendix 4). Table 3.2 gives the
mean, standard deviation (SD) and intra-TEM of anthropometrical
measurements collected in 3 population groups; overweight (n=20), obese
(n=20), and morbidly obese (n=16).
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Figure 3.4 shows the relative TEM expressed as a percentage. ISAK defines
the acceptable limits of tolerance as 5% for skin-folds and 1% for all other
measures. In each population group all measurements were under these
thresholds (Fig.3.4). However, it is noted that the % variation increased
concurrently with degree of obesity, with the greatest intra-observer % TEM
scores seen in the morbidly obese group. Figure 3.4 also illustrates that
within the morbidly obese population, skinfolds around the trunk had the
highest intra-observer %TEM, which reflects the difficulty in taking up a fold
of skin correctly in that area of the body.
From TEM, the coefficient of reliability (R) can be determined, which ranges
from 0 (not reliable) to 1 (complete reliability). This coefficient shows the
proportion of the between-subject variance (total measurement variance) that
is not due to measurement error (WHO, 2006). The formula to determine the
coefficient of reliability is:
1_ ((TEM)2)
(SD)2
where SD is the standard deviation of all measurements
An R of 0.8 means that 80% of the total variability is true variation, while the
remaining proportion (20%), is attributable to measurement error. This is
described by the WHO Multicentre Growth Reference Study (2006) as
imprecision and unreliability. Although there are no recommended values for
R, Ulijaszek & Kerr (1999), suggest that coefficients of reliabilittes above 0.95
(Le. a human measurement error of up to 5%) are indicative of good quality
control. However, even at R values of approximately 95%, there is the
occasional gross measurement error that is likely to have important
consequences. Only when R is in the region of 99% is such an error unlikely
(Moreno et al., 2003). R was calculated for the three aforementioned
population groups and reliability for all measures ranged from 98% to 100%,
thus indicating high levels of reliability and minimal error.
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The use of multiple measurers to collect data risks the introduction of
systematic measurement errors with the potential to affect the results
(Adams et al., 2002). In particular, research evidence suggests that waist
and hip circumference show strong between-observer differences and
should, where possible, be carried out by one observer (Ulijaszek & Kerr,
1999). All data collection in the forthcoming studies were conducted by one
observer thus eliminating between-observer error. However, to further
examine the anthropometrist's expertise, inter-observer TEMs (compared
with a level 3 criterion anthropometrist with over 10 years practical
experience) were also calculated. Tolerance levels were again within
acceptable limits as governed by ISAK (Appendix 4).
These quality assurance methods, including standardised data collection
methodology and rigorous training and maintenance, similar to those utilised
by the World Health Organisation in the Multicentre Growth Reference Study
(2006), have been implemented to further increase reliability of data.
Frequent equipment calibration was also conducted to minimise instrument
error (Goto & Mascie-Taylor, 2007).
3.2 Approaches to somatotype analysis
Specific statistical procedures to analyse anthropometric data are detailed in
subsequent chapters. However, somatotype is a 3-number rating; therefore
for meaningful analysis unique analytical procedures are required. Prior to
the development of sophisticated analyses for analysis of the somatotype as
a whole, the somatotype component ratings were analysed separately. As
discussed by Marfell-Jones et al. (2006), this prematurely separates the
somatotype into three components and does not analyse the whole
somatotype. The strength of the somatotype concept is the combination of all
three component values into one expression (Ducquet & Carter, 2009).
Specialised techniques to analyse the somatotype as a whole include
somatotype categories and somatotype attitudinal distance (SAD) techniques
(Ducquet & Carter, 2009).
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Somatotypes with similar relationships between the dominance of
components are grouped into categories named to reflect those relationships
(Norton & Olds, 1996). This gives a more qualitative description of the
individual somatotype, in terms of the dominant component or components
(Duquet & Carter, 2001). A total of 13 somatotype categories were defined
by Carter and Heath (1990) (Table 3.3).
Table 3.3. Somatotype categories and corresponding dominance variation,
as defined by Carter and Heath (1990).
Somatotype
Dominance Variation
Category
Central
No component differs by more than one unit from the other
two.
Balanced Endomorphy is dominant and mesomorphy and ectomorphy
endomorph are equal (or do not differ by more than one-half unit).
Mesomorphic Endomorphy is dominant and mesomorphy is greater than
endomorph ectomorphy.
Mesomorph Endomorphy and mesomorphy are equal (or do not differ by
endomorph more than one half unit), and ectomorphy is smaller.
Endomorphic Mesomorphy is dominant and endomorphy is greater than
mesomorph ectomorphy.
Balanced Mesomorphy is dominant and endomorphy and ectomorphy
mesomorph are equal (or do not differ by more than one-half unit).
Ectomorphic Mesomorphy is dominant and ectomorphy is greater than
mesomorph endomorphy
Mesomorph Mesomorphy and ectomorphy are equal (or do not differ by
ectomorph more than one-half unit), and endomorphy is smaller.
Mesomorphic Ectomorphy is dominant and mesomorphy is greater than
ectomorph endomorphy.
Balanced Ectomorphy is dominant and endomorphy and mesomorphy
ectomorph are equal (or do not differ by more than one-half unit).
Endomorphic Ectomorphy is dominant and endomorphy is greater than
ectomorph mesomorphy.
Balanced Ectomorphy is dominant and endomorphy and mesomorphy
ectomorph: are equal (or do not differ by more than one-half unit).
Endomorph- Endomorphy and ectomorphy are equal (or do not differ by
ectomorph: more than one-half unit), and mesomorphy is lower.
Ectomorphic Endomorphy is dominant and ectomorphy is greater than
endomorph: mesomorphy.
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The differences or similarities in somatotypes of subjects or groups of
subjects can be visualised by plotting them on a somatochart, shown in
Figure 3.5 (Ouquet & Carter, 2001). This provides a bi-dimensional
representation of the tri-dimensional somatotype (Norton & Olds, 1996). The
left apex represents a 7-1-1 (extreme endomorph) somatotype; the top apex
represents a 1-7-1 (extreme mesomorph) somatotype; and the right apex
represents a 1-1-7 (extreme ectomorph) somatotype. The centre of the
somatochart represents a (balanced) somatotype (Siders & Rue, 1992).
Somatotypes lying outside the arc-sided triangle can be identified as
extremes for their particular category (Carter & Heath, 2005).
Bi\I.l'U'CSD
HBSo)!()fll':f.I
• = Somatopoint 1
= Somatopoint 2
EN'IlQKORPHIC
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= SAD
I ... IJ =MD
..,.
Figure 3.5. 2-D somatochart showing co-ordinates and somatotype categories
(Norton & Olds, 1996) with 3 example somatotpoints plotted to illustrate SAD
and MD.
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Using appropriate equations (Box 3.3) the distance between somatotypes
can be quantified in two or three dimensions (Martell-Jones et al., 2006).
Two and three dimensional distances between pairs of somatotypes are
called the somatotype dispersion distance (SOD) and somatotype attitudinal
distance (SAD), respectively. The average of the distribution of somatotypes
about their mean can also be calculated in two dimensions (somatotype
dispersion mean; SDM) and three dimensions (somatotype attitudinal mean;
SAM) (Carter & Heath, 2005).
The three-dimensional approach is recommended for most analyses as SAD
and SAM contain more accurate information about the true distances
between somatotypes than the SOD and SDM (Martell-Jones et al., 2006).
The SAD is the exact difference, in component units between two
somatotypes (A, an individual or group, and B, an individual or group), or
between a subject and a group mean (e.g. subject A and group mean B)
(Duquet & Carter, 2009). In this study, A and B were the same individual
between two time points, for example from baseline to month 2 (Box 3.3).
The migratory distance (MD) is a quantitative way to describe the total
change in somatotype over time. This is calculated by summing SAD values,
calculated from each consecutive pair of somatotypes of the subject. For
example in this study, the sum of change in somatotype from baseline to
month 2, month 2-3 and month 3-4 .......month 11-12. (Box 3.3).
A number of parametric and non-parametric techniques can be applied to
analyse somatotype data, however not all are appropriate for every study
(Martell-Jones et aI., 2006) and exact procedures of analysis are determined
by the nature of the data, the numbers of subjects and the kinds of groups to
be compared (Carter & Heath, 2005). Carter and Heath (2005) recommend
the use of descriptive statistics and a somatochart as a minimum for any
study involving somatotype data. Therefore, the studies within this thesis will
present somatotype category distributions and somatocharts alongside
descriptive data including mean endomorphy, mesomorphy and ectomorphy
ratings, and SAM, SAD and MD values. To test for differences between the
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distributions of somatotype category between samples, Chi-square test can
be applied (Carter & Heath, 2005). However Chi-square test cannot be used
in a repeated measures design and there are no universally-accepted 'post-
hoc' with categorical tests. Thus this procedure is unsuitable to the analysis
aims of the studies that comprise this thesis and were not utilised.
SAD(A; B) = (end(A) - end(B))2 +(mes(A) - mes(B))2 + (ect(A) - ect(B))2
(Where SAD = somatotype attitudinal distance; A and B = same individual at
two different time points; end = endomorphy; mes = mesomorphy; and ect =
ectomorphy)
(Where SAM = somatotype attitudinal mean; SAD = somatotype attitudinal
distance; X = a group; X = somatotype mean of group; Xi = an individual
member of a group; Nx = number of participants in group X)
MD(a; z) = SAD(a; b) + SAD(b; c)+ ... + SAD (y; z)
(Where a = first observation, b = second observation; .... ;z = last observation;
SAD(p;q) = change from somatotype p to somatotype q)
Box 3.3. Equations to derive somatotype attitudinal distance (SAD), somatotype
attitudinal mean (SAM) and migratory distance (MD) (Carter & Heath, 2005).
To compare between two or more somatotypes in a repeated measures
design analysis of variance (ANOVA) using SAD values calculated for each
individual can be used (Carter & Heath, 2005). These values do not give the
actual direction of change, thus somaotcharts are used to identify direction
(Carter, personal communication, 2010). Therefore, in all studies, analysis of
global somatotype in three-dimensional space was calculated by plotting the
mean somatotype (S) at each month on a somatotchart, and calculating each
individuals SAD between each month. MD was also calculated to examine
changes over longer time periods. A repeated measures analysis of variance
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(ANOVA) was used to compare the mean somatotypes, using the calculated
SAD scores. Bonferonni multiple comparison procedure was applied to
determine which means were different, using a critical value of 0.49 SAD
units. This value is considered a meaningful and practical difference between
somatotype means (Carter et al., 1997). If there were changes over time,
each individual component was tested using repeated measures ANOVA to
see which changed significantly.
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4. STUDY ONE: Longitudinal change in
anthropometric measures
This chapter examines the change in a range of anthropometric measures in
an overweight/obese population, actively trying to lose weight, in order to
identify the most discernible measure of change. Data are presented in two
parts. Part A first examines the changes in both traditional and alternative
body composition measures over a 4 month period. This was to establish
whether these measures changed Significantly in the short-term, thus
justifying longitudinal investigation. Long-term outcomes may provide more
information about the sustainability of these anthropometric measures as
tools to monitor weight loss over time. Therefore, part B examined and
compared change in traditional and alternative anthropometric measures
over an extended time period of a year, in order to identify whether
alternative anthropometric measures showed greater magnitudes of change
than traditional anthropometric measures. This chapter also includes
consideration of the controversies surrounding the measurement of change
and the issues associated with unit variation when analysing and comparing
variables. This was an issue in the current study and various analysis
methods are discussed and justification provided for the choice of analysis
used in the data analysis conducted in part B.
4.1 Introduction
Establishing the best technique to measure obesity has long been a matter
of dispute (Franzosi, 2006; James, 2005). Weight related parameters, such
as body weight and BMI, are the most commonly used methods to determine
obesity status and define success within weight management programmes
(Carmichael, 1999). However, the limitations of these measures are well
documented (Norton & Olds, 1996; Cook et al., 2005; Blair & LaMonte,
2006). The composition of the body; comprising of lean body tissue and body
fat or adipose tissue, is an important factor to consider when assessing
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obesity and health status. Both the total amount of body fat and the way in
which fat is regionally distributed affect the risk and severity of many chronic
diseases (Heyward & Wagner, 2004). For example, independent of BMI,
both cross-sectional and longitudinal studies have related central fat to
T2DM and CVD (Pi-Sunyer, 2004). Furthermore, health benefits are often
seen independent of weight loss. This is highlighted in a study by Lee at al.
(2005) who found that regular exercise without weight loss was associated
with a substantial reduction in total and visceral fat and in skeletal muscle
lipid in both obesity and T2DM. A summary statement from the American
Heart Association authored by Poirier et aI., (2006) acknowledges the lack of
prospective trials that show change in mortality with weight loss in obese
patients, studies have reported that individuals who intentionally try to lose
weight present significantly lower all cause mortality, independent of weight
change. For example, in a sample of 6391 overweight and obese individuals
(BMI ~25kg.m-2) aged at least 35 years, Gregg et al. (2003) reported 24%
lower mortality rates in those reporting intentional weight loss compared to
persons not trying to lose weight and reporting no weight change. A 31%
higher mortality rate was observed in those with unintentional weight loss
compared to persons not trying to lose weight and reporting no change.
Furthermore, in a prospective analysis with a 12-year mortality follow-up of
4,970 overweight individuals with diabetes, aged 40-64 years, intentional
weight loss was associated with a 23% reduction in mortality (Williamson et
al., 2000). However, the reasons for weight-change in these studies are
unclear and do permit any assumptions of causality. In order to determine
the true effect of weight loss on mortality, more long-term prospective studies
are needed.
In light of the recognition that fat distribution, independent of overall obesity,
is associated with metabolic disturbances and increased disease risk
(Snijder et aI., 2006) the need for improved measures of body fat and fat
distribution has been recognised (Deitel et al., 2007). In particular these
improved analytical methods should be sensitive to intra-individual change
(Teixeira et al., 2005). The method of somatotyping combines an appraisal of
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relative adiposity, musculo-skeletal robustness and linearity into a three
number rating - summarising the physique as a unified whole (Kaur, 2009;
Gakhar & Malik, 2002). As a consequence of this uniqueness, somatotyping
has been used to study many aspects of exercise, sports sciences and
human biology (Carter et aI., 2005). It has been used to describe and
compare the physiques of athletes at all levels of competition and in a variety
of sports. It has also been used to describe the changes in physique during
growth, ageing and training, as well as in relation to physical performance
(Duquet & Carter, 2001). However the use of somatotyping in an
overweighUobese population has to date received little attention. Even the
limited somatotype surveys of the general population that have been
conducted are unlikely to reflect the incidence of obesity because the obese
generally avoid such exposure (Carter & Heath, 2005).
In a study by Fett et al., (2006) somatotype data were collected on
overweight or obese sedentary women assigned to either a circuit training
(n=14), or jogging intervention (n=12). The mean BMI of the circuit training
group and jogging group at baseline was 33±8kg.m-2 with mean
endomorphy, mesomorphy and ectomorphy scores of 10.0-7.0-0.6,
respectively. In comparison the jogging group (n=12) had a mean BMI of
28±1kg.m-2 at baseline with mean endomorphy, mesomorphy and
ectomorphy scores of 9.0-5.0-0.4 respectively. These endomorphy and
mesomorphy scores are higher than those observed in a study by Seltzer
and Mayer (1969), cited by Carter and Heath (2005), who identified mean
somatotype ratings of 8.5-4.5-1.0 in a population of 90 adult, obese
Caucasian women, aged 24-70 years and 61.7kg - 155.5kg. The circuit
training group showed a significant reduction in endomorphy from month one
to month two, decreasing from 10 to 8. Mesomorphy and ectomorphy
showed no significant change. In contrast, the jogging group showed
significant change in all somatotype SUb-componentsfrom baseline to month
2 (9.0-5.0-0.4 and 7.0-5.0-1.5, respectively).
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As exclusive or excessive focus on weight as an outcome is a recognised
limitation of current research (Teixeira et al., 2005) Study One aimed to
compare the discernibility of traditional and alternative anthropometric
measures. In order to increase the likelihood of change occurring, both parts
A and 8 of the current study focused on change in overweight/obese
individuals actively trying to lose weight. As the study aimed to identify the
most discernible measure to monitor change, identifying this within the
population that it would be most likely used (i.e. monitoring weight loss of
individuals over their ideal weight) was deemed most appropriate. Part A
first examined these changes over a 4 month period.
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4.2 PART A
4.2.1 Aims and hypotheses
Part A of Study One aimed to examine the change in traditional and
alternative body composition measures within an overweight/obese
population over a four month period. No comparison was made between
traditional and alternative anthropometric measures at this stage as the aim
was solely to identify whether significant changes occurred, in order to
warrant further investigation. The following alternative (experimental)
hypotheses were formulated:
H1) Alternative anthropometric measures would change significantly over a 4
month period.
H2) Traditional anthropometric measures would change significantly over a 4
month period.
4.2.2 Methods
4.2.2.1 Study design & participants
The fundamental design of Study One was a longitudinal prospective study
consisting of a cohort group. Cohort studies do not have randomisation of
study participants therefore they are more vulnerable to selection bias and
may affect the reliability and validity of results. However, in the current study
no intervention was given as each participant acted as their own control. For
example, all participants received the same treatment (body composition
assessment) regardless of what diet or exercise programme they may have
been following. The change in one anthropometric measure was compared
with the change in another anthropometric measure of that same individual.
Thus the vulnerability of selection bias, common in cohort studies (Rochon et
al., 2005), was controlled in the current study. Furthermore cohort study data
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permits the longitudinal observations of an individual through time (Tager,
1998), thus temporal relations can be clarified (Sabin & Phillips, 2001). As
Part B of Study One focused on longitudinal observations, cohort data suited
the nature of the study's aims and objectives.
Participants were recruited via distribution of leaflets and posters at GP
surgeries within the Portsmouth area, poster advertising in local fitness
facilities, and presentations at local slimming organisations and community
groups in the Portsmouth area. All studies that comprise this thesis ran
concurrently and Appendix 5 provides a flowchart to denote participants'
progression through the studies.
Potential participants were invited to an orientation session where height and
mass were confirmed and the study objectives and design were explained
and a participant information sheet provided (Appendix 6). Inclusion criteria
consisted of a BMI >24.9, actively trying to lose weight, and satisfactory
completion of the relevant physical activity readiness-questionnaire (PAR-Q)
and consent form (Appendices 7 and 8, respectively). Participant's
approaches to weight loss included following commercial slimming
programmes, organised walking programmes and self-directed diet and
exercise programmes. If participants' resting heart rate (HR) or blood
pressure (BP) were above pre-determined thresholds of 90bpm (heart rate),
150mmHg (systolic BP) or 90mmHg (diastolic BP), GP approval for the
participants involvement was sought (Appendix 9). Participants were male or
female, between the ages of 15-75 years. Written informed consent was
obtained from each participant and kept on file. An a priori power analysis
revealed that a sample size of 100, with an a priori alpha level of 0.05 would
yield a power (1-13)of 0.9539 (two-tailed test) or 0.9778 (one-tailed test).
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4.2.3 Procedures
Level I restricted profiles were conducted on 90 partipants (male n=17,
female n=73) on a monthly basis over a 4 month period. Using the
internationally recognised BMI classification system, participants were
classified as overweight (n=27), obese (n=34) or morbidly obese (n=29).
Resting HR and BP, measured whilst seated, were also collected monthly.
All data were collected following the protocols detailed in Chapter 3.1. The
mean time between each measurement session is shown in Table 4.1. All
participants were asked to complete a 3 day food and exercise diary
between each measurement session (Appendix 10).
Table 4.1. Mean (±SO) time (days) between measurement sessions over
four month testing period.
Mean (±SO) time between measurement sessions (days)
Baseline and
Month 2 and 3
Baseline and
Month 3 and 4
month2 month 4
33.8 ± 6.0 31.9 ± 5.6 33.9 ± 6.0 99.3 ± 11.0
4.2.3.1 Statistical analyses
4.2.3.1.1 Tests of normal distribution
All statistical analyses were performed using Predictive Analytic Software
(PASW) statistics computer package, with an alpha level of 0.05 for all
statistical tests. Initially distribution of data were analysed through
examination of histograms, evaluation for skewness and kurtosis, and more
formally through the Shapiro-Wilk and Kolmogorov-Smirnov test statistic.
Homogeneity of variance was also examined through Levene's test. All
anthropometric variables were normally distributed.
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4.2.3.1.2 Tests of difference
The frequency of somatotype by category were examined and the SAD
(between months) and MD (over the four month period) calculated. To
identify the change in anthropometric variables, a within subjects Wilk's
Lambda multivariate repeated measures ANOVA, with Bonferonni
adjustment was conducted, with time as an independent factor and BMI,
body mass, WHR, %BF, L8SF, SAM, SAD, MD and the individual
somatotype sub-components; endomorphy, mesomorphy and ectomorphy,
as dependent variables.
Since the variables being compared were calculated from the same set of
anthropometrical measuring points, it was possible that some would
influence others therefore checks for covariance were made. Mauchly's test
indicated that the assumption of sphericity had been violated. Therefore
when examining month on month change, degrees of freedom were
corrected using Greenhouse-Geisser estimates of sphericity. When
examining residual plots, no variables appeared to be influencing or were
being influenced by other variables.
4.2.4 Results
Results are presented for a total of 90 participants who attended all
measurement sessions. Baseline demographic and anthropometric
measures are provided in Table 4.2. Figure 4.1 provides a breakdown of the
dietary methods/services utilised by participants at baseline. Over half of all
participants followed their own healthy eating plan (55%), with the remainder
following commercial slimming programmes (most commonly Weight
Watchers (18%) or Slimming World (11%)) or receiving dietetic support (4%).
Data was unavailable for 9% of participants.
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Weig ht Watchers
18%
Slimf Slimming World
11%
Lig hter Life
2%
Unknown
7%
Dietetic support
4%
Own healthy
eating plan
55%
Figure 4.1: Breakdown of current dietary methods/services utilised by
participants (n=90) at baseline.
Figure 4.2 provides a breakdown of the physical activity and exercise
methods/services utilised by participants at baseline. Almost half of
participants were members of a leisure facility (45%), accessing the
gymnasium and/or exercise classes. 29% were members of a local walking
group with an additional 9% of participants also accessing exercise classes
in addition to membership of the walking group. 17% of participants followed
their own exercise plans. Data was unavaliable for the remaining 9% of
participants. Further data regarding participants' diet and exercise habits as
they progressed throughout the study are not presented due to non-
compliance of participants filling out monthly food and exercise diaries.
Unknown
9%
Leisure facility -
gym and classes
15%
Own exercise
plan
17%
--- Leisure facility -
gym
13%
Leisure facility
classes and
walking
programme
9%
Walking
programme
29%
Leisure facility -
classes
8%
Figure 4.2: Breakdown of current physical activity methods/services
utilised by participants (n=90) at baseline. 72
Figure 4.3 represents the group distribution of all participants, based on their
individual somatotype evaluation at baseline and at month 4. Of the possible
13 somatotype categories, all examined participants fell into three
categories; mesomorph-endomorph, endomorphic mesomorph, and
mesomorphic endomorph.
oMesomorph-
endomorph
• Endomorphic -
mesomorph
IIMesomorphic -
endomorph
Figure 4.3. Somatotype distribution of participants (n=90) at baseline (a)
and month 4 (b).
The proportion of participants classified as mesomorph endomorphs was
almost identical at baseline (31%) and month 4 (32%), respectively (Fig. 4.1).
Almost half of participants (49%) were classified as endomorphic-
mesomorphs at baseline and this increased to 58% at month 4. The reverse
was seen in the proportion of mesomorphic endomorphs reducing to 10% at
month 4, from 20% at baseline.
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Due to the small changes in global somatotype between months only the
mean somatotype at baseline and month 4 are plotted on the somatochart
(Fig. 4.4) to aid visualisation. The differences between the scatter of
somatotypes about their means (SAMs) at baseline and month 4 did not
differ, with a narrow range of 1.9-2.0 (F=1.22,3,87,P>0.05,Eta2=0.04, 1-J3=0.3).
When the whole somatotype means were compared, significant differences
were observed (F=206.405,3,57,P<0.05,Eta2=0.699,1-J3=1.00). No significant
change in somatotype means were observed between months (SAD),
however the change from baseline to month 4 was significant (MD=0.8±0.05,
P<0.05). The mean somatoplots in Figure 4.4 reflect this difference as they
move from left to right across the somatochart.
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Figure 4.4. Mean somatotype (n=90) for baseline and 4.
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Examination of anthropometric variables, including individual somatotype
component ratings, identified significant change over time
(F=4.4098,24741 P<0.05,Eta2=0.667,1-!3=1.00). Within the alternative
anthropometric measures L8SF showed a significant mean decrease of
15.4±2.1 mm, endomorphy showed a significant mean decrease of 0.29±0.04
and ectomorphy showed a significant mean increase of 0.03±0.01 (Fig. 4.5).
Of the traditional measures, BMI, mass and %BF showed significant change,
decreasing by 0.6±0.1 kg.m-2, 1.5±0.4kg and 1.0±0.2%, respectively (Fig.
4.6).
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Figure 4.5. Mean change of alternative anthropometric measures from baseline
to month 4 (n=90).
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Vertical bars show standard errors of the mean
0.5
BMI(kg.m-2)
0
Q)
C)
r::: -0.5cu
.r:::
CJ
r:::cu -1Q)
~
-1.5
-2
Mass(kg) WHR BF(%)
*
*
Figure 4.6. Mean change of traditional anthropometric measures from baseline
to month 4 (n=90). 76
*P<0.05
Vertical bars show standard errors of the mean
When examining month on month change within alternative anthropometric
measures, L8SF and endomorphy show significant change at all time points
(Table 4.3). In contrast, whilst ectomorphy showed significant change over
the four month period pre and post (Fig. 4.5), the only significant change that
was observed between months was a mean 0.02±0.01 decrease between
months 3 and 4. No significant changes were observed between months in
mesomorphy. Within traditional measures, %BF changed significantly at all
time points, BMI and mass showed significant change between some months
but not others and WHR showed no significant change between any months
(Table 4.3).
Table 4.3. Mean change of traditional and alternative anthropometric
variables between months (n=90).
~ Baseline- ~ Month ~ Month ~ Baseline-
month 2 2-3 3- 4 month 4
TRADITIONAL
BMI (kq.rn") -0.31 ±O.06* -0.22±0.06 -0.04±0.06 -0.57±0.12*
Mass (kg) -0.83±0.19* -0.62±0.17* -0.10±0.17 -1.54±0.35*
WHR -0.01±0.00 -0.01±0.00 -0.01±0.00 -0.02±0.00
BF (%) -0.32±0.09* -0.38±0.08* -0.23±0.07* -1.00±0.15*
AL TERNATIVE
L8SF mm) -5.22±1.36* -5.84±0.86* -4.28±0.87* -15.4±2.06*
Endomorphy -0.11±0.03* -0.11 ±0.02* -0.07±0.02* -0.29±0.04*
Mesomorphy -0.04±0.02 -0.03±0.02 -0.01±0.02 -0.07±0.04
Ectomorphy 0.01±0.01 0.01±0.01 0.02±0.01* 0.03±0.01*
SAD 0.3±0.02 0.2±0.02 0.2±0.02 -
MD - - - 0.8±0.05*
*P<O.05
Values rounded to two decimal places
In summary global somatotype means showed significant change from
baseline to month 4 (Fig. 4.4) and examination of individual component
ratings identified that endomorphy decreased significantly over this time
period and ectomorphy increased (Fig. 4.5). Furthermore, L8SF also showed
a significant decrease from baseline to month 4, and also showed significant
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change between months, as did endomorphy (Table 4.3). Thus H1, that
alternative anthropometric measures would show significant change over
time, is supported for all alternative anthropometric measures with the
exception of mesomorphy. BMI, mass and %BF all showed significant
change from baseline to month 4 (Fig. 4.6) and %BF also showed significant
change between months. Thus H2, that traditional anthropometric measures
would show significant change over time, is supported for all traditional
anthropometric measures with the exception of WHR.
4.2.4 Discussion
The results reported indicate that collectively both traditional and alternative
anthropometric variables show change over a 4 month period (Fig. 4.4 - 4.6).
However when examining change month on month differences are apparent
in the traditional and alternative anthropometric measures, with some
demonstrating significant change every month and others at some time
points but not others (Table 4.3). For example, endomorphy showed
significant decreases at every monthly interval over the 4 month period,
indicating a positive change in the composition of the body in that relative
fatness decreased over time. In contrast BMI showed a significant decrease
only in the initial stages, between months one and two, then no further
significant change was evident.
Weight maintenance seems to require an ongoing adherence to weight-
related behaviours (Elfhag & Rossner, 2005). Moderate to large levels of
attrition are frequent in many published studies in the area of obesity and
retention over time remains a challenge (Goldberg & Kiernan, 2004). For
example, reported attrition rates in obesity studies range from 20-45% (Clark
et al., 1996) with others reporting rates as high as 80% (Farley et al., 2003).
A study of 80 women randomly assigned to a commercial weight reduction
program or a control group reported 12 week attrition rates of 25% and 65%,
respectively (Rippe et al., 1998). More recently in a study of 160 people
comparing the effectiveness of four popular diets, attrition rates were 21%
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and 34% by months 2 and 6 respectively (Dansinger et al., 2005). Other
studies involving obese patients enrolled in weight loss programs and treated
for an average of 26 weeks report attrition rates from 19 to 56% (Anderson et
al., 1994; Wadden et al., 1992; Walsh & Flynn, 1995). These results may
have important implications. From a feedback perspective, focusing on
measures that do not change readily or do not adequately reflect changes in
body composition may be discouraging and de-motivating to an individual,
leading to increased drop-out from weight management programmes.
Pertinent to this is the common occurrence of weight regain. Pronounced
initial weight loss may illustrate the successful start in carrying out the
decision to lose weight (Elfhag & Rossner, 2005), however weight regain is a
common occurrence which can affect individual's motivation and self-efficacy
(Ulen, 2008; Warziski, 2007). Figure 4.7 shows the weight regain patterns in
participants following a structured commercial weight loss programme and
those in a control group following self-directed weight loss programmes
(Heshka et al., 2003). Whilst a statistically significant weight loss was found
in the commercial weight loss programme, at 26 weeks both groups started
to regain weight. At the end of the 2 years the control group has almost
returned to their initial starting weights with only 16% of the commercial
weight loss group maintaining a loss of 10 % or their initial body weight.
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Figure 4.7. Weight change (kg) in self-help group vs. commercial weight
management programme over a 2 year period (Heshka et al., 2003).
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Gardner et al. (2007) compared 4 common diets in 311 overweight/obese
women over a 12 month period and also showed evidence of weight regain.
Most weight loss occurred within the first two months, with no visible change
for three of the four diets between months 2 and 6 (Figure 4.8). Weight
regain occurred in all groups after 6 months.
Baseline 2 6 12
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Figure 4.8. Weight loss patterns in 4 diet groups over 1 year (Gardner et
al., 2007).
When examining post-treatment weight change over a 12 month period
following a 16-week activity intervention, Andersen et al. (2001) found similar
patterns of weight regain (Figure 4.9). Participants that attended quarterly
follow up meetings (n=33) were classified in to one of three activity groups
according to the percentage of weeks that met or exceeded the Surgeon
general's guidelines for physical activity in the year after completion of
treatment. No differences in weight regain were apparent between activity
groups at months 3 and 6 however by month 9 the least active group had
regained significantly more weight than the most active group, which by
contrast had lost weight (Figure 4.6). From month 9 all activity groups
experienced weight regain with the middle active group returning to near
baseline levels and the most active group experiencing a 1.2kg regain from
month 9 to month 12 (Andersen et al., 2001).
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Figure 4.9. Post-treatment weight change in 3 activity groups over 1 year
(Andersen et al., 2001).
The significant weight loss of 1.S±0.4kg over 4 months in the current study
(Fig. 4.6) is less than the 2.3-S.2kg losses observed by Gardner et al. (2007)
over the same time period. An explanation for this could be that the
participants involved in the present study were following self-directed
programmes as opposed to structured diet programmes followed in the study
conducted by Gardner et al. (2007). For example, at 16 weeks the weight
loss observed in the self-help control group in the study conducted by
Heshka et al. (2003) was 1.Skg, comparable to the present study results,
thus providing support for this explanation.
Although changes in body mass and BMI have been examined over 12
months (Andersen et al., 2001; Berkowitz et al., 2003; Doshi et al., 2009;
Gardner et al., 2007; Heshka et al., 2003) less is known about the changes
in other anthropometric measures such as somatotype scores over this
longer time period. Isolating the individual importance of each
anthropometrical variable may facilitate the understanding of the most
appropriate measure to be used at specific time points as a successful
strategy for weight loss maintenance. Additionally, it is well documented that
health benefits can occur in the absence of weight loss and many studies
have documented changes in body composition despite no concurrent
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changes in body mass and BMI (Lee et al., 2005). For example, in a sample
of 15 healthy obese women aged 35±9.B years, with a BMI of 36.4±7.1 kg.m-2
Ross et al. (1993), found a Significant 16.Bcm2 decrease in visceral adipose
tissue despite a non-significant weight loss of 0.5kg. Error values reported by
Ross et al., (1993) for the measurement of visceral and subcutaneous fat in
the study were just 5.5% and 1.1%, respectively, highlighting the quality of
this research. More recently Hunter et al. (2002) in a study on elderly
individuals involved in resistance training, found a significant mean decrease
of 9.2kg of fat mass, however no significant decrease in body mass.
The results of the current study suggest that positive changes in the
composition of the body occurred every month, as illustrated by the
significant decreases shown in LBSF, endomorphy and %BF at every
monthly interval (Table 4.3). Body mass and BMI also showed positive
changes, however these anthropometric measures only demonstrated
Significant change between baseline and month 2 (BMI and mass) and
months 2 and 3 (mass only). Retrospective studies of successful weight
maintainers, defined as an initial weight loss that has been subsequently
maintained for at least 6 months, have shown that individuals who
successfully maintain lower body weights, particularly women, show more
concern with shape and appearance (Elfhag & Rossner, 2005). Thus utilising
non weight related parameters that focus on body shape/composition may
further contribute to successful weight loss and maintenance.
Studies reporting weight losses of 6-13kg over 6 months in women (Pascale
et al., 1992); and 9-16kg over 6 months in men (Pascale et al., 1992; Wing et
at., 1992) have reported concurrent changes in WHR of 0.01 - 0.02, and
0.04, respectively. In contrast, in a comparison of four commercial weight
loss programmes, Gardner et aI., (2007) reported no significant change in
WHR in any of the four weight loss programmes, despite signficant weight
losses. The results of the present study indicate no statistically significant
change in WHR from baseline to month 4 (Fig. 4.6) or between months
(Table 4.3). Wing et al. (1992) reports no association between weight loss
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and change in WHR when weight loss is below 6.8kg, therefore the non-
significant changes in WHR may be due to the smaller changes in body
mass of <2kg in the present study.
The somatotype sob-component mesomorphy (that relates to relative
muscularity) showed no significant change over the four month period (Fig.
4.5). Weight training exercise has been found to facilitate body fat loss and
can preserve or increase fat-free mass (Ballor & Keesey, 1991). In a
comparison of the effects of structured aerobic activity and moderate lifestyle
activity on weight loss Andersen et al. (1999) found that the aerobic group
lost significantly less fat-free mass (0.5kg) than the lifestyle group (1.4kg).
Energy expenditure accounts for much of the variance associated with
changes in fat-free mass (Ballor & Keesey, 1991) and the fact that the
participants in the present study were not following structured exercise
programmes may explain the negligible change in mesomorphy over the four
months.
With regard to the ectomorphy somatotype sub-component, significant
change was observed from baseline to month 4 (Fig. 4.5), however between
months a significant increase was only observed between months 3 and 4
(Table 4.3). FeU et al. (2006) observed that ectomorphy was positively
related to the skeletal factor and negatively related to the muscular factor
and body fat. It is not a tissue-based measure but a ratio of mass to stature
and as such gives no direct body composition information. Therefore the
minimal variation of ectomorphy in the present study (.1 = 0.03±0.01) is in line
with expectations. Carter and Heath (2005) suggest it is better to consider
the criterion body composition variables to be endomorphy and
mesomorphy.
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4.2.5 Conclusion
The results of Study One, Part A indicate that both traditional and alternative
anthropometric measures used to monitor change in overweight and obese
individuals, showed significant change over a four month period with the
exception of mesomorphy and WHR (Fig. 4.4-4.6). When examining month
on month change, differences between the measures were observed, with
%BF, r8SF and endomorphy showing significant change more frequently
than BMI, Mass, WHR, mesomorphy and ectomorphy (Table 4.3). Therefore
it is concluded that traditional and alternative anthropometric measures show
significant change and H1, that alternative anthropometric measures would
show significant change over a four month period is accepted for all
measures, excluding mesomorphy. H2, that traditional anthropometric
measures would show significant change over a four month period is
accepted for all measures, excludingWHR.
It is well known that individual change takes place continuously over time
and repeated anthropometric measures allow the continuous process of
human change to be documented effectively (Willet, 1995). Having
established that the traditional and alternative anthropometric measures
showed significant change over a four month period, and varied in their
change at specific time points, further analysis was warranted over a longer-
time period in order to inform their utility as tools to evaluate weight loss
success. Thus Part B of Study One examined and compared the change in
the traditional and alternative anthropometric measures over a longer time-
period.
84
4.3 PART B
4.3.1 Aims and hypotheses
The aim of Study One, Part B was to compare the change in traditional and
alternative anthropometric measures within an overweight/obese population
over an extended time period of a year. More specifically, the study sought to
identify whether alternative anthropometric measures showed greater
magnitudes of change than traditional anthropometric measures. The
following alternative (experimental) hypotheses were formulated:
H3) Alternative anthropometric measures and traditional anthropometric
measures will change significantly over a year.
H4) Alternative anthropometric measures will show greater magnitude of
change over a year than traditional anthropometric measures.
4.3.2 Methods
4.3.2.1 Study design and participants
Participants already involved in Part A of Study One continued to partake in
monthly assessments to meet the requirements of Part B. Therefore no
further recruitment and preliminary assessment was required. Please refer to
Chapter 4.2.3.1 for details regarding recruitment processes, inclusion and
exclusion criteria and preliminary screening methods.
4.3.3. Procedure
The same procedure as detailed in Chapter 4.2.4 was followed, with
measurements being collected over the extended time period of a year. The
mean time between measurement sessions is shown in Table 4.4.
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Table 4.4. Mean (±SD) time (days) between measurement sessions over the
12 month testing period.
Month Mean± SDtime (days) between months
Baseline - 2 33.8 ± 6.0
2-3 31.9 ± 5.6
3-4 33.9 ± 6.0
4-5 33.5 ± 6.1
5-6 31.7±6.0
6-7 32.2 ± 7.4
7-8 29.5 ± 6.9
8-9 31.6 ± 8.8
9-10 30.9 ± 7.1
10-11 33.0 ± 8.6
11 -12 33.9 ± 6.9
Baseline - 12 354.4 ± 25.2
4.3.4 Dataanalysis considerations for the measurement of change
4.3.4.1Growth and change
"Growth and change are normal features of biological, psychological and
sociological phenomena" (Stull, 2008). The analysis of change is a
fundamental component of many research endeavours in almost every
discipline (Fitzmaurice & Molenberghs, 2008), enabling the documentation of
an individuals' progress. Despite its obvious substantive importance, there
has been much controversy over the years about the measurement of
change (Willett, 1994) and in the measurement of change the reliability of the
difference score has been one of the most discussed, yet least understood
topics.
A general misconception in the measurement of change is that individual
change should be viewed as an increment, as the difference between
'before' and 'after' (Willett, 1994). Traditionally, individual change has been
measured by the collection of data at two points in time and the computation
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of a difference score, a residual change score, a regression estimate of true
change, or some other two-wave measure of growth (Willett, 1989).
Difference scores, the subtraction of one score from another to create a
measure of a distinct construct (Peter et al., 1993), have been criticised as
they purport a negative correlation with initial status (Willett, 1994). Residual
change scores intend to describe the true change that each person would
have experienced, if everyone had 'started out equal' or had the same 'initial
status' (Willet, 1994), thus overcoming this issue (Willet, 1989). However,
current status is a product of prior change, and current change determines
future status. Thus "a correlation between change and status is an almost
inevitable fact of life" (Willett, 1995).
Despite the issues discussed above many studies do lend themselves to the
measurement of change (Singer & Willett, 2003), however as with any study
in order to adequately address the research hypotheses the most
appropriate and powerful analysis technique should be employed. Willett
(1994) suggests there are three requisite methodological features of any
study of change. The availability of (1) multiple waves of data; (2) a
substantively meaningful metric for time; and (3) an outcome that changes
systematically.
4.3.4.2 Multiple waves of data
Conceptualising change as an increment accrued between the beginning
and the end of a particular period of growth can ignore the potentially
interesting features of change that occur continuously throughout the
duration of an investigation (Miller et al., 2007; Willett, 1998). For example,
Figure 4.10 depicts three hypothetical weight losses from month one to
month 6 and Figure 4.11 depicts the same hypothetical weight losses
measured at monthly intervals over the same time period. If viewing change
as the increment accrued between month one and six, it would be concluded
that all individuals showed no change over this time period. This would be
true for example X, however this would ignore the patterns of change of
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examples Y and Z (Fig. 4.11). Thus two-wave (before and after) studies are
insufficient for studying change (Willet, 1994) as they ignore potentially
interesting changes that may occur in between these two waves of data.
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Figure 4.10. Hypothetical weight Figure 4.11. Hypothetical weight
loss (kg) over 6 months measured loss (kg) over 6 months measured
pre and post 6 months. at monthly intervals over 6 months.
This issue can be overcome by the collection of more than two waves of data
(Willet, 1997). Repeated measurements over extended periods of time allow
the continuous process of change to be easily and efficiently documented
(Willet, 1995), permitting analysis of change patterns over time. For example,
for the hypothetical weight loss patterns shown in Figure 4.11, including six
waves of data, it could be concluded that although pattern Z indicates no
change from month 1 to month 6, a continual decrease in body weight
occurred for the first 3 months, where after weight was maintained until
month 5, before increasing to initial starting weight. Without these additional
waves of data this pattern of change would be undetected.
In order to adequately represent change patterns it is important to choose
the appropriate number of waves. If the attribute of interest is changing
steadily and smoothly over a long period of time, perhaps three or four widely
spaced measurements on each person will be sufficient to capture the shape
and direction of change. But many more closely spaced measurements may
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be required for more complex patterns of change (Willett, 1994). The
collection of more waves of data leads to greater reliability and precision for
the measurement of change (Donnellan & Conger, 2007) and in general,
more waves are always better, within cost and logistical constraints (Singer &
Willett, 2003). Ideally, theory should guide the rational choice of the
frequency of measuring change so that subsequent analyses have
meaningful substantive interpretations (Willett, 1997).
4.3.4.3 Time metric
Time is the fundamental predictor in every study of change; it must be
measured reliably and validly in a sensible metric (Singer & Willett, 2003).
Choice of a time metric affects several interrelated decisions about the
number and spacing of data collection waves. Each of these, in turn, involves
consideration of costs, substantive needs, and statistical benefits (Singer &
Willett, 2003). Often the decision of when to assess participants is based on
practical considerations rather than deriving from theoretical or conceptual
concern which can be deleterious. There is no single answer about the most
sensible metric for time, simply one that reflects the time you expect to be
most useful for your outcome should be chosen. In light of the weight loss
and weight re-gain patterns depicted in Figures 4.7 - 4.9, and research
evidence that suggests frequent monitoring of weight loss can help maintain
weight loss and can be used as a long-term technique for managing weight,
(Boutelle & Kirschenbaum, 1998; Butryn et al., 2007; Klem et al., 1997;
McGuire et al., 1999; O'Neill & Brown, 2005) the present study aimed to
collect 12 waves of data at monthly intervals.
4.3.4.4 Systematic change
Individual growth models are designed for continuous outcomes whose
values change systematically over time (Singer & Willet, 2003). An issue
fundamental to the measurement of growth and change is whether the
selected measure remains construct valid across subsequent occasions of
89
measurement, and whether the scores obtained are equitable from occasion
to occasion (Willett, 1989). Reliability can be defined as the consistence of
measurements, or of an individual's performance on a test; or the 'absence
of measurement error' (Atkinson & Nevill, 1997). Although the reliability of
change measurement depends directly on outcome reliability, the precision
with which estimates of individual change are made depend more on the
number and spacing of the waves of data collection. The efforts made in the
present study to control measurement reliability and precision (Chapter 3.6),
and choosing a suitable number of waves of data collection at appropriate
time intervals, should offset the deleterious effects of measurement error in
the outcome variables (Singer & Willett, 2003).
4.3.5 Data analysis considerations for the measurement of change in
Study One, Part B
The aim of the Study One, Part B, is to examine change in traditional and
alternative anthropometric measures over an extended time period of a year,
and compare their magnitudes of change, in order to identify whether some
discern greater change than others. However, due to the differing units of
measurement of these anthropometric variables, comparison using absolute
change is inappropriate. Historically, the primary variable of interest in
measuring weight loss program intervention success has been pounds lost
during the program (Sargent et al., 2000). However, this measure, the classic
standard of success, does not account for individual variability (Atkinson,
1993).
Reporting a percentage change provides immediately accessible data in
relevant terms, which is why researchers commonly report this statistic
(Vickers, 2001). Indeed in obesity research the concept of utilising percent
change as an outcome variable is widely accepted with much research
focusing on percent weight change or percent BMI change (Table 4.5).
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However, it is acknowledged that this method is not without limitation.
Vickers (2001) reported that when constructing regression models, the
highest statistical power was obtained by using post-treatment scores by
baseline score. When compared to the use of absolute differences or
percentage change from baseline, post-treatment scores by baseline score
still resulted in higher statistical power.
The variables in study one differ not only in their units of measurement, but
also in their capacity for change. Table 4.6 shows examples of the
percentage changes that could occur if transferring from a high risk category
to a low risk category. This highlights that the variables are non-comparable
when using percentage change due to their differing variances. Even with the
potential of defining a theoretical range for each variable and then dividing
the percentage change by its theoretical range the use of percentage change
in the current study was deemed unacceptable.
Table 4.6. Risk categories for select anthropometric variables and their
capacity for change (for females)
Risk Category WHR1 BF(%)2 BMI (kg.m-2)3
Low Risk SO.80 23-35 25-27
Moderate Risk 0.81 - 0.89 35-40 27-32
High Risk >0.89 >40 32-34
Percentage change when
transferring from low risk 11.3% 73.9% 20%
to high risk category*
..
"Calculations based on maximum low risk score and rmmmurn high risk score
1Welborn et al., 2003; 2Gallagher et al., 2000; 3Whitney & Rolfes, 2005
Another technique considered to overcome the aforementioned issues was
that of the Phantom Stratagem; a method used to convert raw data of
different anthropometric variables to one common raw value (Ferreira et al.,
2004; Gaines, 2001). Phantom stratagem is essentially based on the concept
of a theoretical reference human, which is named as phantom (Singh &
Singh, 2007). It is an arbitrary unisex reference human with specified
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anthropometric characteristics such as height, mass, percent body fat, fat
and muscle mass, girths, skinfold thicknesses and breadths (Norton & Olds,
1996). The primary use of the Phantom model is to scale anthropometric
variables to a standard height (170.18cm) or size, using the equation:
Where p is the phantom mean value, s is the phantom
standard deviation, and Vadj is the true adjusted
measurement (Singh & Singh, 2007).
It was assumed that in the population of Phantom models each of these
characteristics was normally distributed about the Phantom value (p) with a
standard deviation (s). Reported male and female coefficients of variation
were used to calculate the s values (Ross & Martell-Jones, 1991). The
authors of the technique maintain that because data have been scaled to a
common standard, and expressed as ratios to the corresponding standard
deviations, different anthropometric variables can be compared both
between and within samples (Shephard, 1991). The Phantom strategy has
since been applied to longitudinal and cross-sectional growth studies and
comparative studies of athletes (Norton & Olds, 1996), allowing quantification
of differences between individuals or within an individual in terms of
differences in z-scores. Positive z values indicate that a particular variable is
larger than the phantom reference model and negative values indicate that it
is smaller (Shephard, 1991).
Ross and Wilson based the Phantom's anthropometric characteristics on
large population surveys. Girths were taken from data of Wilmore and
Behnke (1969, 1970), skinfolds thicknesses from unpublished data of
Yuhasz (Norton & Olds, 1996) and other measures from Garrett and
Kennedy (1971) (Ross & Martell-Jones, 1991). A list of the Phantom means
and standard deviations included within an ISAK Level I restricted profile can
be found in Table 4.7.
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Table 4.7. Phantom means and standard deviations
Mean (p) SO (s)
BASIC
Stature (cm) 170.18 6.29
Mass (kg) 64.58 8.60
Triceps 15.4 4.47
Subscapular 17.2 5.07
Biceps 8 2.00
SKINFOLDS Iliac Crest 22.4 6.80
(mm) Supraspinale 15.4 4.47
Abdominal 25.4 7.78
Front thigh 27 8.33
Medial Calf 16 4.67
Arm relaxed 26.89 2.33
Arm (flexed & tensed) 29.41 2.37
GIRTHS (cm)
Waist (min) 71.91 4.45
Waist (umbillical) 79.06 6.95
Hips 94.67 5.58
Calf 35.25 2.30
BREADTHS Humerus 6.48 0.35
(cm) Femur 9.52 0.48
(Ross & Martell-Jones, 1991).
It is important to note that Ross and his colleagues used a relatively small
heterogeneous convenience sample to create their reference phantom
(Shephard, 1991), thus limiting its applicability to the wider population. The
phantom is also a calculation scaling device rather than a normative system
(Nevill et al., 2006). It is a hypothetical, unisex reference human with defined
p values for many anthropometric measures, which each were ascribed a
standard deviation in an assumed, symmetrical, unimodal distribution (Ross
& Martell-Jones, 1991). Consequently, the interpretation of Z score of the
Phantom model like a percentile, cannot be a complete interpretation, but
only a first approach that will have later to be clarified based on
characteristics like: sex, age, diet, physical activity or ethnic group of the
subject of study (Romay, 2006). Furthermore, reference data are only
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available for the individual skinfold, girth and breadth measures detailed in
Table 4.7, with standard deviation scores calculated using male and female
coefficients of variation (Ross & Martell-Jones, 1991). Whilst mean scores
could be used to calculate somatotype ratings, L8SF and %BF, no standard
deviation measures would be available, thus making z scores unattainable.
Therefore, this data handling method was also discarded. However, the use
of Z-scores as a scaling system was considered further. The Z scale
converts raw scores to units of standard deviation in which the mean is zero
and a standard deviation is 1.0 (Thomas & Nelson, 2001). The Z-score can
be defined as the difference between the value for an individual and the
median value of the reference populations for the same age or height,
divided by the standard deviation of the reference population. This can be
written in equation form as:
(observed value) - (mean reference value)
Z - score = ...:._------.;__--------..:,.
standard deviation of reference population
Z-scores are commonly used because they offer two major advantages;
allowing identification of a fixed point in the distribution of different indices,
and the calculation of summary statistics (WHO: Physical Status, 2005).
They are also particularly useful when amalgamating scores on different
scales (Diamond & Julie, 2001). As the anthropometric variables in the
current study differ in their units of measurement and in their scales of
measurement, direct comparison between them is difficult. However,
converting these anthropometric measures into Z-scores permits comparison
because all distributions of Z-scores have the same mean and the same
standard deviation (Graveter & Wallnau, 2009), therefore one variable can
be compared to another with respect to their positions in distributions.
Neither the shape of the distribution of a particular variable, nor its correlation
with another variable is affected by transforming it to a Z-score (Cohen et aI.,
2003). Additionally it does not change an individual's position in the
distribution (Graveter & Wallnau, 2009).
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4.3.6 Data handling and statistical analysis for Study One, Part B
In order to examine change in traditional and alternative anthropometric
measures over a year, and answer H3, the same statistical procedures
utilised in Study One, Part A were used. In order to compare magnitudes of
change in anthropometric variables, baseline data was converted to Z-
scores, allowing identification of how many standard deviations away from
the mean each individual's score was for each anthropometric variable. All
further anthropometric scores at each time point were converted to Z-scores
using the baseline population mean and standard deviation. The Z-scores,
representing each individuals change from the baseline population mean are
unit free. A multivariate ANOVA with Bonferonni adjustment for multiple
comparisons was then used to answer H4.
Mauchly's test again indicated that the assumption of sphericity had been
violated. Therefore when examining change using Wilk's Lambda Repeated
Measures Manova, degrees of freedom were corrected using Greenhouse-
Geisser estimates of sphericity. When examining residual plots, no variables
appeared to be influencing or were being influenced by other variables.
4.3.7 Results
Data are presented for all participants who completed all 12 anthropometric
measurement sessions (n=60). Baseline demographic, traditional and
alternative anthropometric measures are provided in Table 4.8. Participant
drop out and retention rates are provided in Table 4.9. All data are presented
in raw form (Chapter 4.3.7.1) or Z-score form (Chapter 4.3.7.2) with an alpha
level set at 0.05.
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Table 4.9. Number of participants at each time point, grouped by gender and
BMI classification*, and retention rates over the testing period (%).
Month
1 2 3 4 5 6 7 8 9 10 11 12
Male 17 17 17 17 12 12 12 11 11 11 11 11
Female 73 73 73 73 65 62 56 52 50 50 49 49
Overweight 27 27 27 27 25 25 24 24 23 23 23 23
Obese 34 34 34 34 31 29 25 22 21 21 21 21
Morbidly Obese 29 29 29 29 21 20 19 17 17 17 16 16
Total 90 90 90 90 77 74 68 63 61 61 60 60
Retention (%)** 100 100 100 86 82 76 70 68 67 66 66
*as defined in Table 2.1
**calculated from month one (n=90)
4.3.7.1 Change in anthropometric measures
Figure 4.12 shows that similar proportions of the participants were classified
as mesomorph-endomorphs at baseline and month 12 (32% and 27%,
respectively). The number of participants classified as endomorphic
mesomorphs between baseline and month 12 increased from 43% at
baseline, to 67% at month 12. A decrease was observed in the number of
participants classified as mesomorphic endomorphs (25% to 6%). Figure
4.13 illustrates the pattern of change over the year testing period.
oMesomorph-
endomorph
• Endomorphic -
mesomorph
Mesomorphic -
endomorph
Figure 4.12. Somatotype distribution of participants (n=60) at baseline (a) and
month 12 (b). 98
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Figure 4.13. Somatotype distribution of participants (n=60) from baseline to
month 12.
Due to the small changes in global somatotype only the mean somatotype at
baseline, and months 4, 8 and 12 are plotted on the somatochart (Fig. 4.14)
to aid visualisation. The differences among the scatter of somatotypes about
their means (SAMs) did not differ, with a narrow range of 1.8-1.9
(F=O.89,11,57.P>O.OS,Eta2=O.01S,1-J3=O.S06).When the whole somatotype
means were compared significant differences were observed
(F=207.393,11.57.P<O.OS,Eta2=O.779,1-J3=1.00).No significant changes were
observed between months (SAD), however from baseline to month 12 a
significant change was observed (MD=2.2±O.2, P<O.OS).
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Baseline Month 4 Month 8 Month 12
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Figure 4.14. Mean somatotype (n=60) at baseline and months 4,8 and 12
* S=mean somatotype, SAM=somatotype attitudinal mean,
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Figures 4.15 and 4.16 illustrate the mean change between baseline and
month 12 for alternative and traditional anthropometric measures ,
respectively. All somatotype components showed significant change
(endomorphy; F=35.408, P<0.05, Eta2=0.37, 1-13=1.00, mesomorphy;
F=1.190, P<0.05, Eta2=0.31, 1-13=0.656; and ectomorphy; F=5.520,P<0.05,
Eta2=0.10, 1-13=0.951). L8SF also showed significant change, decreasing by
34±4mm (F=33.632, P<0.05, Eta2=0.37, 1-13=1.00).
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Figure 4.15. Mean change in alternative anthropometric measures from
baseline to month 12 (n=60).
*P<0.05
Vertical bars show standard errors of the mean
BMI, mass and %BF decreased significantly from baseline to month 12
(F=9.878, P<0.05, Eta2=0.24, 1-13=0.98; F=9.403, P<0.05, Eta2=0.26, 1-
13=0.974; F=26.123, P<0.05, Eta2=0.31, 1-13=1.00, respectively). WHR was
the only anthropometric variable not to show significant change over the year
(F=3.537, P>0.05, Eta2=0.06, 1-13=0.820).
BMI(kg.m·2) Mass (kg) WHR
0
-1
Cl) -2Cl *C
CV.c
U -3
c
CV
Cl)
:!: -4
-5
BF(%)
*
*
-6
Figure 4.16. Mean change in traditional anthropometric measures from
baseline to month 12 (n=60)
*P<0.05
Vertical bars show standard errors of the mean
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The only anthropometric variables that showed significant change between
months were BMI, mass, %BF, LBSF and endomorphy between months one
and two (mean difference -0.4±0.1 kg.m-2, P<0.05; -1.0±0.2kg, P<0.05; -
0.4±0.1 %, P<0.05; 5.9±1.5mm, P<0.05 and -0.2±0.03, P<0.05, respectively),
and I:BSF, endomorphy and %BF between months 2 and 3 (mean difference
-5.7±1.1 mm, P<0.05; -0.1±0.03, P<0.05, -0.4±0.1 %).
The results in Table 4.10 separate the change in anthropometric variables
over three discrete time periods and indicate that %BF, LBSF and
endomorphy were the only anthropometric variables that showed significant
change over each time period. BMI, WHR, and mesomorphy failed to show
significant change at any of the time periods, and mass showed significant
change between months 4 and B. Analysis of global somatotype means
between these time periods identified significant change from baseline to
month 4, months 4 to B, and months B to 12 (Table 4.10). The mean
somatoplots in Figure 4.14 reflect this difference, as they move from left to
right across the somatochart.
Table 4.10. Mean change between months in traditional and alternative
anthropometric variables (n=60).
~ Baseline ~ Month 4- ~ Month ~ Baseline-
month 4 8 8 -12 month 12
TRADITIONAL
BMI (kq.rn") -0.6±0.2 -0.3±0.2 -0.5±0.2 -1.4±0.3*
Mass (kg) -1.7±0.5 -0.9±0.5* -1.3±0.4 -3.9±0.9*
WHR -0.01±0.01 -0.01±0.00 -0.01±0.00 -0.03±0.01
BF (%) -1.0±0.2* -0.7±0.2* -0.7±0.2* -2.4±0.3*
AL TERNATIVE
LBSF (mm) -15.7+2.6* -7.9±2.1* -10.1±1.9* -33.7±4.14*
Endomorphy -0.3±0.1* -0.2±0.1* -0.2±0.1 * -0.B±0.1*
Mesomorphy -0.01+0.04 -0.01±0.03 -0.03±0.03 -0.10±0.07*
Ectomorphy 0.05±0.02 0.03±0.02 0.04±0.02 0.12±0.03*
MD 0.7* 0.7* O.B* 2.2*
*P<0.05
Values rounded to two decimal places
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In summary, all traditional and alternative anthropometric variables showed
significant change from baseline to month 12, with the exception of WHR
(Fig.4.15-4.16). Additionally global somatotype, endomorphy L8SF and %BF
Significantly decreased at all interim periods (Table 4.10). Thus H3, that
alternative and traditional anthropometric measures would show significant
change over a year, is accepted for all alternative anthropometric variables
and all traditional anthropometric variables excludingWHR.
4.3.7.2 Comparison of magnitude of change
Due to the small variation in ectomorphy values among participants,
particularly in those classified as morbidly obese, it was not possible to
standardise the magnitude of change using the procedures described in
Chapter 4.3.6. As identified by Carter & Heath (2005) focusing on
endomorphy and mesomorphy components are more practical. Furthermore,
as the analysis of global somatotype change already involves specialised
procedures to calculate the 3-dimensional distance between two
somatopoints, again applying further transformation procedures was deemed
inappropriate. Thus the following section will compare the magnitude of
change between traditional anthropometric measures and the following
alternative anthropometric measures only; L8SF, endomorphy and
mesomorphy.
When comparing magnitudes of change from baseline to month 12
significant differences were apparent (F=7.027, P<0.05, Eta2=0.99, 1-
J3=1.00). Figure 4.17 illustrates the magnitude of change (Z-scores) in
alternative anthropometric measures in comparison to traditional
anthropometric measures. L8SF showed a significant decrease of -1.1±0.1
Z-score over the year testing period. This was significantly greater than the
decrease observed in mass (-0.42±0.2 Z-scores) and WHR (-0.32±0.2 Z-
scores). However, this was not significantly greater than the changes
observed in BMI and %BF.
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The same pattern was observed when comparing the magnitude of change
in endomorphy over the year testing period, with the magnitudes of change
in traditional anthropometric measures (Fig. 4.17). Endomorphy showed the
greatest magnitude of change, decreasing by -1.0±0.1 Z-scores. This was
significantly greater than the decrease observed in mass (-0.42±0.2 Z-
scores) and WHR (-0.32±0.2 Z-scores). This was not however significantly
greater than the changes observed in BMI and %BF.
Significant differences were apparent between the magnitude of change in
mesomorphy and BMI and %BF, with significantly larger changes observed
in BMI and %BF (Fig. 4.17). BMI showed a decrease of -0.77±0.1 Z scores,
almost 4 times the change seen in mesomorphy. %BF showed a decrease of
-0.74±0.1 Z scores, again significantly larger than the -0.1B±0.1 Z score
change observed in mesomorphy from baseline to month 12.
Although BMI, mass, %BF, LBSF and endomorphy showed significant
change between months one and two, the magnitudes of change between
these measures were not significantly different. BMI, %BF, LBSF and
endomorphy did show significantly larger magnitudes than WHR (mean
difference, -0.26, P<0.05; -0.16, P<0.05; -0.14, P<0.05; and -0.21, P<0.05,
respectively), however the change in WHR between months 2 and 3 was not
statistically significant. LBSF, endomorphy and %BF also showed significant
change between months 2 and 3, however again the magnitude of change
between these measures was not significantly different.
From baseline to month 4 the magnitudes of change in anthropometric
measures were significantly different (F=2.992, P<0.05, Eta2=0.04, 1-
13=0.90). Significant differences were also apparent from months 4 to B, and
B to 12 (F=2.623, P<0.05, Eta2=0.04, 1-13=0.B6 and F=2.627, P<0.05,
Eta2=0.04, 1-13=0.B6).Comparison of magnitudes of change from baseline to
month 4 showed that LBSF showed the greatest magnitude of change (Z-
scores) showing a decrease of -0.5±0.1 Z-scores. Whilst this was
significantly greater than the change observed in mesomorphy, mesomorphy
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did not show significant change from baseline to month 4. There was no
significant difference in the magnitude of change observed between
traditional and alternative anthropometric measures. The same patterns of
change were observed between months 4 to 8, and 8 to 12, with no
significant difference between the magnitudes of change in any of the
traditional or alternative measures.
To summarise, L8SF and endomorphy both showed significantly greater
magnitudes of change than mass and WHR from baseline to month 12,
however comparable magnitudes of change with BMI and %BF (Fig.4.17).
Mesomorphy did not show significantly greater magnitude of change
compared to any traditional measure from baseline to month 12. In fact it
showed significantly smaller magnitude of change than BMI and %BF. There
was no significant difference in the magnitudes of change between traditional
and alternative anthropometric between any of the interim periods. Therefore
H4, that alternative measures would show greater magnitudes of change
than traditional measures over a year, is accepted for L8SF and
endomorphy compared to mass andWHR only.
4.3.8 Discussion
4.3.8.1 Change in anthropometric measures over time
At baseline, all participants in the current study were classified as extreme
mesomorphic-endomorphs, mesomorph-endomorphs and endomorphic-
mesomorphs (Fig.4.12). Few studies have examined somatotype in obese
populations however the above results are similar to those of Koleva et al.
(2000), who examined somatotype characteristics in an obese population. Of
194 individuals classified as obese, all fell in to three somatotype categories
observed in the present study. The analysis of whole somatotype change,
identified that participants that were classified as mesomorph-endomorphs
changed their categorisation to endomorphic-mesomorphs from baseline to
month 12 (Fig.4.12), suggesting a reduction in the fat component. This was
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verified by the significant reduction observed in the endomorphy component
(Fig. 4.15) observed from baseline to month 12 and by the movement of the
mean somatotpoints plotted in Figure.4.14 from left to right. This highlights a
benefit of the use of somatotype, in that it can show a 'type' alteration in the
physique, not only in the quantification and proportion of fat and fat-free
mass (Fett et aI., 2006).
The results reported in the present study indicate that all traditional and
alternative anthropometric variables showed significant change over the year
testing period, with the exception of WHR (Fig. 4.15 and 4.16), thus H3 is
accepted. The use of WHR to assess changes in fat distribution is
questionable (Van der Kooy et al., 1993) with some studies failing to show
change in WHR with weight loss (Gardner et al., 2007; Ross et al., 1991;
Slentz et al., 2004; Zamboni et al., 1993). Those that have found significant
change in WHR have reported relatively small changes and the change has
not been predictive of change in visceral fat (Van der Kooy et aI., 1993;
Seidell et al., 2001). Thus it could be concluded that WHR is not an
acceptable measure of change. Van der Kooy et al. (1993) identified
numerous reasons for the relatively stability of this measure during weight
loss including: 1) a relatively small weight loss; 2) the sites where waist and
hip circumferences are measured; 3) an insufficient number of particpants to
detect relatively small changes in circumferences and their ratio and 4) waist
and; hip circumference changing at the same rate.
When examining change month on month, significant changes were only
observed in a limited number of traditional and alternative anthropometric
measures during the initial months. For example BMI and mass, %BF and
endomorphy showed significant decreases from baseline to month 2 then no
further significant changes in these measures were evident. With %BF,
L8SF and endomorphy decreasing significantly between baseline and month
2, and between months 2 and 3, with no further significant changes
observed. An explanation for these results could be a decline in adherence
to a programme that aims to promote weight loss, be it self-directed or a
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more formal intervention. Dansinger et al., (2005) assessed the adherence
and effectiveness of 4 popular diets and with each diet group (n=40) dietary
adherence and self-reported adherence showed significant decline over time.
Furthermore, the results reported by Dansinger et al., (2006) show a
significant reduction of between 1.2-1.3 kg from baseline to month 2 in all
diet groups, however at 6 months, 2 of the diet groups showed no further
change and 2 showed only a further O.4kg decrease. This highlights the
greater initial weight loss observed in the initial stages of weight loss, as
identified in the present study. These results may have implications
regarding the appropriate frequency of monitoring changes in body
composition, indicating that following initial weight loss, measuring
individuals on a monthly basis does not give sufficient time for changes in the
composition of the body to occur. Monitoring provides an opportunity for
Positive reinforcement when weight loss/changes in body composition
correspond to changes in behaviour (Butryn et al., 2007). Thus it is possible
that the sampling frequency in the present study was too great to allow
changes to be observed and thus decreased participants motivation.
Bernadot (2006) states that assessing body composition two to four times a
year is an appropriate frequency to determine and monitor body composition
change in athletes. It could be hypothesised that this could also apply to an
overweight/obese population as when examining body composition changes
over longer time periods of 4 months, the current study identified significant
changes in some variables.
Recognising that month on month change may not have provided sufficient
time for changes in the composition of the body to occur, changes over long
time periods were assessed. This elicited interesting findings, identifying
significant changes in L8SF, endomorphy and %BF from baseline to month
4, month 4 to month 8, and month 8 to month 12. In contrast, no other
traditional or alternative anthropometric measure showed significant change
during these time periods, with the exception of body mass from month 4 to
month 8. These results reinforce the need for measures that account for
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changes in body composition, as without this information false conclusions
could have been made. For example, with just body mass and BMI
information available it would have been concluded that participants in the
present study had been unsuccessful in their weight loss attempts over the
first four months. However, the results indicate that from baseline to month 4,
L8SF showed a significant mean reduction of 15.7±2.6mm. Furthermore,
endomorphy (relative fatness) and %BF also showed significant reductions
over this time period.
Successful weight loss maintenance is associated with numerous factors,
including greater initial weight loss that in turn enhances individual's
motivation and self-efficacy (Elfhag & Rossner, 2005). Furthermore, it is a
common place judgement that patients that do not achieve positive
outcomes are more likely to drop out of treatment programmes (Ayyad &
Andersen, 2000). As the present study has identified that L8SF, endomorphy
and %BF showed significant reductions without a concurrent significant
reduction in body mass or BMI, providing this more detailed feedback
regarding body composition changes may aid the maintenance of motivation
and self-efficacy levels and reduce attrition. In the present study there was a
100% retention rate up until month 5, with an overall attrition rate of 36% by
month 12 (Table 4.9) This is similar to findings of Womble et al., (2004) who
reported a 34% attrition rate at both 16 and 52 weeks, in a study of 47
women enrolled in a commercial weight reduction program. In comparison to
attrition figures reported in obesity literature, ranging from 20-80% (Clark et
al., 1996; Farley et al., 2003), attrition in the present study was reasonably
low. Furthermore, it has been hypothesised that emphasis on bodyweight
sometimes diverts an individual's attention away from relevant aspects of
energy balance behaviour (Cohen et al., 2005). Thus, by focusing attention
on other parameters and transferring the emphasis from body weight, may
also be beneficial in increasing individual's adherence to a healthier lifestyle.
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This transference may also help address the dramatic disparity between
recommended weight loss goals and individual's actual weight loss goals.
Based on substantial evidence that many obesity-related conditions are
improved with weight losses of 5% to 10% of initial body weight, changes of
this magnitude are commonly recommended (Tate et al., 2001). In a review
of individuals' goals and duration of weight loss attempts, Williamson et al.,
(1992) reported the average participant trying to lose weight wanted to lose
13.6kg (30 pounds). Foster et al. (1997), when assessing participants'
perceptions of a 'reasonable' weight loss, found that in a population of 60
obese women goal weight averaged a 32% reduction in body weight.
Unrealistic expectations were evident, with a 17-kg weight loss was
considered disappointed; a 25-kg loss, was acceptable. Thus, focusing on
other parameters may reduce participant's focus on unattainable weight loss
goals.
4.3.8.1 Comparison of magnitude of change
Although L8SF showed the greatest magnitude of change during interim
periods, this was not significantly greater than the magnitude of change in
any other traditional or alternative anthropometric measure. However from
baseline to month 12, both L8SF and endomorphy showed significantly
greater magnitudes of change than body mass and WHR (Fig. 4.17). This
suggests that these may be more useful measures to determine success and
monitor change in overweight and obese individuals than body mass and
WHR in the long term (i.e. with those individuals who remain with the
programme). However, BMI and %BF showed comparable magnitudes of
change to L8SF and endomorphy. Considering BMI first, this is a quick and
easy measure to calculate and requires limited equipment and expertise
(Rowland, 1990). However its main shortcoming, that the non-fat and fat
masses are not accurately considered is well recognised (Baumgartner et al.,
2003; Burkhauser & Cawley, 2008; Garcia et al., 2005; Norton & Olds, 1996).
Furthermore, research has identified that this measure is not sensitive
enough to recognise small yet clinically significant weight losses (Cook et al.,
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2005). The results of the present study, identifying significant change in fat-
related parameters during interim periods when BMI failed to show significant
change, supports this view.
In contrast, %BF, a measure that represents change in the composition of
the body, showed significant change at all interim periods and also showed
comparable magnitudes of change to L8SF and endomorphy from baseline
to month 12 (Fig.4.17). However, Ellis (2000) highlighted the population
specific limitations between SF and %BF, reporting over 100 SF prediction
equations published in current literature. Furthermore, the use of
sophisticated techniques to measure %BF, such as MRI, DXA and
densitometry, are impractical in most population studies (Snijder et al.,
2006). A cheaper and relatively easier method to predict %BF is BIA,
however in obese individuals with BMls >34kg.m-2, there is currently
insufficient validation of BIA equations (Kyle et al., 2003). Additionally,
despite these devices being marketed to the general public, their accuracy
for the measurement of an individual's body fatness remains unclear (Ellis,
2000).
Therefore, whilst L8SF and %BF showed comparable magnitudes of change
and both have been shown to be a sensitive measure of change in an
overweight and obese population, using SF measures in their raw form is
recommended as these measures are more reliable indices of regional
fatness (Wells & Fewtrell, 2006) and are highly correlated with hydrostatically
determined body density (Baumgartner et al., 2003) considered a valid
reference method, yet one that is limited due to its expense and
cumbersome nature (Stewart et al., 2003). Furthermore, although the
measurement of SFs is subject to measurement error (Van Loan, 1997), with
adequate training and adherence to protocols, this need not be equated with
lack of validity (Stewart et al., 2003). Further research identifying specific
skinfolds measures that are sensitive to change could overcome issues such
as time constraints and the error associated with summation of measures.
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The strength of the somatotype is that it summarises the physique as a
unified whole, by combining the appraisal of adiposity, musculoskleteal
robustness and linearity, into a three-number rating. No somatotype sub-
component showed greater magnitude of change than BMI or O/OBF.
Furthermore, endomorphy was the only sub-component to show greater
magnitude of change than body mass and WHR and the only component to
show significant change at interim periods. Thus, the benefits of utilising
somatotype as opposed to traditional anthropometric measures to monitor
weight loss are less apparent. Whilst somatotype accounts for changes in
body composition, 10 measurements are required for its calculation requiring
considerable time and expertise. Therefore, although at the individual level
benefits may be gained by monitoring somatotype, the benefits of
somatotyping do not appear sufficient to warrant the use of somatotyping in
obesity research.
4.3.8.3 Limitations
A strength of the present study includes the longitudinal research design,
however an inherent limitation of longitudinal research designs include high
attrition rates. Although longitudinal analyses are less sensitive to missing
data (Karason et al., 1997), to minimise any biasing effects results of those
who dropped out were extracted, resulting in a relatively small sample size.
Sampling bias is another pervasive problem in obesity research and obesity
trials are often biased towards women (Moore et al., 2003). The current
sample was predominantly female and did not represent a random sample of
individuals, but rather a convenient sample of volunteers. This group
therefore cannot be considered representative of the obese population in
general.
Overall weight loss and body composition changes in the present study were
modest, likely due to the participants following self-directed programmes. In
light of this, it is important to acknowledge that despite the anthropometrist's
satisfactory TEMs and coefficient of reliability ranges of 0.98-1.00,
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measurement error may have confounded results, particularly as change
was not calculated using confidence intervals.
A more serious methodological limitation of the present study is the lack of
valid information regarding participants' diet and exercise habits throughout
the duration of the study. It is well recognised that weight and fat-mass
reductions are directly related to the individually induced energy deficits
between energy intake and output (Stiegler & Cunliffe, 2006). Thus, the
addition of this information may have provided an insight into the
mechanisms that contributed to weight and body composition changes.
Furthermore, no attempt was made to ascertain the status of participants
prior to partaking in the studies. For example, details regarding previous
weight loss attempts and duration of ongoing weight loss efforts. This could
have impacted findings if for example, participants had previously lost a
significant amount of weight, thus limiting the changes observed in the
present study.
4.3.8.9 Future directions
Having established that 2:8SF is a sensitive measure of change that provides
detail regarding the composition of the body this measure could be utilized to
provide greater insight into gender differences during weight loss.
Furthermore, due to expensive instrumentation and the practicality of
methods such as DXA and densitometry, longitudinal studies have rarely
tracked body composition changes long enough to detect age-based trends
(Fantin et al., 2007). Thus future research could examine age-based trends
in body composition change, utilising cheaper methods such as SF
measures that overcome these barriers.
An additional avenue of research could examine the effect of seasonality on
changes in body composition in order to identify critical time periods in which
individuals are more susceptible to relapse and may require additional weight
management support. Further analysis may also wish to explore patterns of
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change in individual skinfold measures, in order to identify a smaller subset
of skinfold measures that provide the same benefits, yet reduce economic
costs from both a time and financial perspective. Finally, research should
explore patterns of body composition change as a result of varying weight
loss treatment modalities such as diet, exercise, or a combination there of, in
order to identify the most efficacious weight loss method.
4.3.9 Conclusion
L8SF has been shown to be a sensitive measure that shows greater
magnitude of change than mass and WHR. Furthermore it does not suffer
the same limitations as BMI and %BF as it represents the composition of the
body and is not limited by transformation from other variables. Additionally
L8SF showed significant change that was unapparent when considering only
weight-related parameters. This could provide a positive feedback
mechanism for individuals that may in turn enhance motivation and self-
efficacy levels leading to reduced attrition, a common issue in obesity
research and treatment. Therefore, it is concluded that L8SF, a measure that
requires little instrumentation and can be routinely used in the field, could be
utilised in an overweight and obese population to monitor weight loss.
Conversely, the benefits of somatotype to monitor weight loss are less
evident and should not be considered for routine use.
Finally, it is clear from the results of the present study that simple two wave
'before and after' designs may miss important fluctuations that occur in body
weight and the composition of the body. It is concluded that future studies
should consider the inclusion of more frequent monitoring to limit the
possibility of false conclusions regarding success/failure, although monitoring
at monthly intervals may be too frequent to observe a change and longer
time periods (e.g. 3-4 months) should be considered.
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5. STUDY TWO: Anthropometric measures and
physical self-perceptions
This chapter provides an overview of the relationship between obesity and
psychological health, an area that is less clearly delineated in comparison to
the medical co-morbidity of obesity that is readily apparent (Steinbeck,
2004). The chapter introduces self-concept, focusing on the development of
the multidimensional self-concept and more specifically, perceptions of the
physical self that are thought to have important implications on psychological
health (Carron et al., 2003). This is followed by a review of research
examining the relationship between physical self-perceptions and body
composition. Following the development of adequate instrumentation to
assess physical self-perceptions, researchers have been able to establish
links between physical self-perceptions and body composition; however this
research has primarily focused on traditional anthropometric measures
(Polman & Borkoles, 2007; Shaw et al., 2000; Van Vorst et al., 2002).
Subsequently, the present study aimed to provide an understanding of the
link between physical self-perceptions and alternative anthropometric
measures. Relationships between traditional anthropometric measures and
physical self-perceptions were compared with relationships between
alternative anthropometric measures and physical self-perceptions. The
relationship between changes in these measures were also examined, as
identifying objective anthropometric measures that relate to physical self-
perceptions, and understanding their interaction, may inform appropriate
feedback mechanisms for improved management of overweight and obese
individuals.
5.1 Introduction
Although the medical co-morbidity of obesity is readily apparent (Steinbeck,
2004), it has become increasingly clear that the problems associated with
obesity are not restricted to its effect on physical health (Fontaine, 2002).
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Although less clearly delineated, obesity is also thought to have an impact on
a person's psychological well-being (Doll et al., 2000; Friedman & Brownell,
1995) and the psychological and social burdens of obesity can be significant
(National Audit Office, 2001).
How humans perceive themselves has important implications for their
psychological health (Carron et al., 2003). Two of the earliest self-
perceptions studied were self-esteem (also known as self-worth) and self-
concept (Gill & Williams, 2008). The terms are often used interchangeably
however evident themes within literature suggest that self-concept is the
overall descriptive perception of the self, and self-esteem is the evaluative
aspect of the self (Butler, 2005).
Global self-esteem is underpinned by self-perceptions in many different life
domains including work, family, spiritual and social (Thogersen-Ntoumani et
al., 2005). Although all dimensions contribute to self-esteem, physical self-
esteem, reflecting an individual's opinion of his or her appearance, strength,
condition, co-ordination and other related aspects of the physical self
(Schneider et al., 2008), seem to play a superlative role (Berger et al., 2002;
Crocker et al., 2000, Fox, 2000). Consistently high relationships between
aspects of the physical self and self-esteem are apparent in literature
(Thogersen-Ntuomani et al., 2005) therefore the physical self was of interest
in the present study.
There are many instruments used to evaluate the physical self (Buckworth &
Dishman, 2002) including the Physical Self-Perception Profile (PSPP; Fox &
Corbin, 1989), the Physical Self-Concept Scale (PSC; Richards, 1988), and
the Physical Self-Description Questionnaire (PSDQ; Marsh et al., 1994). The
theoretical frameworks behind these measures have the same generic
structure (Fig. 5.1), with global self-concept and global self-esteem at the
apex, overall physical self-worth at the domain level, and specific physical
self-perceptions at the base (sub-domains) of the model (Crocker et al.,
2006). The development of these multidimensional, hierarchical physical self-
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concept instruments have overcome the limitations of early research that
were reliant on instruments that did not clearly measure physical self-
concept, or distinguish physical self-concept from other domains of global
self-esteem (Burgess et al., 2006; Hayes et al., 1999; Marsh, 2002).
SPORT COMPETENCE (SC) - athletic ability, ability to learn a sport,
confidence in sport
BODY ATTRACTIVENESS (BA) - attractive physique, ability to maintain
an attractive body, confidence in appearance
PERCEIVED STRENGTH (PS) - perceived strength, muscle development,
confidence in situations requiring strength
PHYSICAL CONDITION (PC) - condition, stamina, fitness, ability to
maintain exercise, confidence in exercise-setting
PHYSICAL SELF WORTH (PSW) - general feeling of pride, satisfaction,
happiness, and confidence in the physical self
Figure 5.1. Hierarchical organisation of physical self-perceptions (Fox,
2001) and breakdown of sub-domain levels (Marsh, 1997).
It is the specific physical self-perceptions at the base of the model that
separate the physical self-concept measures. The PSDQ (Marsh &
Redmayne, 1994) measures nine elements of the physical self (strength,
body fat, activity, endurance/fitness, sports competence, coordination,
health, appearance, and flexibility). The PSC has six subdomains (body
build, appearance, health, physical competence, strength, action orientation;
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Marsh et al., 1994) and the PSPP (Fox & Corbin, 1989) measures
perceptions of sport competence (SC), physical strength (PS), physical
condition (PC), body attractiveness (BA) (Biddle & Mutrie, 2008) (Fig 5.1). In
addition, the PSPP assesses the more global construct of physical self worth
(PSW; Polman & Borkoles, 2007), defined as general feelings of pride,
satisfaction, happiness, and confidence in the physical self (Hayes et al.,
1999).
The PSDQ has been demonstrated to have good reliability (Marsh, 1996a), a
well defined, replicable factor structure (Marsh et aI., 1994) and good test-
retest stability (Marsh, 1996b). However, the PSDQ was designed for use
with adolescents and although Marsh and Redmayne (1994) have postulated
that the instrument should also be appropriate for use with adults there is an
absence of construct validity research to substantiate this claim. According
to Ostrow's directory (1990), the PSPP is the strongest multi-dimensional
physical self-concept instrument.
Initial evidence supporting the validity and reliability of the PSPP was
demonstrated with a large sample of U.S. University Students (Hayes et al.,
1999). However, Fox (1990) suggests the PSPP offers models of
investigation of other groups and a study conducted by Page et al. (1993),
has since established that the instrument is equally valuable for use within a
British population. Additionally, the scale has not been found to be gender or
age dependent which has important implications as age is thought to be an
important moderator of the relationship between obesity and well-being (Hill,
2005). There is also evidence supporting the cross-cultural validity of the
instrument (Page et aI., 1993). Reasonably similar factor patterns for males
and females have also been found with the PSPP, making gender
comparisons possible (Fox, 1990).
Instruments used to measure physical self-perceptions such as SC, BA, PS,
PC and PSW have been used extensively in research to examine age,
gender (Hayes, 1999; McAuley et el., 1995; Sonstroem, 1998) and cross-
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cultural differences (Page et aI., 1993; Riley et aI., 1998) in physical self-
perceptions. The relationship between these physical self-perceptions (SC,
BA, PS, PC and PSW) and exercise has also received attention
(Thorgersen-Ntuomani et al., 2005), identifying that regular physical activity
participation is moderately associated with positive physical self-perceptions
(Fox, 2001). The relationship between changes in these variables over time
has also been examined (Crocker et aI., 2003; Daley et aI., 2005; Ransdell et
al., 2001) with a general consensus that exercise can improve physical self-
perceptions. However, the mechanisms underpinning these changes are
unknown, although Fox (2001) postulates several mechanisms, some tied to
improvements in fitness and weight loss, and others linked to social
significance and the exercise setting.
Body composition is another area that has been examined in relation to
physical self-concept, both in terms of composition changes and cross-
sectional comparisons (Polman & Brokoles, 2007; Shaw et al., 2000; Van
Vorst et al., 2002). Research to date has been equivocal with some studies
identifying a negative relationship between body mass and psychological
well-being (Carr et al., 2007; Dong et al., 2004; Rippe et al., 1998; Schwartz
& Brownell 2004; Wadden et al., 2006) and others finding non-significant
associations (Istvan et al., 1992).
In a population of Caucasian women, aged 50-75 years, Shaw et al. (2000)
examined body composition and physical self-concept changes as a function
of strength training. The authors concluded that body composition was
significantly related to overall physical self-concept. As a result of the
strength training intervention total body fat decreased, however only
decreases in leg fat were able to predict improvements in perceptions of
physical appearance. Van Vorst et al. (2002) found similar results in a
college population, identifying improvements in lower body strength, not
upper body strength, were associated with improvements in physical self-
concept.
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More recently, Polman and Brokoles (2007) examined whether body
composition and engagement in an exercise program influenced participant's
physical self-perceptions. Significant decreases in %BF and BMI were
apparent in participants who adhered to the exercise program, and these
changes were associated with improved perceptions of PC and PS.
Additionally decreases in %BF were correlated with BA, with decreases in
WHR associated with the SC, BA and PS dimensions (Polman & Brokoles,
2007).
In a primary care exercise referral programme, involving 40-70 year olds,
Taylor and Fox (2005) reported that changes in anthropometric measures
were related to changes in physical self-perceptions. Conversely, in a mother
and daughter sample following a 3-month fitness building exercise
programme, Ransdell et al. (2004) found no relationship between changes in
body mass and physical self-perceptions. The authors however suggested
that this finding might be due to the limited changes in the body mass of the
participants.
Previous research in the area of body composition has investigated the
associations of physical self-perceptions with body composition parameters
such as BMI, WHR and %BF (Polman & Borkoles, 2007; Shawet al., 2000;
Van Vorst et al., 2002). Little research has examined the association
between somatotype and physical self-perceptions, with those that have
focusing on body image. Body image is an integral component contributing to
an individual's physical self-worth (Carron et al., 2003) and includes
affective, cognitive and perceptual components (Thompson, 2004). It is
usually conceptualised as incorporating body size estimation, evaluation of
body attractiveness and emotions associated with body shape and size
(Grogan, 2006). Thompson et al., (1999) identified 14 definitions of different
components of body image; however this number has since dramatically
increased (Stewart & Williamson, 2004). Consequently, numerous body
image tools have been developed, all purporting to measure one or more of
the body image dimensions (Grogan, 2006).
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In a study of active and inactive adults, Bahram and Shafizadeh (2006)
examined the relationship between body composition, including somatotype,
and body image, focusing specifically on the appearance and fat sub-scales
of the PSDQ. Significant moderate inverse correlations were found between
the fat sub-scale and %BF and BMI. These findings confirm those of Sullivan
(1993) and Eklund and Crawford (1994). Significant moderate inverse
correlations were also evident between the fat sub-scale with endomorphy
and mesomorphy and direct correlation with ectomorphy. This suggests that
an adult's attitude toward their body emanate from their body size and type
(Bahram & Shafizadeh, 2006). Although Bahram and Shafizadeh (2006)
examined gender and activity level differences in their study sample,
correlation analysis of body composition measures and PSDQ sub-scale
scores were conducted on the study sample as a whole. Viviano (2001)
identified that females tend to place greater importance on their appearance
than men and dissatisfaction with body size and shape has been widely
reported to be less pronounced in men than women (Kay, 2001). It has also
been identified that women generally prefer an ectomorphic shape (Kay,
2001) with men desiring a mesomorphic build (Sands et al., 2004). Bahram
and Shafizadeh (2006) identified a Significant interaction of gender and
activity level on the appearance sub-scale, thus separate correlation analysis
may have identified different relationships to those presented.
As somatotype surveys on obese individuals have generally shown obese
women to be considerably less ectomorphic than comparable samples of
'normal' women (Carter & Heath, 2005), with average ectomorphy scores
1.0-1.5 (Fett et al., 2006), obese women may experience greater degrees of
body dissatisfaction, thus it is an area that warrants attention. Early research
found little psychological predictive utility in somatotype variables, however
Carter and Heath (2005) suggest this may be due to inadequate
understanding of somatotyping and the use of different somatotyping
methods. Furthermore, studies have correlated psychological variables with
either components of somatotype or with the 'gestalt' somatotype (calculated
as one reading measure) which may contribute to these findings.
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Research in the area of body image has been based primarily on
anthropometric representations that are rarely based on genuine
anthropometric measurements (Stewart et aI., 2003). Examples of methods
that have been used in current research to construct these representations
include computer graphic methods (Gruber et aI., 2001; Kagawa et aI., 2006;
Letosa-Porta et aI., 2005), linear analogue and figural drawing scales
(Cachelin et aI., 2002; Gardner & Brown, 2010; Maximova et aI., 2008) and
questionnaires (Cooper et aI., 2006; Riley et aI., 1998). Limitations of these
methods have been well documented. For example, no single questionnaire
can broadly measure a continuum of body image disturbance (Cash et .al.,
2004). Furthermore, by altering arc sizes and overlapping ellipsoids
(Schlundt & Bell, 1993) computer generated techniques have allowed
individuals to alter body silhouettes to make them thinner or fatter. However,
these techniques have failed to produce realistic images (Stewart et aI.,
2003). Benson et al. (1999) suggest this is due to the simple reason that a
real, recognisable body image is not presented. Distortion can also be
unrealistic and limited in range and direction (e.g. thinner, fatter) and cannot
measure specific body parts (Benson et aI., 1999).
The need for addressing specific body areas, not just the global silhouette, is
well recognised (Aclaniz et aI., 2003). Stewart et al. (2003) have identified
that assessment of body image can proceed from detailed assessment of the
body, yet is frequently overlooked. Andersen et al. (2006) suggest that the
use of objective anthropometric and body composition measures, which are
more sensitive indexes of physical changes than body mass, may provide
greater insight into the relationship between physical changes and changes
in physical self-perceptions.
5.2 Aims and Hypotheses
122
5.2 Aims and Hypotheses
Increasing existing awareness of factors influencing psychological health in
an overweight/obese population may be helpful in terms of public health
(Laforest et al., 2009). Identifying objective anthropometric measures that
relate to physical self-perceptions, and understanding their interaction, may
inform appropriate feedback mechanisms for improved management of
overweight and obese individuals. Study Two therefore aimed primarily to
examine and compare the relationship between traditional and alternative
anthropometric measures with physical self-perceptions (as measured by the
PSPP) in a population of overweight and obese individuals. Secondly, the
study examined changes in PSPP constructs over time and then moved
forward to investigate the association between changes in traditional and
alternative anthropometric measures with changes in PSPP constructs. The
following alternative (experimental) hypotheses were formulated:
Hs) Alternative anthropometric measures would show stronger correlation
with PSPP constructs compared to traditional anthropometric measures with
PSPP constructs.
Ha)PSPP constructs would improve over time.
H7) Changes in alternative anthropometric measures would show stronger
correlation with changes in PSPP constructs compared to changes in
traditional anthropometric measures with changes in PSPP constructs.
Many studies examining changes in physical self-perceptions have
investigated these changes over different time periods ranging from 6-12
weeks (Burgess et al., 2006; Polman & Borkoles, 2007; Rippe, et al., 1998)
to 4-12 months (Crocker et al., 2003; Daley et al., 2005; Schneider et al.,
2008; Teixeira et al., 2006). However it is not clear what the optimal time lag
to assess causal effects in physical self-perceptions is (Crocker et aI., 2006).
Welk and Eklund (2005) suggest that longitudinal designs examining
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changes in physical self-perceptions over time may be useful in determining
the relevance of physical self- perceptions on health-related outcomes.
Therefore, to advance traditional cross-sectional research on the physical
self, the current study collected data over a year, in order to examine how
perceptions of the physical self change over a longer time period.
However, as identified in Chapter 3.5.1 individual change takes place
continuously over time and should not be viewed as a 'before and after'
phenomenon (Willett, 1994). Furthermore, it is well established that weight
loss maintenance, defined as intentional weight loss that has subsequently
been maintained for at least 6 months (Elfhag & Rossner, 2005) is
problematic. Weight cycling, whereby individuals repeatedly lose and regain
weight, is another common problem experienced by individuals trying to lose
weight (Brownell & Rodin, 1994). As the current study aimed to examine how
objective anthropometric variables and physical self-perceptions change over
time, examination over shorter-time periods may identify relationships that
would not be apparent when examining change over a year. Changes in self-
perceptions have been evident in programmes longer than 8 weeks in
duration (Andersen et al., 2006). Therefore, the relationship between change
in traditional and alternative anthropometric measures and PSPP constructs
at the following intermittent time periods; from baseline to month 4, months 4
to 8, and month 8 to 12, were also examined.
5.3 Methods
5.3.1 Study design and participants
Ethical approval for Study Two was received from the BioSciences Research
Ethics Committee of the University of Portsmouth. A total of 60 participants,
male (n=10) and female (n=50) between 35-79 years completed a shortened
version of Fox and Corbins (1989) PSPP and underwent anthropometric
profiling. Please refer to Chapter 4.2.2.1 for details regarding determination
of sample size a priori, and to Chapter 4.2.3 for details regarding recruitment
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processes, inclusion and exclusion criteria and preliminary screening
methods.
5.4 Procedures
5.4.1 Anthropometric Data Collection
All anthropometric data were collected using the same protocol described in
Chapter 3.1 and the data handling procedures described in Chapter 4.2 were
followed to allow calculation of BMI, WHR, %BF, r8SF and the three
somatotype sub-components; endomorphy, mesomorphy and ectomorphy.
Data were collected on 4 separate occasions; at baseline and at months 4, 8
and 12.
5.4.2 Use of the PSPP
The PSPP has been subjected to extensive psychometric scrutiny during its
development and the reliability, integrity and hierarchical organisation of the
subscales have been confirmed (Page et al., 1993). A particular strength of
the PSPP is its content validation (Marsh, 1997). The factor structure
appears to be robust across populations, and subscales are internally
consistent, which encourages confidence in the normative properties of the
scale (Fox & Corbin, 1989). The Likert-type scale is familiar to most
individuals (Buckworth & Dishman, 2002) and the structured alternative
format of the PSPP has been shown to reduce social desirability responding
(Fox, 1998; Fox & Corbin, 1999), a problem which has plagued self-esteem
research in the past (Marsh, 1997). Furthermore, as an indicator of change in
mental well-being, the PSPP is thought to have particular relevance to
exercise and weight management settings (Page et al., 1993). Therefore, the
PSPP was the psychological instrument used in the current investigation.
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5.4.3 PSPP data collection
The PSPP has 5 factors (PC, PS, SC, BA, PSW) with each factor consisting
of 6 items. The item score can range from 1 (low) to 4 (high) on a structured-
alternative scale (Hayes et al., 1999). Respondents first select which of two
contrasting statements relates to them, then decide whether the statement is
'sort of true' or 'really true' for them. A total subscale score of 6 (low) to 24
(high) is available for each factor. A copy of the PSPP and sheet for
recording scores by hand are provided in Appendices 11 and 12,
respectvely. Previous studies have identified that the PSPP constructs PS
and SC, are most susceptible to change through exercise (Fox, 1997). As
the aim of the study was not exercise, strength or sport focused, and given
the nature of the sample (individuals with some degree of overweight or
obesity), the SC and PS items were removed to avoid redundancy. Fox and
Corbin (1989) suggest that satisfaction with appearance is the domain of
self-worth most affected by obesity (Hill, 2005) and perceptions of body
appearance and physical self-worth are linked to weight management
(Crocker et al., 2006). Therefore the construct of BA, PC and PSW
remained.
Sample items characterising each of the scales used are as follows: "I am
often admired because my physique/figure is considered attractive" (BA
esteem); "I feel confident that I maintain excellent conditioning and fitness"
(PC esteem) and "I feel extremely proud of who I am and what I can do
physically (PSW esteem). All PSPP data were collected according to the
time scale described above in Chapter 5.4.1, immediately following
anthropometric profiling. Verbal feedback of all anthropometric changes were
provided prior to completion of the questionnaire.
5.4.4 Statistical Analyses
Statistical tests of normality and difference for anthropometric data have
previously been described in Chapter 4.2.3.1, thus the remainder of this
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section will discuss the analysis methods applied to PSPP data and detail
the correlation techniques used to examine the relationships between
anthropometric and PSPP data.
5.4.4.1 Tests of normality
Evaluation of skewness and kurtosis identified that the distribution of PC and
BA were normal (z(skew)=2, and z(kurtosis)=1.5; z(skew)=1.8,
z(kurtosis)=1.5), however PSW was not normal (z(skew)=2.9, and
z(kurtosis)=3.5). Kolmogorov-Smirnov's test showed that both PC and BA
were normally distributed (0(60)=0.105, P=0.095, and 0(60)=0.098,
P=0.200) and that PSW was not normally distributed (0(60)=0.158,
P=0.001). Logarithmic transformation of PSW did not improve distribution,
however graphical plots indicated linear patterns and the sample size of 60
was considered sufficient to invoke the central limit theorem (Boslaugh &
Watters, 2008) thus the decision to use parametric tests was taken.
5.4.4.2 Tests of difference
A Wilk's Lambda multivariate repeated measures ANOVA, with Bonferonni
adjustment, was conducted to test H2, with time as an independent factor
and the PSPP constructs PC, BA and PSW as dependent variables.
Mauchly's test indicated that PC, BA and PSW violated assumptions of
sphericity (X2(5) =19.092, P =0.002; X2(5) =11.104, P =0.049; and X2(5)
=21.860, P =0.001), therefore degrees of freedom were corrected using
Greenhouse-Geisser estimates of sphericity (E=0.83).
5.4.4.3 Correlation analysis
A Pearson's Correlation Coefficient was used to examine the correlation of
anthropometric measures with PSPP construct scores at baseline and the
inter-correlation between PSPP constructs. Correlation coefficients <0.29
were defined as weak, between 0.3 and 0.69 moderate and >0.7 strong
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(Jackson, 2009). Any time point could have been chosen to examine the
correlation between anthropometric measures and PSPP construct scores,
however similar strength correlations were observed at all time points, thus
only baseline relationships are presented.
Correlation analysis was also conducted between calculated changes
(between baseline and month four, month 4 to month 8, month 8 to month
12, and baseline to month 12) in all anthropometric measures and PSPP
construct scores. Change was calculated as the difference between initial
and final time point.
It has been argued that the analysis of absolute change between two time
points is not appropriate when there are differences at baseline between the
intervention and control group (Twisk & Proper, 2004). To account for these
differences, methods such as analysis of covariance and analysis of 'residual
change' are often used (Twisk & Proper, 2005). However, the present study
is not comparing an intervention group with a control group. Furthermore,
when only two waves of data are available, calculating difference scores is
intuitively appealing, easy to compute and provides an unbiased estimator of
true change (Olweus & Alasker, 1994; Willett, 1997), thus difference scores
were used in the present analysis.
5.5 Results
Data are presented for participants who attended all anthropometric
measurement sessions and completed the PSPP questionnaire (n=60).
Baseline demographic, traditional and alternative anthropometric measures
have previously been provided in Table 4.8.
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5.5.1 Baseline relationships between anthropometric measures and
PSpp component scores
Three of the four traditional anthropometric measures showed significant
moderate relationships with at least one PSPP construct at baseline (Table
5.1). BMI showed significant inverse correlation with all PSPP constructs,
with the strongest inverse relationship evident between BMI and BA (r(60)=-
O.53,P<O.05). Body mass also showed a significant moderate negative
association with BA (r(60)=-0.43,P<O.05) however did not show a significant
relationship with either PC or PSW (r(60)=-O.23,P>O.05).WHR showed a
significant positive correlation with PC however this was weak. %BF showed
significant correlation with all PSPP constructs with similar strength
relationships seen in PC and BA and the weakest relationship evident
between %BF and PSW.
Three of the four alternative anthropometric measures also showed
significant moderate relationships with at least one PSPP construct at
baseline (Table 5.1). L8SF and endomorphy showed significant moderate
negative correlations with PC and BA (r(60)=-0.45,P<O.05 and r(60)=-
O.54,P<O.05,respectively). Significant inverse correlation was also observed
between L8SF and PSW and endomorphy and PSW (Table 5.1). In contrast,
the somatotype sub-component mesomorphy showed significant negative
correlation only with BA (r(60)=-0.43,P<O.05). Ectomorphy failed to show a
significant association with any PSPP construct.
Inter-correlations between PSPP constructs indicated that PC showed a
strong significant positive correlation with BA and PSW (Table 5.1). BA and
PSW demonstrated the strongest association of all PSPP constructs
(r(60=O.78,P<O.05).
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Table 5.1. Relationship (Pearson's correlation coefficient) of anthropometric
indices with PSPP construct scores at baseline (n=60)
PC BA PSW
TRADITIONAL
BMI (kq.rn") -0.29* -0.53* -0.28*
Mass (kg) -0.23 -0.43* -0.23
WHR 0.26* 0.04 0.17
%BF -0.50* -0.53* -0.34*
ALTERNATIVE
L8SF (mm) -0.45* -0.54* -0.35*
Endomorphy -0.45* -0.54* -0.34*
Mesomorphy -0.21 -0.43* -0.24
Ectomorphy 0.19 0.23 0.02
PSPP CONSTRUCTS
Physical Condition - 0.63* 0.63*
Body Attractiveness 0.63* - 0.78*
*P<O.05
5.5.2. Change in PSPP measures over time
Collectively the PSPP constructs showed significant change over time
(F=3.742,g,512,P<0.05,1-13=0.94).All PSPP constructs showed significant
increases between baseline and month 4, and from baseline to month 12
(Fig.5.2). Additionally, BA showed significant change from baseline to month
8, however no PSPP constructs showed significant changes between other
time points, e.g. month 4-8, 8-12, or 4-12 (Fig. 5.2).The highest baseline
score was seen in PC (12.8±0.5), with the next highest score observed in
PSW (11.6±0.4) and the lowest in BA (10.6±0.4). The greatest improvements
were observed in BA with an increase of 1.1±0.3 from baseline to month 4
and an overall improvement of 2.0±0.4. Smaller, significant changes were
observed in PC and PSW over the testing period, of 1.7±0.5 and 1.5±0.4,
respectively (Fig. 5.2).
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Prior to conducting an analysis to establish a causal relationship between
changes in anthropometric measures and changes in PSPP constructs, it
was first necessary to establish whether these measures changed
significantly over time. The results of Study One, Part B have already
established that all anthropometric variables, with the exception of WHR and
ectomorphy, changed significantly over time (Figs. 4.8-4.9). Additional
analysis confirmed that during interim periods (Le. baseline-month 4, month
4-8, and month 8-12), L8SF, endomorphy and %BF were the only
anthropometric variables that changed significantly (Table 4.9).
5.5.3. Relationship between changes in anthropometric measures and
changes in PSPP component scores
When examining change in traditional anthropometric measures and PSPP
constructs from baseline to month 12, significant inverse associations
between BMI, mass, and %BF were found with the PSPP construct PC
(Table 5.2). WHR was the only anthropometric measure to show a significant
positive association with BA (r(60)=0.30,P<0.05). However all associations
observed between changes in traditional anthropometric measures and
changes in PSPP constructs were either weak or only just reached moderate
strength. For example, change in BMI, mass and %BF were significantly
correlated with change in PC, however the strength of these correlations
were <0.3 (Table 5.2).
When examining change in alternative anthropometric measures and PSPP
constructs from baseline to month 12, a significant inverse correlation
between endomorphy and PC was apparent (Table 5.2). However, this was
also weak (r(60)=-0.25,P<0.05). No other significant correlations were
observed between changes in alternative anthropometric measures and
PSPP constructs. Changes in PC and BA showed strong correlation to
changes in PSW (r(60)=0.65, P<0.05, and r(60)=0.72,P>0.05, respectively.
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Table 5.2. Relationship (Pearson's correlation coefficient) of change in
anthropometric indices with change in PSPP construct scores from baseline
to month 12 (n=60)
Baseline - Month 12
PC BA PSW
TRADITIONAL
BMI (kg.m-£) -0.26* -0.11 -0.16
Mass (kg) -0.27* -0.09 -0.1S
WHR 0.13 0.30* 0.22
%BF -0.28* -0.06 -O.OS
ALTERANTIVE
L8SF (mm) -0.14 -0.00 -O.OS
Endomorphy -0.2S* -0.03 -0.02
Mesomorphy -0.14 -0.03 -0.04
Ectomorphy 0.10 0.00 0.09
PSPP CONSTRUCTS
Physical Condition - 0.63* 0.6S*
Body Attractiveness 0.63* - 0.72*
*P<O.05
When examining changes between interim periods, the strongest
associations between change in anthropometric variables and change in
PSPP constructs occurred between months 8 to 12 (Table S.3), however the
PSPP constructs did not show significant change during this time period (Fig.
S.2). As BMI and mass decreased BA scores increased (r(60)=-
0.40,P<0.OS).Decreases in %BF were associated with increases in PC, BA
and PSW. Reduction in L8SF and endomorphy both correlated with
increases in PC, BA and PSW with the strongest associations evident in
endomorphy. Between months 4 and 8 only two significant but weak
correlations were observed, with reduction in BMI and mass correlating with
increases in PSW (r(60)=-0.27,P<0.OSand r(60)=-0.30,P<0.OS,respectively).
Significant correlations were also observed between baseline and month 4
however these were again weak. The strongest relationships were evident
between change in BMI, mass, and endomorphy with change in PC, showing
similar strength relationships between -0.26 and -0.27. Decreases in
endomorphy also correlated with increases in BA. In contrast, increases in
ectomorphy correlated with increases in BA (r=(60)=0.26,P<0.OS). Weak
correlations were also observed between decreases in BMI and mass with
increases in PSW.
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5.6Discussion
The main aim of the present study was to identify the relationship between
PSPP constructs and anthropometric indices and examine whether changes
in alternative anthropometric measures were more strongly correlated with
changes in PSPP constructs than changes in traditional anthropometric
measures.
5.6.1 Baseline relationships between anthropometric measures and
PSPPcomponent scores
At baseline all PSPP constructs were significantly related to at least one
anthropometric measure (Table 5.1). Perceived PC and BA were also
positively correlated with each other, and with PSW, thus supporting the
hierarchical nature of physical self-perceptions proposed by Fox and Corbin
(1989).
Moderate significant inverse correlations were observed between the
traditional anthropometric variables BMI, mass and %BF (r=-0.43 to -0.53)
with the PSPP construct BA (Table 5.1). These results are in agreement with
research evidence that identifies that BMI, mass and % body fat correlate
closely with BA (Bahram & Shafizadeh, 2006; Caruso & Gill, 1992; Eklund &
Crawford, 1994; Welk & Eklund, 2005; Sullivan, 1993). In contrast to
research by Kay (2001), who proposed that girth ratios such as the WHR
may be useful anthropometric correlates of body dissatisfaction, the present
study showed no significant correlation between WHR and BA. This result
confirms those of Mitchell et al. (2003) who also found no relationship
between WHR and BA when examining body image and anthropometric
measures in exercising and non-exercising women. It has been reported that
BMI explains significantly more variance of BA data than WHR (Tovee et al.,
1998; Smith et al., 2007). Therefore, this may provide explanation for the
lack of association between WHR and BA in the present study.
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However, whether BMI or WHR is a more important factor of attractiveness is
an ongoing debate (Perilloux et al., 2010) and criticisms have been made
that the greater influence of BMI on BA is a result of research using stimuli
with a wide range of BMl's and a relatively restricted range of WHR's (Dixon
& Baogou, 2010). However, WHR ranges were favoured in a study
conducted by Tovee et al. (2002), with BMI ranges limited to 0.55D either
side of the sample mean and WHR ranges averaging 1.655D. Despite the
relative ranges favouring WHR, BMI was still found to be more important in
explaining variance in BA.
Bahram and 5hafizadeh (2006) identified significant inverse correlations
between BA and endomorphy and mesomorphy. The results of the present
study confirm these findings, with the alternative anthropometric measures of
endomorphy and mesomorphy also showing significant moderate inverse
correlations with BA (r=-0.43 to -0.53,P<0.05). In addition L85F showed a
significant moderate inverse correlation with BA (r=-0.54,P<0.05). Western
cultures promote physical attractiveness and leanness as important
standards of beauty and success (Philips & Drummond, 2001). Research
indicates that women are mainly concerned with losing fat (Norton & Olds,
1996), and desire a less muscular body (Oehlhof et al., 2009). As the study
population in the present study consisted primarily of females this may
explain the inverse correlations observed in both endomorphy and
mesomorphy. The strength of correlations observed between both traditional
and alternative anthropometric measures with the P5PP construct BA in the
present study were very similar. This suggests that the influence of overall
morphology on BA, as reflected by somatotype, is as important as the
influence of the physical characteristics of BMI and body mass.
Body dissatisfaction is not only a consequence of obesity; it can also be
causative in weight gain in adults through unhealthy restrictive dieting
behaviours (Goldfield et al., 2007). There is strong research evidence to
suggest that low perception of body image is a strong motivator for exercise,
particularly among women (Courneya & Hellsten, 1998; Davis et al., 1995).
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However, when examining body image concerns related to physical activity
participation, Zabinski et al. (2001) identified that physical activity
interventions may increase concerns in women. These negative
consequences occurred despite the intervention consisting of content
designed to prevent concern over dieting and the importance of weight.
Therefore, the results of the present study identifying associations between
high BMI, mass, L8SF and somatotype scores with low BA scores, suggest
that interventions that aim to reduce weight and improve lifestyle should also
aim to enhance perceptions of BA. Furthermore, the assessment of potential
negative side effects in weight loss and lifestyle interventions, such as
increased concern about body image (Zabinski et al., 2001), unrealistic
weight loss expectations (Foster et al., 1997), and increased body image
concerns following relapse (Kayman et al., 1990), should be considered.
All traditional anthropometric measures showed significant inverse
correlation with PC however those observed in BMI, mass and WHR were
weak (r<0.30). Comparable strength correlations between BMI and PC were
observed by Acsi (2005) and Taylor and Fox (2005). %BF, L8SF and
endomorphy showed significant moderate correlations with PC (Table 5.1).
The stronger correlations observed in anthropometric measures related to
body fat suggest that individuals relate perceptions of their physical condition
to measures related to fat as opposed to weight related parameters of BMI
and body mass. Improvements in specific physical self-perceptions, for
example PC and BA are thought to generalise to PSW (Knappen et al.,
2005). Two traditional and two alternative anthropometric measures showed
significant negative correlation with PSW. L8SF and endomorphy both
showed moderate strength association (r= -0.34,P<0.05 and -0.35, P<0.05
respectively). %BF showed a similar strength correlation although that
observed with BMI was weaker.
Overall, strength of associations between traditional and alternative
measures with the PSPP constructs BA and PSW were comparable. The
highest correlation observed in relation to PC was with the traditional
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anthropometric measure %BF. However, this was of a similar level to
alternative anthropometric measures; L8SF and endomorphy. Thus H4, that
stronger correlations will be observed between alternative anthropometric
measures and PSPP constructs compared to traditional anthropometric
measures, is rejected.
5.6.2 Change in PSPP measures over time
McAuley et al. (2000) examined changes in physical self-perceptions over a
12 month period (6 month exercise intervention and 6 month follow up).
Change in BA over the 12 month period in the walking intervention group
showed comparable change to those observed in BA in the present study,
both showing a significant increase of 1.1±0.3 (Fig.5.2). Increases in PSW
over the 12 month period were slightly higher in the present study (1.5±0.4)
compared to the 1.2 increase observed by McAuley et al. (2000), however
this may be a result of differences in baseline scores. The walking groups
baseline PSW was 1.7 higher than the baseline PSW in the present study.
Baseline PC scores in the present study were comparable with those in the
study by McAuley et al. (2000) however smaller increases were observed in
the present study (Fig.5.2). This could be due to the participants in the study
conducted by McAuley et al. (2000) following a structured program of regular
walking, increasing both in intensity (beginning at 50-55% of V02 max and
increasing to 65-70% of V02 max by the midpoint of the program) and
duration (beginning at 10-15 minutes per session three times a week and
increasing up to 40 minutes per session three times a week). In comparison,
whilst objective measures were not recorded, the participants in the present
study that were taking part in structured walks attended on average 1-2
walks per week of a relatively low intensity (-metabolic equivalent (MET)
value of 3-4), with those that followed home exercise programmes reporting
low activity levels estimated <3 METs. Therefore, the participants' activity
levels may not have been sufficient to result in changes in their perceptions
of their PC.
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In the first interim period (baseline to month 4) significant improvements were
observed in all PSPP constructs (Fig.5.2). These results are in contrast to
those observed by Caruso and Gill (1992) who found no significant changes
in physical self-perceptions over a 10 week exercise program of exercising
and non-exercising students. Asci et al. (1998) also reported similar non-
significant associations. Taylor & Fox (2005) found significant improvements
in PC, BA and PSW over a 16 week period, however, the PSPP scores
analysed in the study were derived for each participant by summing
responses and dividing by the number of items in the scale. Thus,
comparison of item scores is not possible. To summarise, all PSPP
constructs showed significant improvement over the 12 month period
(Fig.5.2), and showed significant improvements from baseline to month 4,
thus Hs, is accepted.
5.6.3 Relationship between changes in anthropometric measures and
changes in PSPPcomponent scores
Although significant associations were apparent between change in
anthropometric measures and change in PSPP constructs over 12 months,
these were all of weak value and observed in traditional anthropometric
measures, with the exception of endomorphy (Table 5.2). This finding is in
direct contrast to Hs, thus it is rejected. In contrast to the non-significant
association between WHR and BA observed at baseline in the present study,
change in WHR was the only anthropometric variable to show significant
correlation with change in BA. This correlation was approaching moderate
strength. However, although BA significantly improved over the 12 month
period, WHR did not change significantly over this time period. Thus, this
should be considered when interpreting the relationship between change in
WHR and change in BA. As WHR is less sensitive to weight gain/loss than
waist and hip girths taken separately (Seidell et al., 2001; Vazequez et al.,
2007), this may explain the lack of significant change and future studies
should consider the analysis of these circumference measures separately, in
addition to WHR.
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Taylor and Fox (2005) examined changes in anthropometric data (including
skinfolds) and changes in physical self-perceptions over a 37 week period.
Sum of 4 skinfolds, including biceps, triceps, subscapular and iliac crest
skinfolds, showed significant negative correlation with PC (-0.46,P<0.05) and
BA (-O.41,P<0.05), but no significant association with PSW. In contrast, the
present study found no association between skinfold measures and any
PSPP construct, albeit using I:8SF. Examining change in individual skinfold
measures may have elicited interesting findings, as evidenced by Taylor and
Fox (2005) who found change in triceps skinfold to show significant
moderate inverse correlation with PSW, PC and BA. Furthermore, in the
study by Taylor and Fox (2005) participants were participating in a primary
care exercise referral programme. Although details are not provided
regarding the specific nature of the exercise programmes, this is likely to
have been more focused than the self-directed programs followed by the
current study participants and this may have contributed to the contrasting
findings.
There was no association between changes in PSW with changes in any
anthropometric measure and although significant inverse correlations were
observed between change in BMI, mass, endomorphy and %BF and change
in PC these were all weak (Table 5.2). A possible explanation for the weak
relationships observed between changes in anthropometric measures and
improvements in PSPP constructs may be due to the level of weight loss
achieved. Research has identified that moderate weight loss (5-10% of initial
weight) can lead to improvements in mood, body satisfaction and self-
confidence (Hill, 2005). It is important to note that whilst participants
achieved a significant weight loss, the mean reduction was 3.9±±0.9kg and
most partiCipantswere still classified as overweight or obese, thus participant
perceptions of their physical self may not have undergone noticeable
changes. Therefore the perceptions of themselves in terms of BA and PC
may not have altered. Furthermore, the degree of importance attached to
each of the constructs may also play a role in examining physical self-
perceptions (Sonstroem, 1998). For example, research by McAuley et al.
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(1996) indicated that the importance placed on BA was found to be
significantly less important at the end of a 20 week intervention than pre-
programme. As a result of participating in the present study, participants may
have realigned their perceptions of their physical self and placed more or
less degree of importance on particular aspects, thus may provide partial
explanation for the lack of correlation between changes in anthropometric
measures and changes in PSPP constructs. Marsh and Sonstroem (1995)
found little support for the contention that importance ratings influence self-
esteem ratings, however limited exploration of such propositions exist
(McAuley et al., 1996).
Although from baseline to month 4 significant correlations were observed
between changes in BMI, mass endomorphy and ectomorphy, with changes
in all PSPP constructs, these were weak (Table 5.3). From month 4 to month
8 changes in BMI and mass showed significant correlations approaching
moderate strength with changes in PSW, however these measures showed
no significant change over this time period. Thus, these relationships should
be interpreted with caution. Van Vorst et al. (2002) found that in a population
of preparation stage exercisers; defined as seriously considering changing
their exercise behaviour within the next month (Prochaska & Velicer, 1997);
improvements in physical self-concept levels were associated with
improvements in lower body strength, but not upper body strength. Similarly,
Shaw et al. (2000) found decreases in total body fat during a strength
training intervention however found that only decreases in leg fat were
related to perceptions of physical appearance. In light of these findings, a
possible explanation for the lack of association between changes in
anthropometric measures and changes in physical self-perceptions observed
in the present study may be that the anthropometric measures used did not
focus on specific body areas.
Furthermore, the PSPP instrument used is not body area specific, including
generic statements such as 'I feel that compared to most, I have an attractive
body'. Thus it may not have identified significant associations. The PSDQ
141
measure may have identified significant associations as it contains items that
are more specific regarding perceptions of attractiveness, such as 'my waist
is too large' and 'I have too much fat on my body' (Marsh et al., 1994).
However, this is a 70-item questionnaire and although the appropriateness
for its use in a range of populations has been established (Marsh et al.,
2002) results suggest that 17% of the items are biased in favour of men, and
23% in women (Fletcher & Hattie, 2005) and the instrument's validity in an
obese population has not been firmly established (Marsh et al., 2005).
Another possible explanation for the lack of associations in the present study
may be due to the importance an individual places on physical self-
perceptions. For example, evidence of a relationship between body
composition and physical condition may be absent in individuals who place
no importance in physical condition, and fitness. Although the use of
perceived importance profiles have yielded mixed findings (Fox & Wilson,
2008), efforts to assess perceived importance may have important practical
implications in physical self-perception research.
Although mesomorphy and ectomorphy showed significant change pre and
post, these somatotype subcomponents did not show significant change at
interim periods. It has been identified that women generally prefer an
ectomorphic shape (Kay, 2001) with men desiring a mesomorphic build
(Sands et al., 2004). As these components did not change significantly in the
present study during interim periods, this may provide explanation for the
lack of association between changes in these components with changes in
PSPP construct scores.
Few significant correlations were observed between changes in
anthropometric measures and change in physical self-perceptions from
baseline to month four (Table 5.3), however all PSPP constructs showed
significant improvement over the time period (Fig.5.2) The opposite was
observed when examining changes from month 8 to month 12, identifying
significant moderate strength relationships between changes in
anthropometric measures and changes in PSPP constructs, yet no
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significant change in physical self-perceptions over the time period. This
pattern could reflect the function of individual's physical self-perceptions over
time, starting as a cognitive function then focusing perceptions in relation to
physical changes, in relation to objective measures.
There is evidence to suggest that body image may be cognitive rather than
physical (Schwartz & Brownell, 2004), in that it may not be associated with
actual weight but may be more strongly associated with perception of weight
(Hill, 2005). For example, Cash et al. (1990) have studied a range of eating
and body image measures in individuals who were currently, formerly, or
never overweight. The positive body image obtained by individuals who were
previously overweight and subsequently lost weight, did not reach the
positive body image levels of those who were never overweight.
Furthermore, although individuals who underwent bariatric surgery reported
greater satisfaction with their own body, decreased feelings of fatness and
increased feelings of body attractiveness 3 years post-surgery, these did not
reach normality when compared to control participants (Adami et al., 1999).
The results of the present study, identifying improvements in BA from
baseline to month 4, with weak correlation to change in anthropometric
measures suggest that these improvements may be a function of individual's
perceptions of improved weight as opposed actual weight.
Fox (2000) also suggests that changes in PSW may be associated with the
perception of improved fitness rather than actual changes. However, a study
by Dionigi and Cannon (2009), examining perceived change in PSW in older
adults following resistance training, suggests that a physiological effect,
however small, precedes a change in PSW. Although correlational analysis
cannot establish causation, the results of the present study, identify
significant associations between changes in anthropometric measures and
changes in PSPP constructs from month 8 to month 12. These results
confirm those of Dionigi and Cannon (2009) and dispute the views put
forward by Fox (2000) and Sonstroem (1997) that there is no relationship
between changes in physiological status and changes in self-perception or
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self-esteem. The present results indicate that physical self-perceptions are
not purely based on psychological mechanisms, however as the physical
self-perceptions did not change significantly over the time period further
research is needed to substantiate the mechanisms that affect physical self-
perceptions.
There are other plausible explanations for the lack of associations observed
between changes in body composition and changes in physical self-
perceptions during months 4-8. When examining physical self-perception
improvements in participants following either a walking program or an
abdominal electrical muscle stimulation (EMS) program, Andersen et al.,
(2006) identified significant improvements in PC only in the walking group.
The authors suggested that the self-perceptions related to PC may have
been more salient in the walking group, focusing on levels of physical
condition, stamina and fitness, whereas the EMS group may have been more
focused on body size changes as a consequence of the use of the EMS belt.
As participants in the present study were following self-directed programs,
their participation in different activities may have influenced the focus of their
perceptions of the physical self.
In the same study Andersen et al. (2006) also found no significant
improvements in BA in either group. However participants did improve
significantly on a body dissatisfaction subscale. The authors provide
explanation for these results highlighting the levels of specificity in the
measures. For example, BA assesses perceptions of general body
attractiveness whilst the dissatisfaction scale focuses on specific body areas.
Monitoring changes in self-perceptions measures at each of the levels in the
present study may have elicited interesting findings.
Overall, limited and weak strength correlations were observed between
changes in anthropometric measures and changes in PSPP constructs
during interim periods until month 8 to month 12 (Table 5.3). Similar
moderate strength correlations were evident between changes in traditional
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and alternative anthropometric measures and changes in BA. Change in
%BF was the only traditional anthropometric measure to show a correlation
with change in PC and PSW, demonstating comparable strength correlations
with those observed in L8SF and endomorphy. Thus H3 is rejected, although
the lack of significant change in physical self-perceptions over the time
period limits the applicability of this finding and further research is needed,
perhaps with additional waves of data, to further examine the relationship
between changes in physical self-perceptions and changes in anthropometric
measure over time in an overweight/obese population.
5.6.5 Limitations
Carr et al. (2007) identified that overweight, obese and morbidly obese
individuals differ significantly from one another in terms of demographic and
socioeconomic characteristics. The present study did not control for these
characteristics, thus their influence on the relationship between body
composition and physical self-perceptions cannot be accounted for. The
study sample did however consist solely of Caucasians, thus limiting the
possible influence of ethnicity on the relationship between body composition
changes and physical self-perceptions. However, the sample also consisted
of both male and female participants and it is recognised that there are
gender differences in self-perceptions (Oehlohf et al., 2009). Therefore this
may have confounded research findings.
Additionally, no attempt was made to ascertain the degree of importance that
participants placed on physical self-perceptions and the PSPP instrument
that was administered includes only generic statements. This may have
impacted the study findings as research suggests that perceived importance
may have practical implications in physical self-perception research and
generic instruments may not identify participants concerns over body specific
areas (Shaw et al., 2000).
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5.6.6 Future Directions
Perceptions of the physical self may be subject to a combination of
anthropometric measures. Thus further analysis using hierarchical multiple
regression analysis could examine the contributions of anthropometric
measures to the PSPP constructs, in order to identify individuals most at risk
of experiencing negative physical self-perceptions, so that interventions can
be targeted effectively.
Furthermore, although research suggests no age effect on physical self-
perceptions, it has been hypothesised that gender-specific consequences of
obesity vary over the life course (Carr et al., 2007). Thus age may be an
important predictor variable of the psychological effects of obesity in different
genders, and is an area of research that may elicit interesting findings.
Additional instruments, such as Fox and Corbins Perceived Importance
Profile could also be utilised to examine the influence that this measure has
on individuals' perceptions of the physical self.
The onset of obesity is another area that deserves attention within the
psychological domain. Research indicates that the age of onset of obesity
does not affect body satisfactions of obese individuals; however the durability
of poor body image following weight loss may be influenced by the onset of
obesity at an early age (Schwartz & Brownell, 2004). Further research on the
relationship between body composition and PSPP constructs or other body
image measures, may wish to examine the possible mediating effects of
previous weight loss success/failure.
5.7 Conclusion
Findings from the present study suggest that high levels of fat, as identified
by L8SF, endomorphy and %BF are associated with low perceptions of PC,
BA and PSW. High BMI and mass are also associated with low perceptions
of BA. However, no differences in the strength of relationships between any
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anthropometric variable and PSPP construct were observed. Thus H5, that
alternative anthropometric measures would show stronger correlation with
PSPP constructs than traditional anthropometric measures with PSPP
constructs, is rejected. All PSPP constructs showed significant improvement
over time, thus H6 is accepted. However changes in PSPP constructs
showed, at best, weak correlations with traditional and alternative
anthropometric measures. Therefore H7 that changes in alternative
anthropometric measures would show stronger correlation with changes in
PSPP constructs than changes in traditional anthropometric measures and
changes in PSPP constructs is rejected.
It is therefore concluded that as calculation of somatotype sub-components
and I:aSF requires considerable time and expertise, and the present results
do not support a stronger association between changes in alternative
anthropometric measures and physical self perceptions, compared to
changes in traditional anthropometric measures and PSPP constructs, the
use of these measures in physical self-perception research cannot be
supported at this time. Furthermore, a more constructive approach to
interventions that aim to reduce obesity may be to focus on health-related
behaviours, such as increasing physical activity levels or improving diet, as
opposed to focusing on reducing anthropometric measures that are known to
be associated with low physical self-perceptions. This may also be useful in
reducing the potential negative side-effects of weight loss interventions, such
as increased concern about body image, by focusing on lifestyle factors that
are within the participants' control and have a direct influence on participants'
body weight and shape.
147
6. STUDY THREE: Anthropometric measures
and metabolic syndrome
The work presented in Chapter Six aims to investigate possible relationship
between changes in MetSyn parameters and associated changes in
traditional and alternative anthropometric measures over a 6 month period. A
review of pertinent research in the area of MetSyn is provided and evaluation
of the methodological procedures and instrumentation considered. First
relationships between traditional and alternative anthropometric measures
with MetSyn parameters are examined. Secondly, the strength of the
relationships are compared in order to identify whether alternative measures
are stronger correlates of health status than traditional measures.
6.1 Introduction
The MetSyn is characterised by a clustering of inter-related risk factors
including insulin resistance, abdominal obesity, increased serum triglycerides
(TG), decreased high density lipoprotein cholesterol (HDL-C) and
hypertension (Kukkonen-Harjula, 2005) (Table 2.6). The management of
MetSyn depends primarily on modifying lifestyle, with a priority for weight
reduction (Hall et al., 2006) and the effects of weight loss on MetSyn risk
factors have been extensively studied. For example, the BP-lowering effect
of weight loss has been documented in many clinical trials (He et al., 2000).
In a meta-analysis of 25 randomised controlled trials (n=4874), Neter et al.
(2003) identified a BP reduction of 4.4/3.6 mmHg for a 5-kg weight loss. This
was by means of energy restriction, physical activity, or a combination of
both treatment modalities. In the Trials of Hypertension Prevention, phase
one (1992), 35-54year old overweight men and women with high-normal
DBP were assigned to a weight loss intervention. After an 18-month follow-
up period average weight loss of 3.9kg was associated with a 51% reduction
in incidence of hypertension, systolic blood pressure (SBP) reducing by 2.9
mmHg, and diastolic blood pressure (DBP) reducing by 2.3 mmHg.
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Weight loss has also been shown to lower total cholesterol (TC) and TG
levels, and raise HDL-C (Liberopoulous et al., 2007). In a population of
middle aged men following an exercise programme, Katzel (1997) reported
17% reductions in TG, 8% reductions in LDL-C, 11% increases in HDL-C
and a 20% improvement in LDLlHDL ratio, following a significant weight loss
of 8.1±0.6kg. Similar TG reductions of 15% were also reported by Tchernof
et al. (2002), however this reduction was seen in association with a 14.5±6.2
kg body weight loss, almost double that reported by Katzel (1997). Increases
in HDL-C were also reported to be much higher in the study by Tchernof et
al., (2002) study, reporting 60.6% increase in HDL-C concentrations.
The effect of weight loss is not restricted to improvements in blood lipids; it
also has positive effects on blood glucose (BG) and insulin levels. Long et
al., (1994) found that weight loss in patients with clinically severe obesity
prevented the progression of impaired glucose tolerance to diabetes by more
than 30-fold. Hamman et al. (2006) provide further support, examining the
contribution of changes in weight, diet and physical activity on the risk of
developing diabetes among patients who took part in intensive lifestyle
modification. A total of 1,079 participants (mean BMI 33.9kg.m-2, mean body
mass 94.1kg) took part in the Diabetes Prevention Programme and a 16%
reduction in diabetes risk was reported for every kilogram of weight lost,
adjusted for changes in diet and activity. Katzel (1999) also reported 8%
reductions in BG levels and 30% improvements in insulin responses
following a significant weight loss of 8.1±0.6kg.
It is well known that the distribution of fat influences the prevalence of
MetSyn for a given BMI (Byrne & Wild, 2007), and plays a key role in the
pathophysiology of all facets of the MetSyn (Case et al., 2002). Furthermore,
as documented in 2.3.2.2 there is some evidence of characteristic
somatotypes being associated with disease and conditions such as CVD and
dyslipidaemia (Carter & Heath, 2005), however, little is known about the
association between MetSyn and somatotypes. Somatotype, a more holistic
measure of one's body type, may have utility in evaluating an individuals'
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metabolic risk, beyond their level of adiposity (Katzmarzyk et al., 2003)
Therefore, the aim of Study Three was to evaluate the efficacy of using
measures of physique (somatotype) as in indicator of health risk.
6.2. Aims and hypotheses
Identifying anthropometric measures that correlate with MetSyn markers may
be helpful in both identifying individuals at risk and improve management of
MetSyn. Therefore, the current study aimed to identify and examine the
relationship between MetSyn risk factors (blood pressure, abdominal obesity
(WC), HDL-C, fasting BG and TG levels) with both traditional and alternative
anthropometric measures. The optimal monitoring interval for individuals with
MetSyn is unknown, however recommendations suggest that fasting lipid
profiles should repeated at 3 to 6 months after initial assessments (National
Heart, Lung & Blood Institute, 2001). Therefore, measurement of MetSyn
markers and anthropometric profiling was conducted at baseline, and at 3
and 6 month intervals. The following alternative (experimental) hypotheses
were formulated:
Ha)Baseline relationships between alternative anthropometric measures and
MetSyn markers will be stronger than the relationship between traditional
anthropometric measures and MetSyn markers.
Hg) Changes in alternative anthropometric measures will show a stronger
correlation with changes in MetSyn markers than changes in traditional
anthropometric measures and changes in MetSyn markers.
6.3 Methods
6.3.1 Study design and participants
Ethical approcal for Study Three was received from the BioSciences
Research Ethics Committee of the University of Portsmouth. The
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fundamental design of this study was a prospective 6 month study,
consisting of a cohort group, selected from Study One. Therefore no further
recruitment and preliminary assessment was required. Please refer to
Chapter 4.2.3 for details regarding recruitment processes, inclusion and
exclusion criteria and preliminary screening methods.
Attempts were made to ensure all participants selected for the current study
had been involved in Study One for no longer than 3 months, in order that
previous changes would not impact the chances of significant changes being
observed in the present study. Participants on antihypertensive medications
or with pre-diagnosed diabetes were not eligible to participate in Study
Three, however participants on cholesterol-lowering medications (n=3) were
not excluded. Furthermore, those with pre-diagnosed diabetes were also
excluded. An a priori power analysis indicated that a sample size of 30, with
a priori alpha level of 0.05 would yield a power of 0.9336. A total of 30
participants (n=7) and female (n=23) were recruited. Participant information
sheets and consent forms are provided in Appendices 13 and 14.
6.4 Procedures
6.4.1Anthropometric data collection
All anthropometric data were collected using the same protocol described in
Chapter 3.1 and the data handling procedures described in Chapter 4.2
followed to allow calculation of BMI, WHR, %BF, L8SF and the three
somatotype sub-components; endomorphy, mesomorphy and ectomorphy.
Data were collected on 3 separate occasions; at baseline, 3 months following
baseline, and 7 months following baseline. This resulted in all data collection
periods being 3 months apart.
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6.4.2 MetSyn data collection
After a period of rest, participants were seated and resting blood pressure
(BP) recorded in duplicate and a mean value recorded, using either a Critical
Care Unit (Minimon 7137B, Kontron, UK) or a portable monitor (HEM-755C,
Omron, Sweden). A cuff suitable for 22-32cm arm girths was usually used,
but a larger cuff size (32-42cms) was used when necessary.
In accordance with the University of Portsmouth's code of practice for taking
of blood samples from human participants, TC, HDL-C, LDL-C, TG and BG
were measured by obtaining a fingertip sample of capillary blood, using a
SoftClix Pro (Accu-Chek, UK). Blood was collected in sodium heparinized
plastic capillary tubes (EKF Diagnostic, UK) to prevent coagulation and blood
droplets were then applied to a glucose panel test strip and lipid panel test
strip (Polymer Technology Systems, USA). These strips were analysed using
a glucose and cholesterol monitor (CardioChek PA, Polymer Technology
Systems, USA).
Although TC and LDL-C are not related to the clinical diagnosis of metabolic
syndrome the NCEP recommends that all individuals have a full lipid profile
(Case et al., 2002) therefore these values were recorded. As stated by
Wilson (2001) and Pottle (2007) TC and HDL levels can be measured at any
time without the patient fasting. However when measuring BG, participants
were required to fast for a period of 12 hours prior to the measurement being
taken. Therefore all data were collected following an overnight fast. All data
were collected according to the time scale described above in Chapter 6.4.1.
6.4.2.1 Use of CardioChek PA
The accuracy of a field method depends on the relationship between the
patient's result and an accepted standard through a hierarchy of methods
and materials (Myers et al., 2000). Because there is variability and system
error in all commercial methods for determining lipid concentration,
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determining the reference value can be difficult. The hierarchy of methods
and materials for cholesterol is known as the National Reference System for
Cholesterol (NRS/Chol) (Myers et al., 2000).
The Cholesterol Reference Method Laboratory Network (CRMLN) was
established to certify manufacturers of clinical diagnostic products that
measure TC, HDL-C and LDL-C (Bennett et al., 1992). The CRMLN (part of
the Centres for Disease Control and Prevention (CDC)) has established test
protocols using accepted 'gold standard' reference methods. Certification
provides evidence of traceability to the NRS/Chol and in order to be CRMLN
certified, results must meet the criteria detailed in Table 6.1.
Table 6.1. CRMLN cholesterol certification criteria, based on meeting
recommendations from the National Cholesterol Education Programme
(NCEP).
Parameter rc HDL-C LDL-C
RZ > 0.975 > 0.975 > 0.975
s 4% at 100mg.dL-1
Bias at s 3% at 200mg.dL-1 s 5% at 40mg.dL-1 (2.59mmoI.L-1)
medical (5.17mmoI.L-1) (1.04mmoI.L-1) s 4% at 130mg.dL-1
decision s 3% at 240mg.dL-1 s 5% at 60mg.dL-1 (3.37mmoI.L-1)
points (6.21mrnol.L") (1.55mmoI.L-1) s 4% at 160mg.dL-1
(4.14mmoI.L-1)
Accuracy* ~3% ~5% ~4%
Precision** ~3% ~4% ~4%
*calculated as: average % bias
**calculated as: among-run coefficient of variation
(Myers et aI., 2000)
Whilst there are no specific criteria for acceptable performance, the National
Cholesterol Education Programme (NCEP) of the National Institutes of
Health (NIH) have established test protocols and guidelines for acceptable
deviation from 'truth' (designed as the NRS/Chol reference value). These
guidelines state that total error (TE) should be within certain limits from the
reference values (Table 6.2).
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Table 6.2. NCEP goals for lipids stated as total error.
TC HDL-C LDL-C TG
Total Error :5 8.9% :5 13.0% :5 12.0% :5 15.0%
*calculated as: total error =average % bias + (1.96 x among-run %CV)
(Warnick et aI., 2002)
The CardioChek PA is a portable whole blood test system that uses
reflectance photometry to determine three lipid concentrations on a single
test strip; TC, HDL-C, TG (Panz et al., 2005). The system calculates low
density lipoprotein cholesterol (LDL-C) levels using the Friedewald equation
through the use of TC, HDL-C and TG levels (Polymer Technology Systems
Inc, 2005). The clinical utility of the CardioChek PA has been tested and
employed in a number of studies (Mendez-Gonazalez, 2008; Panz et al.,
2005; Parikh et al., 2009). In a study of 41 participants the CRMLN certified
that the CardioChek PA system met the required levels of accuracy and
precision individually and the combined measure of total error as defined by
the NCEP for TC and HDL-C. LDL-C, whilst showing excellent precision
(Table 6.3) did not quite reach the certification criteria however shows
excellent correlation to CRMLN criteria.
Whilst the CRMLN does not offer certification for triglycerides, clinical
evaluation performed at three different geographic locations (n=111)
demonstrated that CardioChek results compared favourably to results from
an automated method run at CRMLN laboratory, identifying high accuracy
(R2=0.97) and precision (2.06% at 200mg.dL-1 (2.26mmoI.L-1); 4.17% at
400mg.dL-1 (4.52mmoI.L-1) (Polymer Technology Systems Inc, 2007).
Furthermore, a study by Panz, et al. (2005) compared the precision and
accuracy of the CardioChek PA to those analysed by the National Health
Laboratory Service (NHLS), evaluating for conformance with NCEP
guidelines. The authors concluded that, compared to NHLS methods,
performance of the CardioChek PA system is acceptable, with NCEP
guidelines met for all analyses at the two clinical cut-off points. It was noted
however, that in the high range, TC and LDL-C results were under-
estimated. The authors suggest that this could be attributed to their inclusion
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of more samples with elevated lipid levels and that the ranges measurable by
the analyses were limited. However, as the aim of the CardioChek PA is for
screening, patients with levels outside these ranges would usually be
referred for confirmatory measurements by a clinical diagnostic laboratory
(Panz, et al., 2005).
Table 6.3. CardioChek PA System CRMLN and NCEP results for TC, HDL-C
and LDL-C
Parameter TC Certification Criteria CriterionMet
R2 0.9804 > 0.975 ./
Bias at medical :50.0% at 5.18mmoI.L-1 :53% at 5.18mmoI.L-1 ./
decision points :50.6% at 6.22mmoI.L-1 :53% at 6.22mmoI.L-1
Accuracy* 0.0% :53% ./
Precision** 2.3% :53% ./
Total error*** 4.7% :58.9% ./
,. "~,I,
,I,!' :". ,"""
Parameter HDL-C Certification Criteria CriterionMet
R2 0.98 > 0.975 ./
Bias at medical :52.6% at 1.04mmoI.L-1 :55% at 1.04mmoI.L-1 ./
decision points :51.1% at 1.55mmoI.L-1 :55% at 1.55mmoI.L-1
Accuracy* 2.1% :55% ./
Precision** 1.9% :54% ./
Total error*** 5.9% :5 13.0% ./
,"
,
''''"' j' "
Parameter LDL-C Certification Criteria CriterionMet
R2 0.96 > 0.975 x
Bias at medical :52.6% at 1.04mmoI.L-1 :55% at 1.04mmoI.L-1 ./
decision points :51.1% at 1.55mmoI.L-1 :55% at 1.55mmoI.L-1
Accuracy* 0.1% :54% ./
Precision** 2.6% :54% ./
Total error*** 5.3% :5 12.0% ./
*calculated as: average % bias
**calculated as: among-run CV
*** calculated as: total error = accuracy + (1.96 x precision)
(Polymer Technology Systems Inc, 2007).
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A study by Giampietro et al. (2007) also evaluated the accuracy of the
CardioChek PA analyser in comparison with diagnostic laboratory methods.
TC measurement by CardioChek significantly correlated with laboratory
determination (r=0.79) as did LDL-C. However, TG measurements were
systematically under-estimated. Conversely, other studies indicate
standardised methods consistent with CRMLN laboratory methods with high
level of agreement for TC (r=0.989), HDL-C (r=0.989) and TG (r=0.994). The
sample population in Giampietro et al (2007) study may have again
influenced these results as the population screened consisted purely of
individuals diagnosed with diabetes (n=50).
The lipid panel test strips used with the CardioChek PA have undergone
Clinical Laboratory Improvement Amendments (CLlA) waived tests. This
classification establishes that the lipid panel strips provide accurate, reliable
and timely patient test results (Information on CLiA waivers, 2001).
Interference testing with a wide variety of routinely occurring substances
present in the blood has also demonstrated minimal interference with lipid
panel test strip TC, HDL-C and TG results. Finally precision results testing
two levels of whole blood, have demonstrated accurate and reliable results
for TC, HDL-C and TG measurements with co-efficient of variations ranging
from 4% to 6% (Table 6.4).
Table 6.4. Lipid panel precision testing.
Whole Blood
Sample One Sample Two
No. of observations 20 20
TC Mean concentration (rnq.dt,") 197.2 ± 8.4 251.3 ± 10
Coefficient of variation (%) 4.3 4
No. of observations 20 20
HDL-C Mean concentration (rnq.dl,") 39.2 ± 2.5 61.5 ±2.8
Coefficient of variation (%) 6.4 4.6
No. of observations 20 20
TG Mean concentration [rnq.dt,") 157 ± 6.1 284 ±16.8
Coefficient of variation (%) 3.9 5.9
(Polymer Technology Systems Inc, 2003).
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In conclusion the CardioChek PA system has documented traceability to the
NRS/Chol and meets the NCEP performance criteria for accuracy and
precision, offering a rapid, point-of-care method for the measurement of
lipids (Panz et al., 200S).
6.4.3 Statistical analyses
6.4.3.1 Tests of normality
Evaluation of skewness and kurtosis revealed that TG (z(skew)=S.4, and
z(kurtosis)=10.3) and DBP (z(skew=S.2, and z(kurtosis)=7.3) were not
normal. Furthermore, Kolmogorov-Smirnov's test showed that both TG and
HDL-C were not normally distributed (0(26)=0.334, P<O.OS, and
0(26)=0.193, P<O.OS,respectively). Natural logarithmic transformation was
conducted on TG, and HDL-C however this only improved the distribution of
HDL-C. Therefore, untransformed variables are presented for TG with
transformed variables reported for HDL-C.
6.4.3.2 Tests of difference
Differences in individual MetSyn components between individuals with and
without MetSyn at baseline were evaluated using multivariate analysis of
variance. Somatotype category and change in global somatotype was
analysed using the procedures described in Chapter 3.3. Analysis of
variance for repeated measures with Bonferroni adjustment was used to
investigate the change from baseline, mid measurement and final
measurement of anthropometric measures and MetSyn components.
Mauchly's test indicated that the assumption of sphericity had been violated
for LDL-C and BG (X2(2) = 0.761, P<O.OS,and X2(2) = 0.61S, P<O.OS,
respectively). Therefore, degrees of freedom were corrected using
Greenhouse-Geisser estimates of sphericity (£=0.807 and £=0.722).
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6.4.3.3 Correlation analysis
A Pearson's Correlation Coefficient was used to examine the correlation of
components of the MetSyn at baseline with anthropometric measures at
baseline. Change was calculated from baseline to final measurement
session and normality checks repeated for these change variables. All
change variables (anthropometric and MetSyn) were normally distributed,
even when single measures were non normal. A Pearson's Correlation
Coefficient was used to calculate the correlation of change in components of
MetSyn with changes in anthropometric variables.
6.5 Results
Data are presented for 26 participants who attended all measurement
sessions. Three participants dropped out after the initial measurement
session and one did not attend the final measurement session. Baseline
demographic, traditional and alternative anthropometric measures are
provided in Table 6.5, including breakdown by gender and BMI classification.
The most widely used NCEP-ATP III criteria for MetSyn (Han & Lean, 2006),
were used to determine the presence of the MetSyn (Table 2.8).
6.5.1 Prevalence and baseline characteristics
At baseline 16 of the 26 participants were classified as endomorphic-
mesomorphs, 8 as mesomorph-endomorphs and 2 as mesomorphic-
endomorphs. Fourteen participants had at least three of the five defining
criteria and were classified as having MetSyn (Fig. 6.1). At completion 50%
of those MetSyn cases had resolved.
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Figure 6.1. Number of simultaneous abnormalities observed amongst all
participants at baseline and at final measurement (n=26)
The number of individual metabolic abnormalities observed amongst the
participants are shown in Figure 6.2. Raised TG was the least prevalent
MetSyn component, evident in only 4 of the 26 participants. Low HDL-C and
increased WC (abdominal obesity) were the most prevalent risk factors
affecting 22 and 23 of the 26 participants, respectively. Of the 14 participants
meeting the clinical criteria for the diagnosis of MetSyn (3 or more risk
factors) all participants fulfilled the criterion for abdominal obesity and high
blood pressure (Fig. 6.2) In individuals presenting with 3 risk factors the
leading combination included abdominal obesity, high blood pressure and
low HDL-C. In individuals presenting with 4 risk factors the leading
combination included abdominal obesity, high blood pressure, low HDL-C
and raised TG (Fig. 6.2).
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Figure 6.2. Number of individual metabolic abnormalities observed amongst
all participants (n=26). 159
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Baseline demographic data were collected for all participants and are
displayed in Table 6.6. Individuals with MetSyn had significant differences in
baseline BMI (35.4±6.5kg.m-2 vs. 29.32.4±kg.m-2), body mass (94.B±20.5kg
vs. BO.7±B.1 kg) blood pressure (systolic; 142±14mmHg vs. 122±1BmmHg,
and diastolic; B2±13mmHg vs. 73±7.0mmHg), and triglycerides
(1.56±1.20mmoLL-1 vs. 0.67±O.20mmoLL-1), compared with individuals
without MetSyn. Both groups were of similar age and had similar baseline
levels of blood glucose. Men with MetSyn had significant differences in HOL-
C compared with men without MetSyn (0.4B±O.16mmoLL-1 vs.
O.9B±O.39mmoLL-1). Irrespective of MetSyn status all women displayed
similar HOL-C and LOL-C levels. Waist circumference in both men and
women significantly differed between those with and without MetSyn
(117.9±6.0cm vs. 97.2±2.1 cm for males and 10B.5±1B.Ocm vs. 90.3±6.7cm
for women).
Table 6.6. Mean (±SO) metabolic and haemotological baseline
characteristics of individuals with and without metabolic syndrome (n=26).
With Met Syn Without Met P
Syn
Number of participants 14 12 -
Men (n) (%) 3 (50%) 3 (50%) 0.93
Female (n) (%) 11 (55%) 9 (45%) 0.93
Age (years) 45.7 ± 17.2 43.2 ± 18.2 0.72
BMI (kg.m-:l) 35.4 ± 6.5 29.3 ± 2.4 <0.00*
Mass (kg) 94.8 ± 20.5 80.7 ± 8.1 0.04*
TC (mmol.t,") 4.86 ± 1.75 4.73 ± 1.32 0.B4
HOL-C in men (mrnol.L") 0.48 ± 0.16 0.98 ± 0.39 0.01*
HOL-C in women (mmol.L") 0.86 ± 0.53 1.16±0.75 0.31
LOL-C (mrnol.L") 3.42 ± 1.77 3.32 ± 1.52 0.88
TG (mmot.t,") 1.56 ± 1.25 0.67 ± 0.20 0.02*
BG (rnmol.L") 5.22 ± 0.83 5.83 ± 1.02 0.11
WC in men (cm) 117.9 ± 6.0 97.2 ± 2.1 0.04*
WC in women (cm) 108.5 ± 18.0 90.3 ± 6.7 0.01*
SBP (mmHg) 142 ±14 122 ± 18 <0.00*
OBP (mmHg) 82 ± 13 73 ± 7 0.04*
Values are mean ± SD except as noted.
·significant difference between participants with and without MetSyn at 0.05 level 161
6.5.2 Baseline relationships between anthropometric measures and
MetSyn components in all individuals
At baseline BMI, mass and WHR all showed significant correlation with WC,
SBP and DBP (Table 6.7). BMI showed the strongest correlation with WC
(r(24)=0.89,P<0.OS)and WHR the strongest relationship with both SBP and
DBP; (r(24)=0.67,P<0.OS). Low to moderate relationships were also seen
between BMI and TG; (r(24)=0.38, P<O.OS)and mass and HDL-C; (r(24)=-
0.38, P<O.OS).%BF showed no significant correlation with any Met Syn
marker. L8SF, endomorphy and mesomorphy all showed significant
correlation with WC, with the strongest relationship observed with
mesomorphy (r(24)=0.73,P<0.OS). Ectomorphy was the only anthropometric
measure to correlate with BG (r(24)=0.42, P<O.OS)and mesomorphy the only
alternative anthropometric measure to show correlation with SBP and DBP.
Mesomorphy also showed a significant moderate correlation with TG
(r(24)=0.44,P<0.OS).
Table 6.7. Relationship (Pearson's correlation coefficient) of traditional and
alternative anthropometric indices with components of the metabolic
syndrome at baseline in all individuals (n=26).
Log-HDL-C TG BG WC SBP DBP
TRADITIONAL
BMI -0.38 0.38* -0.26 0.89* 0.S9* 0.S8*
Mass -0.38* 0.23 -0.24 0.81* 0.S6* 0.S3*
WHR -0.34 0.38 0.2S 0.78* 0.67* 0.67*
BF -0.11 0.18 -0.07 0.2S -0.17 -0.22
ALTERNATIVE
L8SF -0.27 0.20 -0.08 0.S4* 0.34 0.14
Endomorphy -0.28 0.2S -O.OS 0.49* 0.10 O.OS
Mesomorphy -0.28 0.44* 0.27 0.73* 0.50* 0.S1*
Ectomorphy 0.44 -0.23 0.42* -0.29 O.OS 0.04
*P<O.05
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6.5.3 Change in anthropometric measures and MetSyn components
6.5.3.1 Individuals with MetSyn
In individuals with MetSyn, collectively all MetSyn components changed
significantly over time (F=4.392,16,38,P<0.05, Eta2= 0.65, 1-~=0.999).
Univariate analysis revealed that significant changes were apparent in BG,
HOL-C, SBP and OBP (F=12.204, P<0.05, Eta2=0.484, 1-~=0.991; F= 4.682,
P<0.05, Eta2=0.171, 1-~=O.359; F=3.495, P<0.05, Eta2=0.212, 1-~=O.601;
and F=6.892, P<0.05, Eta2=0.346, 1-~=0.890, respectively).
TG showed no significant change over time (Fig. 6.3). BG reduced
significantly from baseline to mid measurement (0.9±0.3mmoI.L-1) and
baseline to final measurement (1.1±0.3mmoI.L-1), however between the mid
measurement and final stage no significant change was observed. HOL-C
showed a significant increase of 0.2±0.1mmoI.L-1 from baseline to final
measurement. SBP also showed a significant overall reduction of 6±3mmHg
from baseline to final measurement stage. Significant change was observed
in OBP from baseline to final measurement stage (6±2mmHg) and a
significant reduction of 5±2mmHg from mid measurement to final stage.
In individuals with MetSyn the only traditional anthropometric variable that
showed significant change over time was %BF (F=8.606,P<O.05,
Eta2=O.398, 1-~=0.948), showing an overall reduction of 1.6±0.6% (Fig.6.4).
L8SF and endomorphy also showed statistically significant change
(F=10.323, P<0.05,Eta2=0.443, 1-~=0.907 and F=12.159, P<O.05,
Eta2=0.483, 1-~=0.933). Both variables showed significant reductions
between all stages (Fig.6.5). For example L8SF showed significant reduction
of 9±3mm and 13±4mm between baseline and mid stage, and mid stage and
final stage respectively. Endomorphy showed a significant reduction of
O.6±0.1from baseline to final stage.
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6.5.3.2 All individuals (with and without MetSyn)
When examining change in all individuals (with and without MetSyn), a
significant change in global somatotype was observed
(F=38.033,2,25,P<0.05,Eta2=0.60,1-~=1.00). The mean somatoplots in Figure
6.6 reflect this difference as they move from left to right across the
somatochart.
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Figure 6.6. Mean somatotype (n=26) for baseline to month 6
S = mean somatotype, SAM = somatotype attitudinal mean
Univariate analysis revealed that mass showed a significant reduction from
88.3±17.4kg at baseline to 86.4±17.8kg at final measurement (F=4.850,2,25,
P<0.05, Eta2=0.162, 1-~=0.777). %BF also showed a significant reduction of
1.5±0.5% (F=10.811, 2,25,P<0.05, Eta2=0.302, 1-~=0.959). L8SF and
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endomorphy were the only alternative anthropometric variables that showed
significant change over time (F=15.882, 2,25,P<0.05, Eta2=0.388, 1-[3=0.999
and F=7.002, 2,25,P<0.05, Eta2= 0.219, 1-[3=0.758). L8SF was the only
variable that showed significant reduction at every stage, reducing from
186±56mm at baseline to 175±57mm at mid stage, with a further reduction to
166±57mm at the final stage. Endomorphy decreased from 6.3±1.4 to
5.5±1.8 from baseline to final measurement. When examining change in all
individuals (with and without MetSyn), BG was the only MetSyn component
to show significant change over time, reducing by 1.4±0.2mmoI.L-1
(F=25.389,2,25,P<0.05, Eta2=0.504, 1-[3=1.00).
6.5.4 Relationship between changes in anthropometric measures and
changes in Met Syn components in individuals with Met Syn.
Change in WC showed strong significant correlations with change in all
traditional and alternative anthropometric measures, with the exception of
ectomorphy (Table 6.8). Change in mesomorphy also showed a significant
moderate inverse relationship with change in DBP (r(12)=0.61,P<0.05).
Change in all other MetSyn components did not correlate with change in any
anthropometric measures (Table 6.8).
Table 6.8. Relationship of change in anthropometric variables (pre and post)
with change in components of the MetSyn in individuals with MetSyn (n=14)
HDL-C TG BG we SBP DBP
TRADITIONAL
BMI -0.50 0.30 0.06 0.89* 0.20 -0.33
Mass -0.49 0.13 -0.04 0.82* 0.25 -0.35
WHR -0.35 0.26 0.03 0.81* 0.25 -0.16
BF -0.50 0.30 0.06 0.89* 0.20 -0.33
ALTERNATIVE
L8SF -0.49 0.22 0.04 0.83* 0.17 -0.18
Endomorphy -0.45 0.23 0.18 0.89* 0.17 -0.43
Mesomorphy -0.07 -0.01 0.43 0.61* 0.24 -0.61*
Ectomorphy -0.10 0.17 -0.11 0.12 -0.23 -0.31-- ..-~.----
*P<0.05
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6.5.5 Relationship between changes in anthropometric measures and
changes in Met Syn components in all individuals (with and without
MetSyn)
When examining the relationship between changes in anthropometric
measures and changes in MetSyn components among all individuals (with
and without MetSyn) the number of correlations increased (Table 6.9). HOL-
C, BG, WC, SBP and DBP also showed improvements (increase in HOL-C
and decrease in other components) that correlated with reductions in BMI,
mass and WHR. For example, HOL-C increasds as BMI, mass and WHR
decreased (r(24)=0.46,P<0.05, r=(24)=0.45,P<0.05, and r(24)=0.48,P<0.05),
respectively. %BF was the only anthropometric measure to correlate with
TG, showing a significant moderate association (r(24)=0.50,P<0.05).
Additionally, reduction in L:8SF from baseline to final measurement showed a
significant correlation with a reduction in WC (r(24)=0.43,P<0.05) and OBP
(r(24)=0.41,P<0.05). Change in mesomorphy also showed significant
correlation with HDL-C, BG and WC (r(24)=0.40, P<0.05).
Table 6.9. Relationship of change in anthropometric variables (pre and post)
with change in components of the metabolic syndrome in all individuals
(n=26)
HOL-C I TG --r-- BG [ WC SBP DBP
TRADITIONAL
BMI 0.46* 0.30 0.42* 0.48* 0.45* 0.47*
Mass 0.45* 0.30 0.42* 0.48* 0.45* 0.47*
WHR 0.48* 0.30 0.42* 0.50* 0.48* 0.50*
%BF -0.29 0.50* 0.22 0.73* -0.07 -0.06
ALTERNATIVE
L:8SF 0.34 0.32 0.37 0.43* 0.37 0.41*
Endomorphy 0.30 0.23 0.37 0.38 0.32 0.34
Mesomorphy 0.40* 0.18 0.40* 0.40* 0.37 0.38
Ectomorphy -0.13 -0.12 -0.30 -0.05 -0.02 0.04
*P<0.05
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6.6 Discussion
6.6.1 Prevalence and baseline characteristics
The MetSyn has become one of the major public health challenges around
the world (Fulop et al., 2006; Grundy, 2003) and there has been growing
interest in this constellation of closely related cardiovascular risk factors
(Alberti et al., 2005). In the present study the prevalence of MetSyn, defined
in accordance with NCEP-ATP III criteria was 54% (Fig. 6.1). All 26
individuals in the study had at least one of the risk factors of the MetSyn, in
addition to obesity, and 20% had four or more (Fig. 6.2). Using ATP III
criteria, data derived from the NHANES III identified a 23.7% age-adjusted
prevalence of MetSyn in a population of 8814 men and women >20years
(Ford et al., 2002). Comparable prevalence data (24.4%) were observed in a
study of 14,719 women, aged <45years, (Ridker et al., 2003), with an age
and sex-adjusted prevalence of 24% seen in 3224 Caucasian participants
from the Framingham Offspring Study (Meigs et al., 2003).
In the present study the leading combination of risk factors in individuals
presenting with MetSyn included abdominal obesity, high blood pressure and
low HDL-C. This concurs with results of NHANES III data which found that
abnormal blood pressure or HDL-C occurred in almost 39% and 43% of
individuals with BMI ~30 kg.m-2 (Case et al., 2002). Raised TG was the least
prevalent MetSyn component observed (4 out of 26 participants reaching
clinical criteria >110/mg.dL-1). This is similar to results obtained by Sartorio et
al., (2007) where the lowest prevalence MetSyn component was TG (28%).
Case et al., (2002), identified that neither TC, nor LDL-C were significantly
different between participants with or without MetSyn. The results of the
present study also identify non-significant differences in TC and LDL-C, thus
the NCEP recommendation that all individuals should undergo a full lipid
profile (i.e. TC, HDL-C, LDL-C and TG) seems justified.
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In contrast to TC and LDL-C, the present study identified significant
differences in baseline BMI, body mass, WC, TG and BP between individuals
with and without MetSyn. Obesity has been described as the central
causative component in the development of the MetSyn (Fulop et al., 2006)
thus it is not surprising that the individuals in the present study had higher
BMI and body mass values than those without MetSyn. Furthermore, the first
feature of the MetSyn to appear in most individuals is abdominal obesity
(Byrne & Wild, 2007) and it is well documented that abdominal fat distribution
predisposes individuals to metabolic disorders such as glucose intolerance,
hypertension and dyslipidaemia (Cigoliniet al., 1995). Therefore, the
significantly higher values of WC seen in individuals with MetSyn (males
117.9±6.0cm, females 108.5±18.0cm) compared to those without MetSyn
(males 97.2±2.1cm, female 90.3±6.7cm) are to be expected.
Both former and current smoking has been associated with an increased
incidence of MetSyn with odds ratios of 1.66 (P<0.0001) and 2.38
(P<0.0001), respectively (Ishizuka et al., 2005). Pangiotakas et al. (2004)
identified an association between tobacco smoke and dyslipidemia and
Masulli et al. (2006) reported similar findings in a large population-based
sample of 2412 non-diabetic men, aged 35-65 years. However, Masulli et al.
(2006) identified that other components of MetSyn, such as hypertension and
hyperglycemia, were less common in smokers. This suggests that a higher
prevalence of dyslipidemia (reduced HDL-C and high TG) is the main
contributing factor to the increased prevalence of the MetSyn in smokers.
Whilst it is noted that both studies used cross-section observational data,
thus precluding inferences of a causal relationship, it is acknowledged that a
small proportion of the current study sample were classified as former
smokers (n=3) and recent quitters (n=2), thus may have confounded results.
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6.6.2 Baseline relationships between anthropometric measures and
MetSyncomponents in all individuals
The main aim of the present study was to verify the relationship between
MetSyn components and anthropometric indices and identify whether
changes in anthropometrical measures correlate with changes in MetSyn
components. At baseline, in all individuals, all metabolic and haemotological
measures were statistically significantly related to at least one
anthropometric measure (Table 6.7). Moderate significant correlations were
observed between the traditional anthropometric variables; BMI, mass and
WHR, with the MetSyn component WC. This relationship was strongest in
BMI and mass. These results are in agreement with much research evidence
that identifies that BMI and mass correlate closely with WC (Lean et al.,
1995; Zhu et al., 2002), with lower correlations observed between WHR and
WC (Vazquez et al., 2007).
The somatotype components endomorphy and mesomorphy were also
statistically significantly correlated with WC (Table 6.7) although the strength
of the relationship was lower in endomorphy (r=0.49), compared with the
weight-related parameters of BMI and mass (r=0.80 and 0.81, respectively).
A similar strength of relationship was observed between mesomorphy and
WC (r=0.73) and WHR and WC (r=0.78). When classifying men (n=824)
photoscopically into obesity status, and then into android (central) and
gynoid (generalized) classes of body fat patterning, Mueller and Joos (1985)
found that android obese men were significantly more mesomorphic and less
endomorphic than the gynoid obese (P < 0·01), indicating an association
between abdominal obesity and mesomorphy. This could be explained by
the use of the Sheldonian somatotype where estimates of endomorphy and
mesomorphy relate to the development of the upper (thorax) vs lower
(abdomen) trunk, respectively (Carter & Heath, 2005). However, the present
study also identified a relationship between mesomorphy and abdominal
obesity (as measured by WC) using the Heath-Carter method that does not
include any measurements from the trunk to estimate mesomorphy. A
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possible explanation for the association observed in the present study may
be due to the analysis of mesomorphy as an individual measure, without
accounting for the confounding inter-relationship among the somatotype
components.
Risk estimates based on population studies indicate that obesity, in particular
central obesity, can be directly attributed to at least two-thirds of the
prevalence of hypertension (Narkiewicz, 2006). Furthermore hypertension is
around six times more frequent in obese participants than in lean men and
women (Poierier & Rheaume, 2009). In the present study, BMI, mass and
WHR were significantly related to SBP and DBP providing further support of
the relationship between obesity, and blood pressure (Table 6.7).
Conversely, whilst a high endomorphy rating has been associated with
hypertension in adults (Makgae et al., 2007), no correlation between
endomorphy and blood pressure was evident in the present study. This is in
contrast to other research that has suggested that endomorphy can be
considered a general indicator of the predisposition to various chronic
diseases (Buffa et al., 2007). Mesomorphy however, showed moderate
relationships (r=0.50) with both SBP and DBP in the present study (Table
6.7). These results agree in part with those of Kalichman et al. (2004) who
examined the relationship between BP and components of somatotype using
the methods of Heath and Carter and found individuals with high
endomorphy and mesomorphy displayed high mean values of SBP and DBP.
When examining the relationship between somatotype and coronary heart
disease risk factors however, Malina et al., (1997) note that it may be high
endomorphy and high mesomorphy that may be the predisposing
combination of components for disease risk factors rather than either one
separately. Mass was the only anthropometric variable to show significant
correlation with HDL (r(24)= -0.38, P<0.05), which is in agreement with
findings of Chrzanowska et al. (2006). Furthermore, similar results to
Chrzanowska et al., (2006) were seen in the present study with high levels of
mesomorphy significantly associated with low levels of TG.
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6.6.3 Relationship between changes in anthropometric measures and
changes in Met Syn components
6.6.3.1 Individuals with MetSyn
Abdominal obesity, as measured by WC, was the MetSyn component that
displayed the strongest and greatest number of correlations with
anthropometric variables at baseline in the present study (Table 6.8). When
examining the relationship of change in anthropometric variables with
change in components of the MetSyn, WC and OBP were the only MetSyn
components that produced significant associations (Table 6.8). A possible
explanation may be due to the small participants numbers as only half of the
participants were diagnosed with MetSyn, reducing the numbers to 14. There
are marked differences in how abdominal obesity is defined as a component
of MetSyn (Sartorio, 2007), although it has become a prerequisite for MetSyn
in the newer definitions, such as the IOF and NCEP ATP III criteria. The
results of the present study re-affirm the importance of abdominal obesity in
the diagnosis of MetSyn.
A strong significant relationship was seen between change in WC and
change in WHR (Table 6.8). Whilst WHR is an accepted index of fat
distribution, its use to assess changes in fat distribution is questionable (Van
der Kooy et al., 1993). The use of WHR may not be appropriate to assess
obesity and related health risk because it has statistical limitations (Allison et
al., 1995), is highly age dependent and relationships that may be present
with separate circumference measurements may be obscured when adjusted
to a ratio (Goran et al., 1995). For example, as identified by Seidell et al.
(2001) a narrow waist and large hip circumference may both protect against
CVO, however these specific effects of each girth measure are poorly
captured in the waist-to-hip ratio. Furthermore an individual with enlarged
waist and hip girths can have a 'healthy' WHR, despite the presence of
excess abdominal adipose tissue. WHR is also less sensitive to weight
gain/loss (Vazquez et al., 2007). Indeed when examining individuals with
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MetSyn in the present study, WHR did not show significant change over time
(Fig.6.4). Thus whilst the change in WHR and the change in WC are
significantly correlated, neither showed significant change over time.
Change in BMI and mass also showed significant strong correlation with
change in WC in the present study, although again these measures did not
show significant change over time. In a study of 2635 participants
investigating the correlation between changes in body weight and body
composition parameters, a significant decrease in body weight of 3kg over
one year corresponded to a significant decrease of almost 3cm in WC
(Miyatake et aI., 2007). Although the changes in the present study are much
smaller, the association is still apparent. Furthermore, the relationship
between weight loss and reduction in WC in the present study (r=0.89) is
similar to that obtained by Han et al., (1997) over the same time period
(r=0.68). It is again worth noting that whilst BMI and mass reduced over time,
these changes were not significant.
In individuals with MetSyn there were significant improvements in HDL-C,
BG, SBP and DBP (Fig. 6.3). Whilst these did not correlate with significant
weight loss, the incidence of MetSyn among these participants reduced by
half. Excess adiposity is thought to playa key role in the pathophysiology of
all facets of the MetSyn (Case et al., 2002) therefore the significant changes
observed in endomorphy and ~8SF may have contributed to these
improvements. However, with no correlation evident between the change in
these anthropometric variables and the change in MetSyn components their
utility, from a health perspective, is limited.
It has been suggested that whilst it is the combination of MetSyn
components as opposed to a single component that increases
cardiovascular risk (Bosello & Zamboni, 2003), not all individuals display a
clustering of metabolic and cardiovascular risk factors (Karelis et al., 2004).
Examining change in MetSyn components and anthropometric indices
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across all individuals (with and without MetSyn) may present different
relationships.
6.6.3.2 All individuals (with and without MetSyn)
Questions have been raised regarding whether the clinical treatment of
metabolic abnormalities should be different in the presence or absence of
MetSyn and currently, individual metabolic abnormalities of MetSyn are
treated, not the MetSyn itself (Alhassan, 2008). When examining changes
across individuals (those with and without MetSyn) in the present study, it is
evident that there is a relationship between changes in MetSyn components
and changes in anthropometric measures, thus justifying this treatment
method. For example, decreases in BG, we, SBP and DBP and an increase
in HDL-C showed significant correlations with changes in at least 3
anthropometric measures. BMI, mass and WHR correlated with all of these
MetSyn parameters, however mass was the only traditional anthropometric
variable that changed significantly. Mesomorphy showed significant
correlation with increases in HDL-C, decreased BG and reduced WC,
however it did not show significant change over time. In contrast L8SF
decreased significantly and showed significant correlations with decreases in
WC and DBP. The changes in the MetSyn components were minimal with
only BG significant reduction over time.
In defining eligibility criteria to participate in a particular study, or to make
inferences regarding MetSyn and disease risk, all 4 clinical criteria for
MetSyn are currently used in literature (Alhassan et al., 2008) and the
question remains whether these clinical criteria identify similar or different
individuals. However, whilst there is controversy surrounding the clinical
criteria used to identify MetSyn, it is widely accepted that regardless of the
criteria used weight reduction has been shown to significantly improve all
MetSyn components (Alhassan et al., 2008). Among all individuals in the
present study (those with and without MetSyn) body mass significantly
reduced by 1.9±0.7kg. This showed significant correlation with change in all
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MetSyn components with the exception of TG (Table 6.9). However, the
reduction in BG (1.4±0.2mmoI.L-1), was the only significant reduction of all
MetSyn components.
Researchers such as Corrigan et al. (1991) have identified that weight loss
can reduce blood pressure in overweight hypertensive patients, and weight
loss is considered an effective method for primary prevention of hypertension
(Stevens et al., 2001). Furthermore, in a review of four randomised controlled
trials (RCTs) examining overweight non-hypertensive patients (n=872) the
same relationship between weight loss and reduced blood pressure was
observed (Cutler, 1991). In a meta-analysis of 25 RCTs comprising 4874
participants, an estimated reduction of -1.1/-0.9mmHg was observed per kg
weight loss, by means of energy restriction, physical activity, or both (Neter
et al., 2003). These values are substantially smaller than estimates from a
previous meta-analysis of 12 trials by Staessen et al. (1988) who identified a
-2.4/-1.5mmHg reduction per kg. However, as noted by Neter et al., (2003),
only 2 trials overlapped within the meta-analyses which might explain this
discrepancy. Furthermore, half of the studies in the meta-analysis by
Staessen et al. (1988) were not randomised.
There are several potential biological pathways that may be responsible for
these findings although the exact mechanism of the relation between
hypertension and obesity and effects of weight loss on blood pressure is
unknown (Neter et al., 2003). A central feature of obesity-associated
hypertension is related to abnormalities in sympathetic nervous system and
the renin-angiotensin-aldosterone system that cause changes in sodium
handling (Engeli & Sharma, 2001). Grassi et al., (1995) suggest that human
obesity is associated with a marked sympathetic activation and that this
activation, observed in obese normotensive participants, may be one of the
factors facilitating the development of hypertension. Engeli & Sharma (2001)
suggest that the renin-angiotensin-aldosterone system is overactivated in
obese participants (Engeli & Sharma, 2001) and excessive aldosterone
production observed in obese participants is thought to contribute to
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maladaptive processes that contribute to the development of hypertension
(Sowers, Whaley-Connell & Epstein, 2009).
Improvements in glycemic control are also seen with modest weight
reduction of <10% (Goldstein, 1992). The significant correlations observed
between reduction in BMI and mass with reduction in BG (Table 6.9) provide
support for this. It is worth noting however that of these two anthropometric
variables, mass was the only one to show significant change over time,
showing a 2% reduction. Decrease in WHR also showed the same strength
of correlation as BMI and mass with reduced BG (r=0.42). WHR has been
found to be independently associated with impaired glucose tolerance
(Sakurai et al., 1995). Moreover, this relationship has been identified within
and across sexes (Bertrais, 1999) although is less consistent across ethnic
groups (Patel et al., 1999).
In the present study, mesomorphy also showed a moderate significant
correlation with blood glucose (Table 6.9). This is again in agreement with
research that considers mesomorphy to be the most important somatotype
component when explaining the variance in blood lipids and cholesterol
levels (Katzmarzyk et al., 1998). However, of the somatotype components,
endomorphy was the only one to show significant change over time, reducing
from 6.3±1.4 to 5.5±1.8. Parallel to examining change over time in individuals
with MetSyn, when examining change in all individuals endomorphy and
L8SF both showed significant decreases. Again, although these changes
suggest positive changes in body composition, the lack of correlation
between these variables and MetSyn components limits their usefulness in
identifying individuals at risk.
6.6.4 Limitations
It is important to note that genetic susceptibility could playa major role in the
expression of the MetSyn (Grundy, 2003) and thus could have influenced the
results obtained. Furthermore, the separate treatment of somatotype
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components could have confounded the results and may explain some of the
non-significant interpretations.
This study did not obtain valid information about dietary intake or physical
activity patterns, thus no inference of the possible influence that these factors
may have on the MetSyn components can be made. This may also provide
possible explanation for the modest changes observed, which preclude
meaningful interpretation of correlations observed between changes in body
composition and changes in MetSyn parameters. Furthermore, only 14 of the
26 participants that completed the study met the criteria for MetSyn. Thus a
larger study, consisting of individuals with a diagnosis of MetSyn, may have
sufficient power to demonstrate an association between change in
anthropometric measures and change in MetSyn parameters.
6.6.5 Future directions
Whilst studies have attempted to control for behavioural variables such as
physical activity and dietary habits, a study utilising a direct comparison is
needed to assess the relative contribution these factors have on the MetSyn.
It is well known that independent of weight loss exercise can have beneficial
effects in reducing blood pressure and BG levels and increasing HDL-C
levels. However the separate effects of exercise intensity, duration and
frequency are less well known and warrant further investigation. Assessing
changes in MetSyn parameters in response to pharmacological intervention
also warrants attention, as the role of such therapy in the absence of lifestyle
changes, is as yet, unclear.
It is also plausible that the MetSyn may manifest itself as a function of
sample characteristics, such as gender and ethnicity. Further studies
investigating these differences may identify the influence of these sample
characteristics to inform more applicable treatment modalities. Additional
analyses, utilising factorial analysis to examine the separate and combined
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effects of somatotype, may also provide further insight into the relationship
between somatotype and MetSyn parameters.
6.7. Conclusion
Traditional anthropometric measures, namely BMI and mass, showed
stronger correlation with MetSyn markers at baseline than alternative
anthropometric measures. Therefore Ha, that alternative anthropometric
measures would show stronger correlation with MetSyn markers compared
to traditional anthropometric measures, is rejected. Furthermore, when
examining the association between changes in traditional and alternative
anthropometric measures with changes in MetSyn markers, the strongest
relationships were evident in traditional anthropometric measures. Thus Hg
that changes in alternative anthropometric measures would show a stronger
correlation with changes in MetSyn markers compared to changes in
traditional anthropometric measures and changes in MetSyn markers, is also
rejected.
Across all individuals strong linear relationships were found with weight loss
and improvement of each of the MetSyn components, this is in agreement
with results of other investigations conducted on the general population and
highlights the importance of weight as an indicator of health status and
change in health. However, in contrast to previous research, few correlations
between alternative anthropometric measures and MetSyn components were
evident in the present study, and those that were appeared to add little value
in identifying at risk individuals or monitoring health status. Therefore, it is
concluded that in light of the increased time and expertise required to acquire
these variables, their applicability as a health measure is limited and body
mass and BMI (traditional measures) may be more effective measures.
Furthermore, the number and strength of relationships between change in
traditional anthropometric variables and change in MetSyn components
increased when examining all individuals as opposed to focusing on
individuals with MetSyn alone. It therefore seems justified to take a
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preventative approach and focus on individuals with any of these risk factors,
particularly as it is well documented that not all individuals display a
clustering of these risk factors.
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7. CONCLUSIONS, PRACTICAL IMPLICATIONS
AND FUTURE RESEARCH DIRECTIONS
This chapter revisits the original aims of the studies that comprise this thesis,
and provides a summary of thesis findings and the practical implications of
each study. Limitations of the body of work are considered and building on
these limitations, future directions for both research and practice involving
overweight and obese individuals will be identified.
7.1. Revisiting original aims
7.1.1 Study One
By definition, obesity is an excess of body fat. Therefore to accurately assess
an overweight individual, a method must be available that is capable of
measuring body compartments (Kushner et al., 1990) and the need for
measures that are sensitive to change has been recognised (Deitel et al.,
2007; Teixeira et al., 2005). Furthermore, for clinical reasons these methods
should be simple and reliable (Sharma & Kushner, 2009). The limitations of
weight-related parameters for providing reliable assessment of body fat and
its distribution over time are well documented (Burkhauser & Cawley, 2008;
Garcia et al., 2005; Nevill et al., 2006; Sharma & Kushner, 2009). Other
advanced techniques that achieve reliable results require expensive
instrumentation, are impractical for individual use and cannot be easily
transported to test sites in large-scale intervention and epidemiology projects
(Foreyt & Jeor, 1997; Van Loan, 1997). Somatotyping, a technique used to
summarise the physique as a unified whole requires relatively inexpensive
tools that are portable (Bellisari & Roche, 2005), and when used correctly
can provide valid results (Stewart, 2003) and can be laboratory based or field
based (Norton & aids, 1996). Commonly used to describe the changes in
physique during growth, ageing and training (Duquet & Carter, 2001), this
technique may also identify changes in composition of obese individuals.
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Study One therefore aimed to compare the change of traditional
anthropometric measures with alternative anthropometric measures in order
to identify the most discernible measure of change.
7.1.2 Study Two
The detrimental psychological consequences of obesity have been
recognised (Rippe et al., 2004; Schwartz & Brownell, 2004; Wadden et al.,
2006) and how humans perceive themselves is thought to have particular
importance on psychological health (Carron et al., 2003). Physical self-
perceptions have been examined in relation to obesity, both in terms of
composition changes and cross-sectional comparisons (Polman & Brokoles,
2007; Shaw et al., 2000). However, research to date has been equivocal and
little research has examined the association between somatotype and
physical self-perceptions. Identifying objective anthropometric measures that
relate to physical self-perceptions, and understanding their interaction, may
inform appropriate feedback mechanisms for improved management of
overweight and obese individuals. Study Two therefore aimed to investigate
the relationships between traditional and alternative anthropometric
measures with physical self-perception and examine the association
between changes in anthropometric measures and changes in physical self-
perceptions.
7.1.3 Study Three
The increasing prevalence of obesity has been accompanied by a parallel
increase in the prevalence of the MetSyn (Liberopoulos et aI., 2005). Weight
reduction is a priority for the management of MetSyn and the effects of
weight loss on MetSyn risk factors have been extensively studied (Hall et al.,
2006). Although under-researched, there is some limited documented
evidence of characteristic somatotypes being associated with some diseases
and conditions (Herrera et al., 2004) and it is recognised that the use of
somatotyping, a more holistic measure of one's body, may have utility in
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evaluating an individual's metabolic risk (Katzmarzyk et al., 2003). Identifying
anthropometric measures that correlate with MetSyn markers may be helpful
in both identifying individuals at risk and improving management of MetSyn.
Therefore Study Three aimed to investigate the relationships between
traditional and alternative anthropometric measures with MetSyn markers
and examine the association between changes in anthropometric measures
and changes in physical self-perceptions.
7.2 Summary of findings and practical implications
The work described in this thesis has been concerned with the identification
of anthropometric measures that are sensitive to changes in body
composition of overweight and obese individuals, and examining their
association with physiological and psychological health markers.
Main findings of Study One highlight that the alternative anthropometric
measures L8SF and endomorphy and the traditional anthropometric
measure %BF, were able to identify significant change that other traditional
anthropometric parameters were unable to detect (Table 4.12). L8SF and
endomorphy showed comparable magnitudes of change to both BMI and
%BF over the year (Fig. 4.15). However BMI does not account for changes in
body composition and %BF suffers from population specific limitations and
the need for sophisticated techniques to obtain reliable results that are
impractical in most population studies. The best use of SF measurements is
as raw values, where they act as reliable indices of regional fatness, as
opposed to being transformed to other measures such as %BF. The current
study has demonstrated that L8SF is sensitive to change (Fig. 6.5). As this
alternative anthropometric measure represents change in the composition of
the body, focusing on this may be a potential means for reducing attrition
rates commonly seen in weight loss interventions and improving participant
motivation. Additionally, the use of such measures that reduce the central
focus of weight change to define success, may also aid the transition of
individual's to a healthier lifestyle and reduce the dramatic disparity between
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recommended weight loss goals and individual's actual weight loss goals.
Therefore it is concluded that L8SF could be used to monitor weight loss in
overweight/obese individuals. The somatotype sub-component endomorphy
was the only sub-component to show significant change at interim periods
and to show greater magnitudes of change than a traditional anthropometric
measure (mass and WHR). The strength of somatotyping is its three-number
rating, representing the physique as a unified whole. Furthermore, collection
of somatotype data requires considerable skill and expertise. Therefore, it is
concluded that somatotyping is not considered for routine use for monitoring
weight loss in overweight/obese individuals.
The findings of Studies Two and Three highlight that overweight and obese
individuals are presented with the challenge of coping with physical,
physiological and psychological changes during weight loss attempts.
Therefore, researchers are encouraged to assess both physiological and
psychological functioning, when examining overweight and obese
individuals. Additionally, from a public health perspective, strategies and
interventions developed to treat obesity should consider a more holistic
approach to treatment, aiming to improve both physiological and
psychological functioning.
Correlational analyses in Study Two suggest the relationship between
traditional and alternative anthropometric measures and the physical self is
significant in overweight/obese individuals. These data provide a rationale for
future research to further examine the extent of this relationship. Results
highlighted that initially individual's changes in physical self-perceptions were
a result of cognitive changes; however, perceptions become more objective
over time, relating to physical changes. Physical self-perceptions have been
found to be moderate predictors of physical activity and physical activity has
been identified as the single most important behavioural factor in long-term
weight management in obese people. Thus this gives rise for the
consideration of an educational component within all weight management
programmes that focus on enhancing physical self-perceptions, as opposed
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to solely focusing and defining success on measures of weight change.
There was no difference in the strength of relationships between traditional
and alternative anthropometric measures with PSPP constructs. It is
therefore concluded that, due to the time and expertise required to calculate
somatotype and L8SF, the use of these measures in physical self-perception
research cannot be supported at this time.
Main findings of Study Three identified moderate relationships between
weight loss and improvement in MetSyn components, highlighting the utility
of weight as a health indicator and a measure of change in health. Few
correlated variables showed significant change over time and the number of
correlations increased when examining all individuals compared to those with
MetSyn alone. This suggests that from a clinical perspective anthropometric
measures may be better applied in identifying at risk individuals. Furthermore
this provides justification to take a preventative approach to MetSyn,
focusing on individuals with any of these risk factors, particularly as it is well
documented that not all individuals display a clustering of MetSyn risk
factors. Overall, changes in alternative anthropometric measures showed
weaker correlation with changes in MetSyn components compared to
traditional anthropometric measures. Thus it is concluded that the clinical
utility of these alternative anthropometric measures to assess change in
MetSyn status appears limited.
In conclusion, L8SF and endomorphy showed comparable magnitudes of
change to BMI and %BF and showed significant change over time. However,
as L8SF represents changes in body composition and is a sensitive
measure that can be used in its raw form, this measure could be of greater
benefit than BMI and %BF to monitor change in the body composition of
overweight and obese individuals. Conversely, the benefits of somatotyping
over traditional anthropometric measures are less evident and should not be
solely used for this purpose.
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It is noted that the measurement of skinfolds should only be utilised provided
there is adherence to established protocols and the use of experienced
personnel. Furthermore, this measure is acceptable for use in large
population-based studies due to the portable and inexpensive equipment
required. However when assessing individuals for critical health reasons
relating to MetSyn, alternative anthropometric measures appear to have
limited clinical utility in identifying and monitoring at risk individuals. From a
psychological perspective, the application of alternative measures in
physical-self perception research requires further examination before firm
conclusions can be made regarding their practical implications. However, it is
identified that there is a relationship between both traditional and alternative
anthropometric measures and physical self-perceptions. Thus focusing on
other aspects related to maintaining a healthy weight, such as an active
lifestyle and improved dietary habits, as opposed to anthropometric
measures that are associated with negative physical self-perceptions, may
be a more constructive approach to address obesity and psychological well-
being.
To conclude, somatotyping appears to have limited utility for monitoring
change in overweight/obese individuals and no obvious benefit in assessing
an individual's health status from a physiological or psychological standpoint.
However, L8SF, that reflects changes in body composition and is sensitive
to change, may be a useful measure to monitor weight loss in
overweight/obese individuals.
7.3 Limitations
Although this study has made positive contributions to the literature in that
the discernibility of a range of anthropometric measures to measure change
in an overweight/obese people has been established, and the relationship
between these anthropometric measures with metabolic syndrome markers
and physical self-perceptions measures identified, it is important to
acknowledge the studies limitations. Specific limitations pertaining to each
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study are provided in previous chapters; however the main limitations are
discussed here.
Due to attrition, a common occurrence in obesity research, the sample size
was relatively small. Despite this, adequate power for significant differences
and correlational relationships was observed. However, a larger sample size
would provide means for increased confidence in research findings.
Furthermore, no attempt was made to control for lifestyle variables that may
influence body composition and physiological and psychological health, and
there was a lack of valid information regarding physical activity levels and
nutritional intake of the participants in the studies. This precludes any insight
into the mechanisms that contribute to weight and body composition
changes.
Whilst standardised procedures were followed for the collection of
anthropometric data, and satisfactory TEM and coefficient of reliability
ranges demonstrated the anthropometrist's skill and precision, overall weight
loss and body composition changes in the present study were modest.
Therefore, as change was not calculated using confidence intervals, it is
noted that measurement error may have confounded results. Furthermore, it
is important to acknowledge that a number of different measurement
protocols are utilised in research studies that purport to measure the same
thing. Therefore, although the standardised procedures of ISAK were
adhered to throughout the duration of the studies that comprise this thesis,
when comparing the study's results to other published literature, it is
important to acknowledge that different measurement protocols may have
been followed.
7.5 Future directions
There are a number of future research directions that emerged from the
current investigations. Whilst the aim of interventions should be to reduce
obesity and related health issues, potential mediators and moderators need
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to be investigated. Studies are strengthened by homogeneous samples in
order to investigate specific relationships, a larger heterogeneous population
that can be stratified according to gender, or obesity status (e.g. overweight,
obese, morbidly obese). Considering the effects of gender and age on
changes in body composition and associated health issues may aid the
development of population specific interventions. Thus future research
should aim to include an equal male to female ratio, to control for any gender
effects that may arise, and consider participants degree of obesity, in order
to generalise results to larger populations.
Future studies should also attempt to collect valid information regarding
participants' physical activity and dietary habits and moreover, assess body
composition changes in participants following different treatment modalities,
in order to assess the efficacy of weight loss methods. Additional research
should also examine the utility of individual skinfold measures, or a smaller
subset of skinfold measures, in identifying change. Lastly, future research
should endeavour to establish an optimal monitoring frequency to determine
the most practical and useful research design, in order to reduce the
economic implications of obesity research from both a time and financial
perspective, whilst maintaining an appropriate level of support to the obese
individual.
7.6 Final comment
The reality is that the most accurate procedures for estimating body fat are
also the most complicated, expensive, and clinically impractical. Although
current anthropometric measures, such as body mass and BMI, serve their
function and should continue to be reported so that the costs and benefits of
alternative measures can be clarified, these measures should be
complimented by alternative measures. There may not be a single measure
that is best for every application; however greater consideration of alternative
measures of obesity (namely L8SF) in monitoring changes in body
composition and associated health issues may enrich research on obesity.
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Appendix 1 - Anthropometry accreditation levels
The four levels of technical expertise including; technician (restricted profile),
technician (full profile), instructor and criterion anthropometrist are:
• Level 1 (technician); restricted profile; a person who can demonstrate
adequate technical precision in measuring stretch stature, mass, the 9
skinfolds, 5 girths, and 2 breadths of the 'restricted' anthropometric
dimensions.
• Level 2 (technical - full profile); a person who can demonstrate
adequate technical precision in all of the 40 anthropometric
dimensions
• Level 3 (instructor); in addition to technical competence, a level 3
person has adequate theoretical knowledge about anthropometry to
be able to instruct and accredit level I and 2 anthropometrists.
• Level IV (criterion anthropometrist); a criterion anthropometrist has
many years of experience in taking measurements, has a high level of
theoretical knowledge, has been involved in several large
anthropometric projects and has a publication record in
anthropometry.
(Norton & Olds, 1996)
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Appendix 2 - Restricted and full anthropometric profiles
Anthropometric measurements included in a Level I restricted profile:
Skinfolds Girths Bone Breadths
Triceps Arm (relaxed) Humerus
Subscapular Arm (flexed & tensed) Femur
Biceps Waist (minimum)
Iliac crest Gluteal (hips)
Supraspinale Medial calf (maximum)
Abdominal
Front thigh
Medial calf
Mid-axilla
Anthropometric measurements included in a Level 2 restricted profile:
Skinfolds Girths Lengths Breadths/Lenaths
Triceps Head Acromiale-rad iale Biacromial
Subscapular Neck Radiale -stylion Biiliocristal
Biceps Arm (relaxed) Midstylion - Foot length
dactylion
Iliac crest Arm (flexed & tensed) lIiospinale-box Sitting height
height
Supraspinale Forearm (maximum) Trochanterion-box Transverse chest
height
Abdominal Wrist (distal styloids) Trochanterion- AP chest
tibiale laterale
Front thigh Chest (mesosternale) Tibiale-Iaterale Humerus
Medial calf Waist (minimum) Tibiale-mediale- Femur
sphyrion tibiale
Mid-axilla Gluteal (hips)
Thigh (1cm below
gluteal)
Thigh (mid-
trochanterion tibiale
laterale
Medial calf (maximum)
Ankle (minimum)
(Norton & Olds, 1996)
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Appendix 3 - Anthropometry equipment
Anthropometric equipment needed to complete a Level I restricted
anthropometric profile:
Anthropometry Tape: a flexible steel tape (calibrated in centimetres with
millimetre gradations) is recommended for girth measurements. The Lufkin
(W606PM) is the preferred metal tape.
Stadiometer: is required for measuring stature. A sliding head piece that
lowers to the vertex of the head is recommended.
Weighing Scales: are required for the measurement of body mass. The use
of electronic scales is increasing and the accuracy of some of these scales
are equal to or greater than that of the traditionally used beam balance,
provided calibration of both machines is maintained.
Skinfold Calipers: are used for the measurement of skinfolds. Harpenden
calipers have been used as the criterion instrument by ISAK reporting a
compression of 1Og.m-2in new calipers.
Segmometer: can be used to aid landmarking. Manufactured from a steel
carpenters tape which has attached two straight branches, each
approximately 7cms in length.
Small sliding calipers: these calipers are used for biepicondylar humerus
and femur breadths.
Anthropometry Box: can be used to aid the taking of measurements by
asking the subject to stand or sit on the box. This box should have
dimensions with all side lengths of approximately 40cms.
(Norton & Olds, 1996)
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Appendix 4 - Intra- and inter-technical error of measurement
accreditation levels
Anthropometrists' intra- and inter-technical error or measurement for all
accreditation levels (a) following the training course and (b) following
performance of 20 repeated profiles:
Level 1 Level2 Level3
a B A B a B
Post- Post- Post- Post- Post- Post-
course pr~filing course profiling course profiling
Inter- Skinfolds 12.5% 10.0% 10.0% 7.5% 10.0% 7.5%tester
Other 2.5% 2.0% 2.0% 1.5% 2.0% 1.5%
Intra- Skinfolds 10.0% 7.5% 7.5% 5.0% 7.5% 5.0%tester
Other 2.0% 1.5% 1.5% 1.0% 1.5% 1.0%
(Norton & Olds, 1996)
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Appendix 5 - Flowchart of participants progression through Studies
One, Two and Three
PhD Study 1
Part A
PhDStudyl
PartB
PhDStudy2
Pspp
PhD Study 3
PsPP
4 months
duration, n =
90
12 months duration
n = 60, ,
12 months duration
n = 60,
6 months duration
n = 30
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Appendix 6 - Participant information sheet (Study One and Study
Three)
You are asked to read this form carefully. If you consent to take part then you
should sign the consent form. If you have any query, or are unsure or
uncertain about anything, then you should not sign until you problem has
been resolved and you are completely happy to partake.
The programme for which you are being asked to volunteer is being carried
out in order to monitor the body composition changes that occur during
weight loss. Body composition is a technical term used to describe the
different components that make up a person's body weight, and refers
primarily to the distribution of muscle and fat in the body. Various health
measures and body composition will be measured each month on a one-to-
one basis.
A
Your blood pressure will be recorded using a standard
blood pressure monitor and will involve you wearing an arm
cuff for a short while (A).
In order to determine your body composition, various
measurements of your body will be taken, such as
circumferences and simple skinfold-thickness
measurements. These will be measured using a measuring
tape (B) and a device called a skinfold caliper (e).
These measurements are painless and will be carried out in
a private environment with no-one present other than the
measurer. You are asked to wear loose fitting clothing when
you are having your measurements recorded and it is
estimated that the recording of these measurements will
require approximately 45 minutes to one hour.
Body Mass Index (BMI) is a tool used for indicating weight status in adults. It
is a measure of weight for height. This project is primarily aimed at
individuals with a BMI between 27 and 35. If your BMI falls below 27 we can
offer alternative arrangements to provide you with support in your effort to
reduce your BMI into the normal weight range. If your BMI is above 35 it is
likely that you will require more rigorous intervention from external sources,
B
c
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such as dietetic support. We will be pleased to offer you advice in this
process.
At each monthly meeting you will be asked to complete a questionnaire. This
questionnaire is designed to assess perceptions of the physical self in the
domains of physical condition, body attractiveness, and physical self worth.
Additionally, in between appointments you will be asked, at random, to
complete a 3 day diet and exercise log. The aim of this is to monitor and
identify lifestyle habits so improvements can be suggested.
You may at any time withdraw from the experiment. You do not have to give
any reason, and no one can attempt to dissuade you. If you ever require any
further explanation, please do not hesitate to contact the people listed below.
Any information obtained during this trial will remain confidential as to your
identity: if it can be specifically identified with you, your permission will be
sought in writing before it will be published. Other material, which cannot be
identified with you, will be published or presented at meetings with the aim of
benefiting others. All information will be subject to the conditions of the Data
Protection Act 1998 and subsequent statutory instruments.
This trial has received ethical and scientific approval to be undertaken, in
accordance with current University regulations.
Contact Details:
Principal Measurer
Nikki Brown
Tel: 02392 XX XXXX
nikki.brown@xxxxxxxx
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Appendix 7 - Physical activity readiness-questionnaire (PAR-Q)
PAR-Q is designed to help you help yourself. Many health benefits are
associated with regular exercise and the completion of the PAR-Q is a
sensible step to take if you are planning to increase the amount of physical
activity in your life.
For most people, physical activity should not pose any problems or hazards.
PAR-Q has been designed to identify the small number of adults for whom
physical activity might be inappropriate for those who should seek medical
advice concerning the type of activity most suitable for them.
Common sense is your best guide to answering these few questions, please
read them carefully and circle YES or NO, as appropriate.
1. Has your doctor ever said that you have heart trouble? YES/NO
2. Do you frequently have pains in your heart and chest? YES/NO
3. Do you often feel faint or have spells of severe dizziness? YES/NO
4. Has a doctor ever said your blood pressure was too high? YES/NO
5. Has your doctor ever told you that you have bone or joint problems such as
arthritis that has been aggravated by exercise or might be made worse by
exercise? YES/NO
6. Is there any good physical reason not mentioned here why you should not
follow an activity programme even if you wanted to? YES/NO
7. Are you aged 65+ and not accustomed to vigorous exercise? YES/NO
YESto one of more questions:
If you have not recently done so, consult
with your GP by telephone or in person
BEFOREincreasing your physical activity
and/or taking a physical assessment. Tell
your GPwhich questions you answered YES
to on the PAR-Q or present your PAR-Q
copy to him/her.
NO to all questions:
If you answered the PAR-Q accurately, you
have reasonable assurance of your present
suitability for a:
a) Graded exercise programme, gradually
increasing in intensity to aid fitness
development with minimal discomfort
b) Fitnessassessment by a qualified
trainer.
D D
Programmes: Postpone:
After medical evaluation, seek advice from
your GPregarding your suitability for: If you have a temporary minor illness such as a
• Unrestricted physical activity starting off common cold.
easily and progressing gradually .
• Restricted or supervised activity to meet
your specific needs at least on an initial
basis
Appendix 8 - Consent form (Study One and Study Three)
I have read the information sheet, which provides full details of this study,
and have had the opportunity to raise and discuss my questions with either
the Project Officer: Dr Clare Hencken or the Principal measurer: Nikki Brown.
I understand what is expected of me with regard to the general nature,
object, potential risks and duration of the study.
I understand that the aim of the programme is to monitor the body
composition changes that occur during weight loss. Body composition is a
technical term used to describe the different components that make up a
person's body weight, and refers primarily to the distribution of muscle and
fat in the body. Various health measures and body composition will be
measured each month on a one-to-one basis.
I agree to volunteer as a participant for the study described in the
information sheet, I give my full consent to my participation in this study. This
consent is specific to the particular study described in the information sheet
attached, and shall not be taken to imply my consent to participate in any
subsequent data collection or deviation from that detailed here.
I reserve the right to withdraw from this study at any time; I also
understand that I may be withdrawn at any time, and will suffer no penalty as
a result.
Name .
Project Officer/Principal measurer
Signed .
Name .. Oate .
Witnessed .
Name . Oate .
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Appendix 9 - GP referral form
To whom it may concern,
Re: -------------------------------O.O.B: _
The above named patient has volunteered to be a participant in a research
project at the University of Portsmouth. This project is a monitoring and
support programme to assist those who wish to lose weight. It involves
monthly meetings incorporating anthropometrical assessment to appraise the
quality of body composition and monitors additional indices of health such as
resting HR and blood pressure. The project is funded via the University of
Portsmouth and its duration spans 12 months for each participant to aid
adherence and retention.
Although the programme itself does not advocate one specific physical
activity or diet programme, guidance and advice will be provided to
encourage participants to engage in some form of diet plan and exercise
programme. In preparation for this programme, we have asked your patient
to complete a PAR-Q questionnaire to establish any existing medical
problems. We have also undertaken tests of resting HR, resting SBP and
resting OBP.
We are referring them to you because a potential risk (please see attached
form/s) has been identified that requires a GP's evaluation to establish
suitability for:
• an unrestricted physical activity programme starting off easily and
progressing gradually or
• a restricted or supervised activity incorporating a fitness assessment
by a qualified trainer.
We would very much appreciate it, if you consider increased physical activity
suitable for your patient, if you would sign the enclosed form for the patient to
return to us.
If you have any further questions, please do not hesitate to contact
Project leader Principal measurer:
Dr Clare Hencken Nikki Brown
Tel: 02392 XX XXXX Tel: 02392 XX XXXX
E-mail: clare.hencken@XXXXXXXX E-mail: nikki.brown@xxxxxxxx
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Appendix 10 - Particpants food and exercise diary
FOOD AND EXERCISE DIARY
• Sometimes we are unaware of the amount of food we actually eat in one
day.
• Keeping a diary can help you become more aware of eating and activity
habits, and identify problem areas.
• It may also help in other ways such as:
Giving you a basis from which to plan changes.
Keeping you focused on your goals and monitor changes.
Encouraging you to make conscious choices about what you eat & do.
WHAT TO DO
• Write down everything you eat and drink over the day, for three days.
• It's hard to remember what you've eaten at the end of the day, so try to
record things as you go.
• Be sure to write down the time of the day and the amount you eat.
• It can also help to make a note of any thoughts or feelings linked to eating,
especially if you find you often eat for comfort or when you're not actually
hungry.
Here is an example:
Time Food/Drink Item How Much WhereIWho With MoodlThoughts
8am Orange juice. 1 glass Home with family Rushing to get everything
organised
9am Choc-chip cookies. 2 Coffee shop - alone Stressed, needed something
Coffee. 1 large mug sweet
Cheese & ham sandwich 2 rounds - white bread
Noon Packet of crisps Ready salted (walkers) Alone, watching TV Bored
Diet coke 1 lar:g_e_glass
It also helps to track your activity.
• Include chores and housework as activity as well as any kind of structured
activity or exercise.
• Remember to record how long you take part in the activity and how hard you
worked.
• Try using a scale of 1-10 to indicate how hard you are working. 1 = really
easy, 10 = working really hard.
• It's also worth jotting down how you were feeling before/during/after your
activity. It might remind you how good you felt last time and encourage you
to do it again!
Time Activity
Time Spent How Hard Were
MoodlThoughtsDoing Activity You Working
12:30pm Walking 30 minutes 6 Felt tired but once I got started felt more energetic
6pm Hoovering 20 minutes 5 Usually takes 30 mins but worked harder
7:30pm Aerobics Class 50 minutes 8 Went with a friend, good motivation 236
Food Diary
DAY 1:
Time Food/Drink Item How Much WherelWho With MoodlThoughts
DAY2:
Time Food/Drink Item How Much WherelWho With MoodlThoughts
DAY3:
Time Food/Drink Item How Much WherelWho With MoodlThou_g_hts
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Exercise Diary
DAY 1:
Time Activity
Time Spent How Hard Were You
Doing Activity Working Moodrrhoughts
DAY2:
Time Activity
Time Spent How Hard Were You
MoodrrhoughtsDoing Activity Working
DAY3:
Time Activity
Time Spent How Hard Were You
MoodrrhoughtsDoing Activity Working
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Appendix 11 - Physical Self-Perception Profile
WHAT AM I LIKE?
These are statements which allow people to describe themselves.
There are no right or wrong answers since people differ a lot.
First, decide which one of the two statements best describes you.
Then, go to that side of the statement and check if it is just
'sort of true' or 'really true' FOR YOU.
Really
true
forme
Sort
of
true
for
me
Sort of Really
true true
for me for me
I am not quite so
_j U I am very competitive BUT competitive U LL....-----l L._____J----------'--- ----t______.J ..._____.
REMEMBER to check only ONE of the four boxes
1. DD I am not very I always feel confident DDconfident about my that I maintainlevel of physical BUT excellent conditioningconditioning and and fitness
fitness
2. DD I feel that compared I feel that compared toDDto most, I have an BUT most, my body is not
attractive body quite so attractive
3.
DD I feel extremely proud I am sometimes not DDof who I am and what BUT quite so proud of who I
I can do physically am physically
4. I make certain that I I don't often manageDD take part in some DDform of regular BUT to keep up regularvigorous physicalvigorous physical
exerciseexercise
5. DD I feel that I have I feel that I am easily DDdifficulty maintaining BUT able to keep my body
an attractive body looking attractive
6. I am some-times not I always feel happyDD so happy with the DDBUT about the kind ofway I am or what I person I am physically
can physically do
7. DD I do not usually have I always maintain a DDhigh levels of stamina BUT high level of stamina
and fitness and fitness
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8. I feel embarrassed by I do not feel DDDD my body when it BUT embarrassed by mycomes to wearing body when it comes to
few clothes wearing few clothes
9. When it comes to the BUT I seem to have a realDD physical side of sense of confidence in 0 0myself I do not feel the physical side of
very confident myself
10. I tend to feel a little BUT I feel confident and atDD ease at all times in DDuneasy in fitness and fitness and exercise
exercise settings settings
11'00
I feel that I am often I rarely feel that I DDadmired because my BUT receive admiration forphysique or figure is the way my body looks
considered attractive
12. I always have a really I sometimes do notDD positive feeling about BUT feel positive about the DDthe physical side of physical side of myselfmyself
13'00 I feel extremely I don't feel quite as DDconfident about my confident about my
ability to maintain BUT ability to maintain
regular exercise and regular exercise and
physical condition physical condition
14. I feel that compared I feel that compared to
DD to most, my body BUT most my body always DDdoes not look in the look in excellent
best of sha~e _Rhysical shape
15.DD I wish that I could I always have great DDhave more respect BUT respect for my
for my physical self
_ ..- physical self
16. I feel that compared I feel that compared toDD to most I always DDmost my level ofmaintain a high level BUT physical conditioningof physical is not usually so highconditioning
17'00
I am extremely I am a little self-
DDconfident about the BUT conscious about theappearance of my appearance of my
__ b9dy__ body
18. I am extremely I sometimes feel aDD satisfied with the kind DDof person I am BUT little dissatisfied with
___QI:lysically my physical self----
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Appendix 12 - Physical self perception profile scoring sheet
pspp Item Scores (r == reverse scoring)
Physical Condition Body Attractiveness Physical Self-Worth
1: 2r: 3r:
4r: 5: 6:
7: 8: 9:
10: 11r: 12r:
13r: 14: 15:
16r: 17r: 18r:
Total: Total: Total:
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Appendix 13 - Participation information sheet (Study Three)
You are asked to read this form carefully. If you consent to take part then you
should sign the consent form. If you have any query, or are unsure or
uncertain about anything, then you should not sign until you problem has
been resolved and you are completely happy to partake.
Amongst other things, this programme monitors body composition. Body
composition is a technical term used to describe the different components
that make up a person's body weight, and refers primarily to the distribution
of muscle and fat in the body. In order to determine your body composition,
various measurements of your body will be taken, such as circumferences
and simple skinfold-thickness measurements. These will be measured using
a measuring tape (A) and a device called a skinfold caliper (B).
A These measurements are painless and will be carried out in a
private environment with no-one present other than the
measurer. You are asked to wear loose fitting clothing when you
are having your measurements recorded and it is estimated that
the recording of these measurements will require approximately
45 minutes to one hour.
B
The screening will enable us to provide you with information
about your current health status. We will provide information
about your body shape (somatotype) and frame as well as
indications regarding your fat distribution. These measures will
help us provide you with some guidance and suggestions for
optimizing your health.
Cholesterol, blood glucose and triglyceride levels will be measured by a
single finger prick to obtain a small blood sample (C). A small droplet of
blood is then transferred to a test strip (0) and this test strip is then inserted
in to the meter (E) to obtain your cholesterol/glucose measurement. Blood
pressure will be recorded using a standard blood pressure monitor and will
involve you wearing an arm cuff for a short while (F).
c D E F
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You will be required to fast for 12 hours prior to the measurements being
taken, therefore we ask that you attend an early morning session in the
Department of Sport & Exercise Science at the University of Portsmouth,
having not consumed any food.
Any information obtained during this trial will remain confidential as to your
identity: if it can be specifically identified with you, your permission will be
sought in writing before it will be published. Other material, which cannot be
identified with you, will be published or presented at meetings with the aim of
benefiting others. All information will be subject to the conditions of the Data
Protection Act 1998 and subsequent statutory instruments.
You may at any time withdraw from the programme. You do not have to give
any reason, and no one can attempt to dissuade you. If you ever require any
further explanation, please do not hesitate to contact the people listed below.
This trial has received ethical and scientific approval to be undertaken, in
accordance with current University regulations.
Contact details:
PrinciDal Measurer
Nikki Brown
Tel: 02392 XX XXXX
nikki. brown@xxxxxxxx
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Appendix 14 - Consent form (Study Three)
Please initial the boxes and sign below:
1) I have read the information sheet, which provides full details ofD
the blood screening, and have had the opportunity to raise and
discuss my questions with either the Project Officer: Dr Clare
Hencken or the Principal measurer: Nikki Brown. I understand
what is expected of me with regard to the general nature, object,
potential risks and duration of the programme.
2) I understand that in addition to the body composition measures
and health measures that will be taken, measures of cholesterol,
blood glucose and triglyceride levels will also be taken. D
3) I give my full consent to my participation in this programme.
This consent is specific to the particular details described in the
information sheet attached, and shall not be taken to imply myD
consent to participate in any subsequent data collection or
deviation from that detailed here.
4) I understand that my participation is voluntary and that I am
free to withdraw at any time and will suffer no penalty as a result.
D
Signed .
Name . Oate .
Witnessed .
Name . Oate .
Name .
Project Officer/Principal measurer
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